| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 166,890 | USD 77,268,401 0.8% | USD 462.990.8% | |
| AMGN (Amgen Inc) | 209,469 | USD 69,954,2670.7% | USD 333.960.7% | |
| REGN (Regeneron Pharmaceuticals Inc) | 68,723 | USD 53,858,902 -0.2% | USD 783.71-0.2% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 87,919 | USD 35,228,2640.5% | USD 400.690.5% | |
| INSM (Insmed Inc) | 141,916 | USD 25,178,7370.4% | USD 177.420.4% | |
| BIIB (Biogen Inc) | 97,622 | USD 17,213,6870.9% | USD 176.330.9% | |
| ARGX (argenx NV ADR) | 19,375 | USD 16,467,7810.5% | USD 849.950.5% | |
| UTHR (United Therapeutics Corporation) | 28,651 | USD 14,744,9510.8% | USD 514.640.8% | |
| ILMN (Illumina Inc) | 101,674 | USD 13,758,526-0.6% | USD 135.32-0.6% | |
| INCY (Incyte Corporation) | 130,644 | USD 13,121,883-0.5% | USD 100.44-0.5% | |
| RPRX (Royalty Pharma Plc) | 284,298 | USD 11,158,697-0.4% | USD 39.25-0.4% | |
| MEDP (Medpace Holdings Inc) | 18,742 | USD 10,717,8000.4% | USD 571.860.4% | |
| RVMD (Revolution Medicines Inc) | 128,637 | USD 10,444,0381.1% | USD 81.191.1% | |
| ROIV (Roivant Sciences Ltd) | 462,799 | USD 10,412,9780.2% | USD 22.50.2% | |
| BBIO (BridgeBio Pharma Inc) | 128,231 | USD 9,813,5180.2% | USD 76.530.2% | |
| NBIX (Neurocrine Biosciences Inc) | 66,348 | USD 9,748,512-0.2% | USD 146.93-0.2% | |
| VTRS (Viatris Inc) | 766,417 | USD 9,380,9441.8% | USD 12.241.8% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,117 | USD 9,112,8300.1% | USD 602.820.1% | |
| SMMT (Summit Therapeutics PLC) | 495,374 | USD 9,104,9741.4% | USD 18.381.4% | |
| GH (Guardant Health Inc) | 86,093 | USD 8,814,201-0.1% | USD 102.38-0.1% | |
| ASND (Ascendis Pharma AS) | 40,861 | USD 8,695,6291.7% | USD 212.811.7% | |
| IONS (Ionis Pharmaceuticals Inc) | 107,782 | USD 8,692,6180.4% | USD 80.650.4% | |
| SNY (Sanofi ADR) | 176,084 | USD 8,515,4220.1% | USD 48.360.1% | |
| MRNA (Moderna Inc) | 259,966 | USD 8,513,8871.4% | USD 32.751.4% | |
| EXEL (Exelixis Inc) | 178,410 | USD 8,297,849-0.2% | USD 46.51-0.2% | |
| BMRN (Biomarin Pharmaceutical Inc) | 127,837 | USD 7,690,674-1.6% | USD 60.16-1.6% | |
| RNA (Avidity Biosciences Inc) | 100,269 | USD 7,237,4160.1% | USD 72.180.1% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,429 | USD 6,905,2730.8% | USD 170.80.8% | |
| BNTX (BioNTech SE) | 67,280 | USD 6,393,6180.9% | USD 95.030.9% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,375 | USD 6,336,1910.4% | USD 70.110.4% | |
| HALO (Halozyme Therapeutics Inc) | 78,252 | USD 5,353,2190.1% | USD 68.410.1% | |
| CYTK (Cytokinetics Inc) | 81,361 | USD 5,221,7491.4% | USD 64.181.4% | |
| AXSM (Axsome Therapeutics Inc) | 33,551 | USD 5,154,776-0.4% | USD 153.64-0.4% | |
| NUVL (Nuvalent Inc) | 47,878 | USD 5,063,5770.9% | USD 105.760.9% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,406 | USD 4,985,462-0.1% | USD 112.27-0.1% | |
| KRYS (Krystal Biotech Inc) | 19,297 | USD 4,849,143-0.8% | USD 251.29-0.8% | |
| PRAX (Praxis Precision Medicines Inc) | 16,639 | USD 4,571,732-0.4% | USD 274.76-0.4% | |
| PTCT (PTC Therapeutics Inc) | 53,425 | USD 4,186,9170.9% | USD 78.370.9% | |
| PCVX (Vaxcyte Inc) | 87,104 | USD 4,150,506-0.3% | USD 47.65-0.3% | |
| COGT (Cogent Biosciences Inc) | 102,145 | USD 4,058,221-1.1% | USD 39.73-1.1% | |
| KYMR (Kymera Therapeutics Inc) | 47,876 | USD 3,979,932-0.5% | USD 83.13-0.5% | |
| PTGX (Protagonist Therapeutics Inc) | 41,603 | USD 3,696,0110.1% | USD 88.840.1% | |
| CRSP (Crispr Therapeutics AG) | 63,419 | USD 3,596,4910.4% | USD 56.710.4% | |
| SRRK (Scholar Rock Holding Corp) | 68,639 | USD 3,147,785-0.1% | USD 45.86-0.1% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 112,581 | USD 3,137,6320.1% | USD 27.870.1% | |
| IMVT (Immunovant Inc) | 116,630 | USD 3,135,0140.4% | USD 26.880.4% | |
| ALKS (Alkermes Plc) | 109,872 | USD 3,133,5490.1% | USD 28.520.1% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,463 | USD 3,098,626-2.2% | USD 69.69-2.2% | |
| ADMA (ADMA Biologics Inc) | 158,361 | USD 3,094,3740.3% | USD 19.540.3% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,139 | USD 3,075,501-0.3% | USD 48.71-0.3% | |
| FOLD (Amicus Therapeutics Inc) | 205,295 | USD 2,925,4540.3% | USD 14.250.3% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,491 | USD 2,849,5821.0% | USD 78.091.0% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,198 | USD 2,761,4890.9% | USD 80.750.9% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 209,174 | USD 2,692,0690.2% | USD 12.870.2% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,092 | USD 2,580,957-0.1% | USD 197.14-0.1% | |
| ACLX (Arcellx Inc) | 38,476 | USD 2,539,4160.7% | USD 660.7% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,504 | USD 2,400,2930.5% | USD 29.450.5% | |
| TVTX (Travere Therapeutics Inc) | 59,540 | USD 2,398,27113.9% | USD 40.2813.9% | |
| GRAL (GRAIL, LLC) | 25,832 | USD 2,372,9280.5% | USD 91.860.5% | |
| VERA (Vera Therapeutics Inc) | 42,545 | USD 2,368,4803.3% | USD 55.673.3% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,247 | USD 2,330,6600.5% | USD 82.510.5% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,424 | USD 2,314,5941.1% | USD 45.011.1% | |
| VCYT (Veracyte Inc) | 52,601 | USD 2,249,745-0.3% | USD 42.77-0.3% | |
| RARE (Ultragenyx) | 64,200 | USD 2,220,0361.3% | USD 34.581.3% | |
| CGON (CG Oncology, Inc. Common stock) | 53,416 | USD 2,144,1180.2% | USD 40.140.2% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,191 | USD 2,118,2461.4% | USD 25.161.4% | |
| IDYA (Ideaya Biosciences Inc) | 58,340 | USD 2,081,5710.8% | USD 35.680.8% | |
| WVE (Wave Life Sciences Ltd) | 111,236 | USD 2,030,0574.4% | USD 18.254.4% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,158 | USD 1,975,4400.1% | USD 51.770.1% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,663 | USD 1,971,1760.2% | USD 37.430.2% | |
| DYN (Dyne Therapeutics Inc) | 95,030 | USD 1,933,861-0.3% | USD 20.35-0.3% | |
| EWTX (Edgewise Therapeutics Inc) | 70,444 | USD 1,922,41725.5% | USD 27.2925.5% | |
| BEAM (Beam Therapeutics Inc) | 67,523 | USD 1,900,0971.3% | USD 28.141.3% | |
| OCUL (Ocular Therapeutix Inc) | 141,749 | USD 1,801,630-0.2% | USD 12.71-0.2% | |
| SYRE (Spyre Therapeutics Inc.) | 51,628 | USD 1,706,305-0.5% | USD 33.05-0.5% | |
| ADPT (Adaptive Biotechnologies Corp) | 101,582 | USD 1,694,388-0.4% | USD 16.68-0.4% | |
| DNLI (Denali Therapeutics Inc) | 97,583 | USD 1,657,9351.1% | USD 16.991.1% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,200 | USD 1,648,6561.7% | USD 25.681.7% | |
| SRPT (Sarepta Therapeutics Inc) | 70,814 | USD 1,580,5681.5% | USD 22.321.5% | |
| RXRX (Recursion Pharmaceuticals Inc) | 342,108 | USD 1,505,2750.9% | USD 4.40.9% | |
| HRMY (Harmony Biosciences Holdings) | 38,321 | USD 1,474,9750.1% | USD 38.490.1% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,335 | USD 1,436,596-0.8% | USD 27.45-0.8% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 87,720 | USD 1,427,6430.4% | USD 16.2750.4% | |
| IBRX (Immunitybio Inc) | 654,976 | USD 1,401,6491.9% | USD 2.141.9% | |
| TWST (Twist Bioscience Corp) | 40,691 | USD 1,366,404-0.8% | USD 33.58-0.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 49,791 | USD 1,337,3860.3% | USD 26.860.3% | |
| GMAB (Genmab AS) | 38,895 | USD 1,311,5390.2% | USD 33.720.2% | |
| NRIX (Nurix Therapeutics Inc) | 67,450 | USD 1,305,8320.4% | USD 19.360.4% | |
| TXG (10X Genomics Inc) | 77,496 | USD 1,293,4081.2% | USD 16.691.2% | |
| LEGN (Legend Biotech Corp) | 56,030 | USD 1,287,5690.6% | USD 22.980.6% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,024 | USD 1,275,720-0.1% | USD 42.49-0.1% | |
| VCEL (Vericel Corp Ord) | 33,649 | USD 1,263,8560.5% | USD 37.560.5% | |
| SNDX (Syndax Pharmaceuticals Inc) | 57,826 | USD 1,249,042-0.5% | USD 21.6-0.5% | |
| HROW (Harrow Health Inc) | 24,641 | USD 1,235,9932.1% | USD 50.162.1% | |
| ANIP (ANI Pharmaceuticals Inc) | 14,944 | USD 1,228,0981.8% | USD 82.181.8% | |
| STOK (Stoke Therapeutics Inc) | 38,006 | USD 1,222,6531.0% | USD 32.171.0% | |
| MNKD (MannKind Corp) | 204,294 | USD 1,211,463 | USD 5.93 | |
| DVAX (Dynavax Technologies Corporation) | 78,122 | USD 1,201,51638.2% | USD 15.3838.2% | |
| AGIO (Agios Pharm) | 38,800 | USD 1,131,79618.6% | USD 29.1718.6% | |
| PHVS (Pharvaris BV) | 42,620 0.0% | USD 1,105,1370.3% | USD 25.930.3% | |
| FTRE (Fortrea Holdings Inc.) | 61,380 | USD 1,086,426-1.2% | USD 17.7-1.2% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,072 | USD 1,078,5542.3% | USD 7.72.3% | |
| TSHA (Taysha Gene Therapies Inc) | 182,239 | USD 1,077,0323.5% | USD 5.913.5% | |
| IMCR (Immunocore Holdings Ltd) | 28,995 | USD 1,060,3471.1% | USD 36.571.1% | |
| QURE (Uniqure NV) | 41,449 | USD 1,044,1004.2% | USD 25.194.2% | |
| COLL (Collegium Pharmaceutical Inc) | 21,037 | USD 1,043,0141.5% | USD 49.581.5% | |
| NVCR (Novocure Ltd) | 74,506 | USD 1,001,3611.3% | USD 13.441.3% | |
| RLAY (Relay Therapeutics Inc) | 115,305 | USD 997,3884.1% | USD 8.654.1% | |
| PGEN (Precigen Inc) | 235,390 | USD 986,2842.9% | USD 4.192.9% | |
| INVA (Innoviva Inc) | 49,745 | USD 983,4591.3% | USD 19.771.3% | |
| ARDX (Ardelyx Inc) | 161,646 | USD 968,2603.3% | USD 5.993.3% | |
| ANAB (AnaptysBio Inc) | 18,426 | USD 921,484-0.1% | USD 50.01-0.1% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,063 | USD 912,5571.5% | USD 12.491.5% | |
| MNMD (Mind Medicine Inc) | 65,542 | USD 880,229-4.2% | USD 13.43-4.2% | |
| SVRA (Savara Inc) | 135,364 | USD 866,330-0.6% | USD 6.4-0.6% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,334 | USD 835,9182.4% | USD 17.662.4% | |
| AMPH (Amphastar P) | 30,572 | USD 819,6351.4% | USD 26.811.4% | |
| SANA (Sana Biotechnology Inc) | 176,229 | USD 798,317 | USD 4.53 | |
| XERS (Xeris Pharmaceuticals Inc) | 110,376 | USD 795,811-1.0% | USD 7.21-1.0% | |
| TNGX (Tango Therapeutics Inc) | 89,588 | USD 779,4162.0% | USD 8.72.0% | |
| CSTL (Castle Biosciences Inc) | 19,415 | USD 778,347-0.3% | USD 40.09-0.3% | |
| SPRY (Silverback Therapeutics Inc) | 65,762 | USD 754,9484.1% | USD 11.484.1% | |
| NVAX (Novavax Inc) | 107,876 | USD 748,6592.1% | USD 6.942.1% | |
| PCRX (Pacira BioSciences, Inc.) | 28,627 | USD 744,8751.1% | USD 26.021.1% | |
| URGN (UroGen Pharma Ltd) | 31,146 | USD 740,0291.5% | USD 23.761.5% | |
| ABCL (Abcellera Biologics Inc) | 197,787 | USD 735,7680.8% | USD 3.720.8% | |
| NTLA (Intellia Therapeutics Inc) | 76,686 | USD 735,4191.8% | USD 9.591.8% | |
| XNCR (Xencor Inc) | 47,508 | USD 733,999-0.1% | USD 15.45-0.1% | |
| GRFS (Grifols SA ADR) | 81,152 | USD 732,803-0.9% | USD 9.03001-0.9% | |
| IOVA (Iovance Biotherapeutics Inc) | 250,495 | USD 718,9211.8% | USD 2.871.8% | |
| RAPT (RAPT Therapeutics Inc) | 18,441 | USD 660,9251.2% | USD 35.841.2% | |
| ELVN (Enliven Therapeutics Inc.) | 38,987 | USD 652,2531.2% | USD 16.731.2% | |
| ERAS (Erasca Inc) | 188,722 | USD 647,3161.2% | USD 3.431.2% | |
| DAWN (Day One Biopharmaceuticals Inc) | 66,753 | USD 640,829-0.3% | USD 9.6-0.3% | |
| KURA (Kura Oncology Inc) | 57,884 | USD 640,1972.5% | USD 11.062.5% | |
| TBPH (Theravance Biopharma Inc) | 33,112 | USD 620,1880.9% | USD 18.730.9% | |
| ABUS (Arbutus Biopharma Corp) | 127,932 | USD 612,7942.4% | USD 4.792.4% | |
| GERN (Geron Corporation) | 414,795 | USD 580,7135.3% | USD 1.45.3% | |
| JANX (Janux Therapeutics Inc) | 39,228 | USD 561,3531.3% | USD 14.311.3% | |
| VIR (Vir Biotechnology Inc) | 90,239 | USD 551,3602.0% | USD 6.112.0% | |
| PAHC (Phibro Animal Health Corporation) | 14,179 | USD 535,1150.9% | USD 37.740.9% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,123 | USD 532,1271.9% | USD 8.431.9% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,631 | USD 531,0330.3% | USD 15.790.3% | |
| LYEL (Lyell Immunopharma Inc) | 13,573 | USD 523,9183.4% | USD 38.63.4% | |
| REPL (Replimune Group Inc) | 51,900 | USD 523,6713.8% | USD 10.093.8% | |
| ARVN (Arvinas Inc) | 42,724 | USD 519,951-0.1% | USD 12.17-0.1% | |
| RGNX (Regenxbio Inc) | 33,671 | USD 486,8830.8% | USD 14.460.8% | |
| ZLAB (Zai Lab Ltd) | 26,041 | USD 483,8426.3% | USD 18.586.3% | |
| PRME (Prime Medicine, Inc. Common Stock) | 123,484 | USD 440,838-3.3% | USD 3.57-3.3% | |
| VTYX (Ventyx Biosciences Inc) | 47,460 | USD 435,6831.2% | USD 9.181.2% | |
| KROS (Keros Therapeutics Inc) | 20,266 | USD 432,882-0.1% | USD 21.36-0.1% | |
| FULC (Fulcrum Therapeutics Inc) | 36,002 | USD 432,3841.9% | USD 12.011.9% | |
| MGTX (MeiraGTx Holdings PLC) | 51,465 | USD 425,6165.1% | USD 8.270015.1% | |
| CGEM (Cullinan Oncology LLC) | 38,613 | USD 396,1692.6% | USD 10.262.6% | |
| PACB (Pacific Biosciences of California) | 200,762 | USD 377,4333.3% | USD 1.883.3% | |
| PRTA (Prothena Corporation plc) | 38,806 | USD 376,0302.1% | USD 9.692.1% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,180 | USD 352,6671.6% | USD 3.261.6% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,437 | USD 318,2420.3% | USD 3.30.3% | |
| SIGA (SIGA Technologies Inc) | 49,753 | USD 311,9510.6% | USD 6.269990.6% | |
| GLPG (Galapagos NV ADR) | 9,284 | USD 306,2790.2% | USD 32.990.2% | |
| EOLS (Evolus Inc) | 43,107 | USD 295,2830.6% | USD 6.850.6% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,358 | USD 286,4002.5% | USD 8.100012.5% | |
| VNDA (Vanda Pharmaceuticals Inc) | 38,893 | USD 268,7511.0% | USD 6.910011.0% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,592 | USD 265,3281.7% | USD 3.511.7% | |
| TRDA (Entrada Therapeutics Inc) | 25,044 | USD 264,966-0.5% | USD 10.58-0.5% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,537 | USD 234,4240.7% | USD 6.990010.7% | |
| AVXL (Anavex Life Sciences Corp) | 60,781 | USD 226,105-0.3% | USD 3.71999-0.3% | |
| ACIU (AC Immune Ltd) | 70,752 | USD 221,454-0.6% | USD 3.13-0.6% | |
| ACRS (Aclaris Therapeutics Inc) | 72,019 | USD 218,9384.8% | USD 3.044.8% | |
| ALLO (Allogene Therapeutics Inc) | 155,171 | USD 217,2392.9% | USD 1.42.9% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,371 | USD 214,9235.5% | USD 3.625.5% | |
| AUTL (Autolus Therapeutics Ltd) | 125,814 | USD 211,3682.4% | USD 1.682.4% | |
| OABI (OmniAb Inc.) | 87,393 | USD 171,2901.0% | USD 1.961.0% | |
| EDIT (Editas Medicine Inc) | 67,919 | USD 150,1010.9% | USD 2.210.9% | |
| VYGR (Voyager Therapeutics Inc) | 36,440 | USD 148,3112.0% | USD 4.070012.0% | |
| CABA (Cabaletta Bio Inc) | 63,971 | USD 140,0960.5% | USD 2.189990.5% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,189 | USD 131,2291.1% | USD 6.500021.1% | |
| HUMA (Humacyte Inc) | 115,218 | USD 124,435-4.4% | USD 1.08-4.4% | |
| CRBU (Caribou Biosciences Inc) | 62,117 | USD 106,8413.6% | USD 1.723.6% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 166,890 -2.7% | USD 76,637,557-3.0% | USD 459.21-0.2% | |
| AMGN (Amgen Inc) | 209,469 -2.7% | USD 69,436,879-2.7% | USD 331.490.0% | |
| REGN (Regeneron Pharmaceuticals Inc) | 68,723 -2.7% | USD 53,959,238-2.0% | USD 785.170.7% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 87,919 -2.7% | USD 35,053,305-4.9% | USD 398.7-2.2% | |
| INSM (Insmed Inc) | 141,916 -2.7% | USD 25,086,491-2.2% | USD 176.770.6% | |
| BIIB (Biogen Inc) | 97,622 -2.7% | USD 17,066,278-2.7% | USD 174.820.1% | |
| ARGX (argenx NV ADR) | 19,375 -2.7% | USD 16,390,281-3.4% | USD 845.95-0.7% | |
| UTHR (United Therapeutics Corporation) | 28,651 -2.7% | USD 14,624,616-3.4% | USD 510.44-0.7% | |
| ILMN (Illumina Inc) | 101,674 -2.7% | USD 13,846,982-3.7% | USD 136.19-1.0% | |
| INCY (Incyte Corporation) | 130,644 -2.7% | USD 13,183,286-2.5% | USD 100.910.2% | |
| RPRX (Royalty Pharma Plc) | 284,298 -2.7% | USD 11,198,498-1.4% | USD 39.391.4% | |
| MEDP (Medpace Holdings Inc) | 18,742 -2.7% | USD 10,677,317-3.1% | USD 569.7-0.3% | |
| ROIV (Roivant Sciences Ltd) | 462,799 -2.7% | USD 10,389,838-3.7% | USD 22.45-1.0% | |
| RVMD (Revolution Medicines Inc) | 128,637 -2.7% | USD 10,325,692-3.1% | USD 80.27-0.4% | |
| BBIO (BridgeBio Pharma Inc) | 128,231 -2.7% | USD 9,796,848-3.6% | USD 76.4-0.9% | |
| NBIX (Neurocrine Biosciences Inc) | 66,348 -2.7% | USD 9,771,733-2.9% | USD 147.28-0.2% | |
| VTRS (Viatris Inc) | 766,417 -2.7% | USD 9,212,332-2.6% | USD 12.020.1% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,117 -2.7% | USD 9,103,609-2.8% | USD 602.21-0.1% | |
| SMMT (Summit Therapeutics PLC) | 495,374 -2.7% | USD 8,976,177-2.9% | USD 18.12-0.2% | |
| GH (Guardant Health Inc) | 86,093 -2.7% | USD 8,824,533-1.6% | USD 102.51.1% | |
| IONS (Ionis Pharmaceuticals Inc) | 107,782 -2.7% | USD 8,658,128-3.9% | USD 80.33-1.2% | |
| ASND (Ascendis Pharma AS) | 40,861 -2.7% | USD 8,549,347-2.8% | USD 209.23-0.1% | |
| SNY (Sanofi ADR) | 176,084 -2.7% | USD 8,508,379-2.1% | USD 48.320.6% | |
| MRNA (Moderna Inc) | 259,966 -2.7% | USD 8,394,302-10.0% | USD 32.29-7.5% | |
| EXEL (Exelixis Inc) | 178,410 -2.7% | USD 8,315,690-1.8% | USD 46.610.9% | |
| BMRN (Biomarin Pharmaceutical Inc) | 127,837 -2.7% | USD 7,815,9540.3% | USD 61.143.1% | |
| RNA (Avidity Biosciences Inc) | 100,269 -2.7% | USD 7,233,406-2.8% | USD 72.14-0.1% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 40,429 -2.7% | USD 6,851,503-2.9% | USD 169.47-0.1% | |
| BNTX (BioNTech SE) | 67,280 -2.7% | USD 6,333,739-0.6% | USD 94.142.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 90,375 -2.7% | USD 6,310,886-1.6% | USD 69.831.2% | |
| HALO (Halozyme Therapeutics Inc) | 78,252 -2.7% | USD 5,349,307-2.4% | USD 68.360.3% | |
| AXSM (Axsome Therapeutics Inc) | 33,551 -2.7% | USD 5,173,229-3.0% | USD 154.19-0.3% | |
| CYTK (Cytokinetics Inc) | 81,361 -2.7% | USD 5,149,338-6.2% | USD 63.29-3.5% | |
| NUVL (Nuvalent Inc) | 47,878 -2.7% | USD 5,019,051-3.5% | USD 104.83-0.8% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 44,406 -2.7% | USD 4,989,014-3.2% | USD 112.35-0.5% | |
| KRYS (Krystal Biotech Inc) | 19,297 -2.7% | USD 4,889,088-1.3% | USD 253.361.5% | |
| PRAX (Praxis Precision Medicines Inc) | 16,639 -2.7% | USD 4,587,871-4.4% | USD 275.73-1.7% | |
| PCVX (Vaxcyte Inc) | 87,104 -2.7% | USD 4,164,442-3.3% | USD 47.81-0.5% | |
| PTCT (PTC Therapeutics Inc) | 53,425 -2.7% | USD 4,151,123-4.2% | USD 77.7-1.5% | |
| COGT (Cogent Biosciences Inc) | 102,145 -2.7% | USD 4,103,165-0.7% | USD 40.172.1% | |
| KYMR (Kymera Therapeutics Inc) | 47,876 -2.7% | USD 3,999,082-3.7% | USD 83.53-1.0% | |
| PTGX (Protagonist Therapeutics Inc) | 41,603 -2.7% | USD 3,691,434-1.3% | USD 88.731.5% | |
| CRSP (Crispr Therapeutics AG) | 63,419 -2.7% | USD 3,580,637-5.2% | USD 56.46-2.5% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,463 -2.7% | USD 3,169,7679.6% | USD 71.2912.7% | |
| SRRK (Scholar Rock Holding Corp) | 68,639 -2.7% | USD 3,149,844-1.2% | USD 45.891.5% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 112,581 -2.7% | USD 3,133,129-3.5% | USD 27.83-0.8% | |
| ALKS (Alkermes Plc) | 109,872 -2.7% | USD 3,130,253-3.2% | USD 28.49-0.5% | |
| IMVT (Immunovant Inc) | 116,630 -2.7% | USD 3,121,019-5.5% | USD 26.76-2.8% | |
| ADMA (ADMA Biologics Inc) | 158,361 -2.7% | USD 3,086,456-4.6% | USD 19.49-2.0% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 63,139 -2.7% | USD 3,085,603-3.5% | USD 48.87-0.8% | |
| FOLD (Amicus Therapeutics Inc) | 205,295 -2.7% | USD 2,917,242-2.7% | USD 14.21 | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 36,491 -2.7% | USD 2,820,754-3.6% | USD 77.3-0.9% | |
| MIRM (Mirum Pharmaceuticals Inc) | 34,198 -2.7% | USD 2,737,550-4.0% | USD 80.05-1.3% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 209,174 -2.7% | USD 2,685,794-2.6% | USD 12.840.2% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,092 -2.8% | USD 2,584,230-3.0% | USD 197.39-0.3% | |
| ACLX (Arcellx Inc) | 38,476 -2.7% | USD 2,520,563-2.2% | USD 65.510.5% | |
| ARQT (Arcutis Biotherapeutics Inc) | 81,504 -2.7% | USD 2,388,882-4.7% | USD 29.31-2.0% | |
| GRAL (GRAIL, LLC) | 25,832 -2.7% | USD 2,360,786-5.8% | USD 91.39-3.1% | |
| TARS (Tarsus Pharmaceuticals Inc) | 28,247 -2.7% | USD 2,319,926-2.5% | USD 82.130.2% | |
| VERA (Vera Therapeutics Inc) | 42,545 -2.7% | USD 2,293,601-2.5% | USD 53.910.2% | |
| XENE (Xenon Pharmaceuticals Inc) | 51,424 -2.7% | USD 2,290,425-6.0% | USD 44.54-3.3% | |
| VCYT (Veracyte Inc) | 52,601 -2.7% | USD 2,257,635-3.1% | USD 42.92-0.4% | |
| RARE (Ultragenyx) | 64,200 -2.7% | USD 2,191,146-4.5% | USD 34.13-1.8% | |
| CGON (CG Oncology, Inc. Common stock) | 53,416 -2.7% | USD 2,139,311-2.8% | USD 40.05-0.1% | |
| TVTX (Travere Therapeutics Inc) | 59,540 -2.7% | USD 2,105,334-5.8% | USD 35.36-3.1% | |
| APLS (Apellis Pharmaceuticals Inc) | 84,191 -2.7% | USD 2,089,621-5.0% | USD 24.82-2.3% | |
| IDYA (Ideaya Biosciences Inc) | 58,340 -2.7% | USD 2,065,819-3.0% | USD 35.41-0.3% | |
| SUPN (Supernus Pharmaceuticals Inc) | 38,158 -2.7% | USD 1,973,150-2.3% | USD 51.710.4% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 52,663 -2.7% | USD 1,966,963-3.3% | USD 37.35-0.6% | |
| WVE (Wave Life Sciences Ltd) | 111,236 -2.7% | USD 1,944,405-5.4% | USD 17.48-2.7% | |
| DYN (Dyne Therapeutics Inc) | 95,030 -2.7% | USD 1,939,562-4.5% | USD 20.41-1.8% | |
| BEAM (Beam Therapeutics Inc) | 67,523 -2.7% | USD 1,875,114-3.3% | USD 27.77-0.5% | |
| OCUL (Ocular Therapeutix Inc) | 141,749 -2.7% | USD 1,805,882-4.4% | USD 12.74-1.7% | |
| SYRE (Spyre Therapeutics Inc.) | 51,628 -2.7% | USD 1,715,598-5.5% | USD 33.23-2.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 101,582 -2.7% | USD 1,701,499-6.4% | USD 16.75-3.8% | |
| DNLI (Denali Therapeutics Inc) | 97,583 -2.7% | USD 1,640,370-6.4% | USD 16.81-3.8% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 64,200 -2.7% | USD 1,621,692-3.2% | USD 25.26-0.5% | |
| SRPT (Sarepta Therapeutics Inc) | 70,814 -2.7% | USD 1,557,9080.8% | USD 223.6% | |
| EWTX (Edgewise Therapeutics Inc) | 70,444 -2.7% | USD 1,531,8051.0% | USD 21.7453.8% | |
| RXRX (Recursion Pharmaceuticals Inc) | 342,108 -2.7% | USD 1,491,591-3.6% | USD 4.36-0.9% | |
| HRMY (Harmony Biosciences Holdings) | 38,321 -2.7% | USD 1,473,059-3.8% | USD 38.44-1.1% | |
| OLMA (Olema Pharmaceuticals Inc) | 52,335 -2.7% | USD 1,448,109-4.5% | USD 27.67-1.8% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 87,720 -2.7% | USD 1,421,941-3.3% | USD 16.21-0.6% | |
| TWST (Twist Bioscience Corp) | 40,691 -2.7% | USD 1,376,983-6.1% | USD 33.84-3.5% | |
| IBRX (Immunitybio Inc) | 654,976 -2.7% | USD 1,375,450-10.0% | USD 2.1-7.5% | |
| ZYME (Zymeworks Inc. Common Stock) | 49,791 -2.7% | USD 1,333,901-5.7% | USD 26.79-3.0% | |
| GMAB (Genmab AS) | 38,895 -2.7% | USD 1,308,817-1.0% | USD 33.651.8% | |
| NRIX (Nurix Therapeutics Inc) | 67,450 -2.7% | USD 1,301,111-3.0% | USD 19.29-0.3% | |
| LEGN (Legend Biotech Corp) | 56,030 -2.7% | USD 1,280,286-2.0% | USD 22.850.7% | |
| TXG (10X Genomics Inc) | 77,496 -2.7% | USD 1,278,684-5.3% | USD 16.5-2.6% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,024 -2.7% | USD 1,276,620-5.0% | USD 42.52-2.3% | |
| VCEL (Vericel Corp Ord) | 33,649 -2.7% | USD 1,257,800-2.7% | USD 37.380.0% | |
| SNDX (Syndax Pharmaceuticals Inc) | 57,826 -2.7% | USD 1,254,824-1.7% | USD 21.71.0% | |
| MNKD (MannKind Corp) | 204,294 -2.7% | USD 1,211,463-3.7% | USD 5.93-1.0% | |
| HROW (Harrow Health Inc) | 24,641 -2.7% | USD 1,211,105-3.2% | USD 49.15-0.5% | |
| STOK (Stoke Therapeutics Inc) | 38,006 -2.7% | USD 1,210,871-7.6% | USD 31.86-5.0% | |
| ANIP (ANI Pharmaceuticals Inc) | 14,944 -2.7% | USD 1,206,429-2.7% | USD 80.730.0% | |
| PHVS (Pharvaris BV) | 42,611 -2.8% | USD 1,101,494-7.1% | USD 25.85-4.5% | |
| FTRE (Fortrea Holdings Inc.) | 61,380 -2.7% | USD 1,099,316-1.5% | USD 17.911.2% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 140,072 -2.7% | USD 1,054,742-3.8% | USD 7.53-1.1% | |
| IMCR (Immunocore Holdings Ltd) | 28,995 -2.7% | USD 1,049,329-2.2% | USD 36.190.6% | |
| TSHA (Taysha Gene Therapies Inc) | 182,239 -2.7% | USD 1,040,585-5.2% | USD 5.71-2.6% | |
| COLL (Collegium Pharmaceutical Inc) | 21,037 -2.7% | USD 1,027,657-2.7% | USD 48.850.0% | |
| QURE (Uniqure NV) | 41,449 -2.7% | USD 1,002,237-5.8% | USD 24.18-3.2% | |
| NVCR (Novocure Ltd) | 74,506 -2.7% | USD 988,695-4.0% | USD 13.27-1.3% | |
| INVA (Innoviva Inc) | 49,745 -2.7% | USD 970,525-5.1% | USD 19.51-2.4% | |
| RLAY (Relay Therapeutics Inc) | 115,305 -2.8% | USD 958,185-6.1% | USD 8.31-3.5% | |
| PGEN (Precigen Inc) | 235,390 -2.8% | USD 958,037-9.6% | USD 4.07-7.1% | |
| AGIO (Agios Pharm) | 38,800 -2.7% | USD 954,092-4.1% | USD 24.59-1.4% | |
| ARDX (Ardelyx Inc) | 161,646 -2.8% | USD 937,547-3.4% | USD 5.8-0.7% | |
| ANAB (AnaptysBio Inc) | 18,426 -2.7% | USD 922,037-3.3% | USD 50.04-0.6% | |
| MNMD (Mind Medicine Inc) | 65,542 -2.7% | USD 918,8992.5% | USD 14.025.4% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 73,063 -2.7% | USD 899,406-4.2% | USD 12.31-1.5% | |
| SVRA (Savara Inc) | 135,364 -2.8% | USD 871,744-3.2% | USD 6.44-0.5% | |
| DVAX (Dynavax Technologies Corporation) | 78,122 -2.7% | USD 869,498-3.0% | USD 11.13-0.3% | |
| PHAT (Phathom Pharmaceuticals Inc) | 47,334 -2.7% | USD 816,512-6.1% | USD 17.25-3.5% | |
| AMPH (Amphastar P) | 30,572 -2.7% | USD 808,629-5.8% | USD 26.45-3.2% | |
| XERS (Xeris Pharmaceuticals Inc) | 110,376 -2.8% | USD 803,537-1.8% | USD 7.281.0% | |
| SANA (Sana Biotechnology Inc) | 176,229 -2.8% | USD 798,317-3.6% | USD 4.53-0.9% | |
| CSTL (Castle Biosciences Inc) | 19,415 -2.7% | USD 780,483-5.5% | USD 40.2-2.9% | |
| TNGX (Tango Therapeutics Inc) | 89,588 -2.8% | USD 764,186-3.8% | USD 8.53-1.0% | |
| GRFS (Grifols SA ADR) | 81,152 -2.8% | USD 739,295-2.4% | USD 9.110.3% | |
| PCRX (Pacira BioSciences, Inc.) | 28,627 -2.7% | USD 736,859-3.8% | USD 25.74-1.1% | |
| XNCR (Xencor Inc) | 47,508 -2.8% | USD 734,949-5.8% | USD 15.47-3.1% | |
| NVAX (Novavax Inc) | 107,876 -2.8% | USD 733,557-4.0% | USD 6.8-1.3% | |
| ABCL (Abcellera Biologics Inc) | 197,787 -2.8% | USD 729,834-3.5% | USD 3.69-0.8% | |
| URGN (UroGen Pharma Ltd) | 31,146 -2.7% | USD 728,816-3.5% | USD 23.4-0.8% | |
| SPRY (Silverback Therapeutics Inc) | 65,762 -2.8% | USD 725,355-5.6% | USD 11.03-2.9% | |
| NTLA (Intellia Therapeutics Inc) | 76,686 -2.8% | USD 722,382-5.6% | USD 9.42-2.9% | |
| IOVA (Iovance Biotherapeutics Inc) | 250,495 -2.8% | USD 706,396-1.4% | USD 2.821.4% | |
| RAPT (RAPT Therapeutics Inc) | 18,441 -2.7% | USD 652,811-5.6% | USD 35.4-2.9% | |
| ELVN (Enliven Therapeutics Inc.) | 38,987 -2.8% | USD 644,455-10.3% | USD 16.53-7.8% | |
| DAWN (Day One Biopharmaceuticals Inc) | 66,753 -2.8% | USD 642,831-2.2% | USD 9.629990.6% | |
| ERAS (Erasca Inc) | 188,722 -2.8% | USD 639,768-9.7% | USD 3.39-7.1% | |
| KURA (Kura Oncology Inc) | 57,884 -2.8% | USD 624,568-6.9% | USD 10.79-4.3% | |
| TBPH (Theravance Biopharma Inc) | 33,112 -2.7% | USD 614,890-4.0% | USD 18.57-1.3% | |
| ABUS (Arbutus Biopharma Corp) | 127,932 -2.8% | USD 598,722-3.6% | USD 4.68-0.8% | |
| JANX (Janux Therapeutics Inc) | 39,228 -2.8% | USD 553,899-2.6% | USD 14.120.2% | |
| GERN (Geron Corporation) | 414,795 -2.8% | USD 551,677-4.2% | USD 1.33-1.5% | |
| VIR (Vir Biotechnology Inc) | 90,239 -2.8% | USD 540,532-3.1% | USD 5.99-0.3% | |
| PAHC (Phibro Animal Health Corporation) | 14,179 -2.7% | USD 530,153-3.8% | USD 37.39-1.2% | |
| KALV (Kalvista Pharmaceuticals Inc) | 33,631 -2.7% | USD 529,688-3.3% | USD 15.75-0.6% | |
| ORIC (Oric Pharmaceuticals Inc) | 63,123 -2.8% | USD 522,027-4.3% | USD 8.27-1.5% | |
| ARVN (Arvinas Inc) | 42,724 -2.8% | USD 520,378-3.9% | USD 12.18-1.1% | |
| LYEL (Lyell Immunopharma Inc) | 13,573 -2.8% | USD 506,680-2.9% | USD 37.33-0.1% | |
| REPL (Replimune Group Inc) | 51,900 -2.8% | USD 504,468-4.8% | USD 9.72-2.1% | |
| RGNX (Regenxbio Inc) | 33,671 -2.8% | USD 483,179-6.8% | USD 14.35-4.1% | |
| PRME (Prime Medicine, Inc. Common Stock) | 123,484 -2.8% | USD 455,656-3.0% | USD 3.69-0.3% | |
| ZLAB (Zai Lab Ltd) | 26,041 -2.8% | USD 455,197-4.0% | USD 17.48-1.3% | |
| KROS (Keros Therapeutics Inc) | 20,266 -2.8% | USD 433,287-2.6% | USD 21.380.2% | |
| VTYX (Ventyx Biosciences Inc) | 47,460 -2.8% | USD 430,462-5.6% | USD 9.07-2.9% | |
| FULC (Fulcrum Therapeutics Inc) | 36,002 -2.8% | USD 424,464-10.3% | USD 11.79-7.7% | |
| MGTX (MeiraGTx Holdings PLC) | 51,465 -2.8% | USD 405,030-7.8% | USD 7.87001-5.2% | |
| CGEM (Cullinan Oncology LLC) | 38,613 -2.8% | USD 386,130-6.0% | USD 10-3.3% | |
| PRTA (Prothena Corporation plc) | 38,806 -2.8% | USD 368,269-4.7% | USD 9.49-2.0% | |
| PACB (Pacific Biosciences of California) | 200,762 -2.8% | USD 365,387-2.8% | USD 1.82 | |
| IRWD (Ironwood Pharmaceuticals Inc) | 108,180 -2.8% | USD 347,258-3.4% | USD 3.21-0.6% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 96,437 -2.8% | USD 317,278-8.6% | USD 3.29-6.0% | |
| SIGA (SIGA Technologies Inc) | 49,753 -2.8% | USD 309,961-3.1% | USD 6.23-0.3% | |
| GLPG (Galapagos NV ADR) | 9,284 -2.8% | USD 305,815-1.4% | USD 32.941.4% | |
| EOLS (Evolus Inc) | 43,107 -2.8% | USD 293,559-7.9% | USD 6.81001-5.3% | |
| FDMT (4D Molecular Therapeutics Inc) | 35,358 -2.8% | USD 279,328-11.8% | USD 7.89999-9.3% | |
| TRDA (Entrada Therapeutics Inc) | 25,044 -2.8% | USD 266,218-2.7% | USD 10.630.1% | |
| VNDA (Vanda Pharmaceuticals Inc) | 38,893 -2.8% | USD 266,028-5.4% | USD 6.84-2.7% | |
| RCKT (Rocket Pharmaceuticals Inc) | 75,592 -2.8% | USD 260,792-5.0% | USD 3.44999-2.3% | |
| BCYC (Bicycle Therapeutics Ltd) | 33,537 -2.8% | USD 232,747-6.2% | USD 6.94001-3.5% | |
| AVXL (Anavex Life Sciences Corp) | 60,781 -2.8% | USD 226,713-3.4% | USD 3.73-0.5% | |
| ACIU (AC Immune Ltd) | 70,752 -2.8% | USD 222,869-3.8% | USD 3.15-0.9% | |
| ALLO (Allogene Therapeutics Inc) | 155,171 -2.8% | USD 211,033-10.1% | USD 1.36-7.5% | |
| ACRS (Aclaris Therapeutics Inc) | 72,019 -2.8% | USD 208,855-8.2% | USD 2.9-5.5% | |
| AUTL (Autolus Therapeutics Ltd) | 125,814 -2.8% | USD 206,335-7.9% | USD 1.64-5.2% | |
| AVIR (Atea Pharmaceuticals Inc) | 59,371 -2.8% | USD 203,6435.1% | USD 3.430018.2% | |
| OABI (OmniAb Inc.) | 87,393 -2.9% | USD 169,542-8.1% | USD 1.94-5.4% | |
| EDIT (Editas Medicine Inc) | 67,919 -2.8% | USD 148,743-8.7% | USD 2.19001-6.0% | |
| VYGR (Voyager Therapeutics Inc) | 36,440 -2.8% | USD 145,396-7.9% | USD 3.99001-5.2% | |
| CABA (Cabaletta Bio Inc) | 63,971 -2.9% | USD 139,457-11.4% | USD 2.18-8.8% | |
| HUMA (Humacyte Inc) | 115,218 -2.9% | USD 130,1962.6% | USD 1.135.6% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,189 -2.8% | USD 129,815-5.2% | USD 6.42999-2.4% | |
| CRBU (Caribou Biosciences Inc) | 62,117 -1.4% | USD 103,114-4.8% | USD 1.66-3.5% | |
| FATE (Fate Therapeutics Inc) | 2,206 -38.1% | USD 2,155-42.4% | USD 0.976881-7.0% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| OKUR (OKUR) | 195 | USD 552-4.3% | USD 2.83077-4.3% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 171,570 | USD 78,975,3870.9% | USD 460.310.9% | |
| AMGN (Amgen Inc) | 215,349 | USD 71,364,5051.2% | USD 331.391.2% | |
| REGN (Regeneron Pharmaceuticals Inc) | 70,655 | USD 55,065,6811.5% | USD 779.361.5% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 90,379 | USD 36,850,2301.9% | USD 407.731.9% | |
| INSM (Insmed Inc) | 145,900 | USD 25,643,3840.5% | USD 175.760.5% | |
| BIIB (Biogen Inc) | 100,358 | USD 17,532,543-0.1% | USD 174.7-0.1% | |
| ARGX (argenx NV ADR) | 19,915 | USD 16,968,377-0.3% | USD 852.04-0.3% | |
| UTHR (United Therapeutics Corporation) | 29,455 | USD 15,133,684-0.6% | USD 513.79-0.6% | |
| ILMN (Illumina Inc) | 104,530 | USD 14,383,3282.1% | USD 137.62.1% | |
| INCY (Incyte Corporation) | 134,304 | USD 13,525,756-1.9% | USD 100.71-1.9% | |
| RPRX (Royalty Pharma Plc) | 292,278 | USD 11,357,9230.7% | USD 38.860.7% | |
| MEDP (Medpace Holdings Inc) | 19,270 | USD 11,013,3830.6% | USD 571.530.6% | |
| ROIV (Roivant Sciences Ltd) | 475,783 | USD 10,790,7581.2% | USD 22.681.2% | |
| RVMD (Revolution Medicines Inc) | 132,249 | USD 10,656,6242.3% | USD 80.582.3% | |
| BBIO (BridgeBio Pharma Inc) | 131,831 | USD 10,162,8521.0% | USD 77.091.0% | |
| NBIX (Neurocrine Biosciences Inc) | 68,208 | USD 10,062,7261.7% | USD 147.531.7% | |
| VTRS (Viatris Inc) | 787,921 | USD 9,462,9310.7% | USD 12.010.7% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,537 | USD 9,366,1702.0% | USD 602.832.0% | |
| MRNA (Moderna Inc) | 267,262 | USD 9,327,4443.3% | USD 34.93.3% | |
| SMMT (Summit Therapeutics PLC) | 509,270 | USD 9,243,2511.9% | USD 18.151.9% | |
| IONS (Ionis Pharmaceuticals Inc) | 110,806 | USD 9,012,9602.2% | USD 81.342.2% | |
| GH (Guardant Health Inc) | 88,505 | USD 8,969,0971.6% | USD 101.341.6% | |
| ASND (Ascendis Pharma AS) | 42,001 | USD 8,796,2694.7% | USD 209.434.7% | |
| SNY (Sanofi ADR) | 181,028 | USD 8,694,775-0.3% | USD 48.03-0.3% | |
| EXEL (Exelixis Inc) | 183,414 | USD 8,471,8934.3% | USD 46.194.3% | |
| BMRN (Biomarin Pharmaceutical Inc) | 131,425 | USD 7,790,874-3.1% | USD 59.28-3.1% | |
| RNA (Avidity Biosciences Inc) | 103,077 | USD 7,442,159-0.2% | USD 72.2-0.2% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 41,569 | USD 7,053,0121.6% | USD 169.671.6% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 92,907 | USD 6,410,5831.2% | USD 691.2% | |
| BNTX (BioNTech SE) | 69,164 | USD 6,374,846-0.4% | USD 92.17-0.4% | |
| CYTK (Cytokinetics Inc) | 83,641 -5.1% | USD 5,486,850-0.7% | USD 65.64.6% | |
| HALO (Halozyme Therapeutics Inc) | 80,448 | USD 5,483,3361.2% | USD 68.161.2% | |
| AXSM (Axsome Therapeutics Inc) | 34,487 | USD 5,335,1391.3% | USD 154.71.3% | |
| NUVL (Nuvalent Inc) | 49,222 | USD 5,203,7501.8% | USD 105.721.8% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 45,654 | USD 5,153,4240.7% | USD 112.880.7% | |
| KRYS (Krystal Biotech Inc) | 19,837 | USD 4,951,5143.7% | USD 249.613.7% | |
| PRAX (Praxis Precision Medicines Inc) | 17,107 | USD 4,796,8032.7% | USD 280.42.7% | |
| PTCT (PTC Therapeutics Inc) | 54,925 | USD 4,333,5830.4% | USD 78.90.4% | |
| PCVX (Vaxcyte Inc) | 89,552 | USD 4,304,7653.6% | USD 48.073.6% | |
| KYMR (Kymera Therapeutics Inc) | 49,220 | USD 4,151,7070.4% | USD 84.350.4% | |
| COGT (Cogent Biosciences Inc) | 105,013 | USD 4,131,211-0.5% | USD 39.34-0.5% | |
| CRSP (Crispr Therapeutics AG) | 65,195 | USD 3,775,4423.7% | USD 57.913.7% | |
| PTGX (Protagonist Therapeutics Inc) | 42,767 | USD 3,738,2631.6% | USD 87.411.6% | |
| IMVT (Immunovant Inc) | 119,906 | USD 3,302,2113.2% | USD 27.543.2% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 115,737 | USD 3,247,5803.3% | USD 28.063.3% | |
| ADMA (ADMA Biologics Inc) | 162,813 | USD 3,236,7221.5% | USD 19.881.5% | |
| ALKS (Alkermes Plc) | 112,956 | USD 3,233,9300.6% | USD 28.630.6% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 64,915 | USD 3,196,4152.6% | USD 49.242.6% | |
| SRRK (Scholar Rock Holding Corp) | 70,559 | USD 3,189,2673.0% | USD 45.23.0% | |
| FOLD (Amicus Therapeutics Inc) | 211,067 | USD 2,999,2620.2% | USD 14.210.2% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 37,511 | USD 2,925,858-0.7% | USD 78-0.7% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 45,711 | USD 2,891,221-2.6% | USD 63.25-2.6% | |
| MIRM (Mirum Pharmaceuticals Inc) | 35,158 | USD 2,850,2594.3% | USD 81.074.3% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 215,054 | USD 2,756,9922.0% | USD 12.822.0% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,464 | USD 2,665,333-1.2% | USD 197.96-1.2% | |
| ACLX (Arcellx Inc) | 39,556 | USD 2,578,2601.9% | USD 65.181.9% | |
| ARQT (Arcutis Biotherapeutics Inc) | 83,796 | USD 2,505,5006.7% | USD 29.96.7% | |
| GRAL (GRAIL, LLC) | 26,552 | USD 2,505,1813.6% | USD 94.353.6% | |
| XENE (Xenon Pharmaceuticals Inc) | 52,864 | USD 2,435,9734.5% | USD 46.084.5% | |
| TARS (Tarsus Pharmaceuticals Inc) | 29,039 | USD 2,380,6170.7% | USD 81.980.7% | |
| VERA (Vera Therapeutics Inc) | 43,733 | USD 2,351,9615.0% | USD 53.785.0% | |
| VCYT (Veracyte Inc) | 54,077 | USD 2,330,1780.4% | USD 43.090.4% | |
| RARE (Ultragenyx) | 66,000 | USD 2,293,5003.7% | USD 34.753.7% | |
| TVTX (Travere Therapeutics Inc) | 61,208 | USD 2,234,0925.8% | USD 36.55.8% | |
| CGON (CG Oncology, Inc. Common stock) | 54,916 | USD 2,201,0332.7% | USD 40.082.7% | |
| APLS (Apellis Pharmaceuticals Inc) | 86,555 | USD 2,198,4973.0% | USD 25.43.0% | |
| IDYA (Ideaya Biosciences Inc) | 59,972 | USD 2,129,0065.8% | USD 35.55.8% | |
| WVE (Wave Life Sciences Ltd) | 114,368 | USD 2,055,19312.5% | USD 17.9712.5% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 54,139 | USD 2,033,4612.0% | USD 37.562.0% | |
| DYN (Dyne Therapeutics Inc) | 97,706 | USD 2,030,3314.7% | USD 20.784.7% | |
| SUPN (Supernus Pharmaceuticals Inc) | 39,226 | USD 2,020,1390.0% | USD 51.50.0% | |
| BEAM (Beam Therapeutics Inc) | 69,419 | USD 1,938,1785.1% | USD 27.925.1% | |
| OCUL (Ocular Therapeutix Inc) | 145,745 | USD 1,888,8553.2% | USD 12.963.2% | |
| ADPT (Adaptive Biotechnologies Corp) | 104,438 | USD 1,818,2662.4% | USD 17.412.4% | |
| SYRE (Spyre Therapeutics Inc.) | 53,080 | USD 1,815,3362.4% | USD 34.22.4% | |
| DNLI (Denali Therapeutics Inc) | 100,331 | USD 1,752,7833.7% | USD 17.473.7% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 66,000 | USD 1,675,0802.1% | USD 25.382.1% | |
| RXRX (Recursion Pharmaceuticals Inc) | 351,756 | USD 1,547,7263.3% | USD 4.43.3% | |
| SRPT (Sarepta Therapeutics Inc) | 72,806 | USD 1,545,6710.9% | USD 21.230.9% | |
| HRMY (Harmony Biosciences Holdings) | 39,401 | USD 1,531,1232.8% | USD 38.862.8% | |
| IBRX (Immunitybio Inc) | 673,444 | USD 1,528,7189.1% | USD 2.279.1% | |
| EWTX (Edgewise Therapeutics Inc) | 72,424 | USD 1,516,559-18.0% | USD 20.94-18.0% | |
| OLMA (Olema Pharmaceuticals Inc) | 53,811 | USD 1,516,3940.9% | USD 28.180.9% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 90,192 | USD 1,471,0320.8% | USD 16.310.8% | |
| TWST (Twist Bioscience Corp) | 41,831 | USD 1,466,5957.8% | USD 35.067.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 51,195 | USD 1,414,0061.4% | USD 27.621.4% | |
| TXG (10X Genomics Inc) | 79,680 | USD 1,349,7795.5% | USD 16.945.5% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,864 | USD 1,343,2010.8% | USD 43.520.8% | |
| NRIX (Nurix Therapeutics Inc) | 69,346 | USD 1,341,1524.4% | USD 19.344.4% | |
| GMAB (Genmab AS) | 39,987 | USD 1,321,9702.1% | USD 33.062.1% | |
| STOK (Stoke Therapeutics Inc) | 39,074 | USD 1,309,7604.9% | USD 33.524.9% | |
| LEGN (Legend Biotech Corp) | 57,602 | USD 1,306,9893.5% | USD 22.693.5% | |
| VCEL (Vericel Corp Ord) | 34,597 | USD 1,292,8903.7% | USD 37.373.7% | |
| SNDX (Syndax Pharmaceuticals Inc) | 59,458 | USD 1,277,1583.4% | USD 21.483.4% | |
| MNKD (MannKind Corp) | 210,066 | USD 1,258,2952.6% | USD 5.992.6% | |
| HROW (Harrow Health Inc) | 25,337 | USD 1,251,1416.4% | USD 49.386.4% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,364 | USD 1,240,182-2.6% | USD 80.72-2.6% | |
| PHVS (Pharvaris BV) | 43,820 | USD 1,186,2075.8% | USD 27.075.8% | |
| FTRE (Fortrea Holdings Inc.) | 63,108 | USD 1,116,381-0.3% | USD 17.69-0.3% | |
| TSHA (Taysha Gene Therapies Inc) | 187,387 | USD 1,098,0886.7% | USD 5.866.7% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 144,032 | USD 1,096,0842.7% | USD 7.612.7% | |
| IMCR (Immunocore Holdings Ltd) | 29,811 | USD 1,072,600-0.1% | USD 35.98-0.1% | |
| QURE (Uniqure NV) | 42,613 | USD 1,064,4734.1% | USD 24.984.1% | |
| PGEN (Precigen Inc) | 242,050 | USD 1,060,1791.4% | USD 4.381.4% | |
| COLL (Collegium Pharmaceutical Inc) | 21,625 | USD 1,056,165-0.1% | USD 48.84-0.1% | |
| NVCR (Novocure Ltd) | 76,606 | USD 1,029,5854.7% | USD 13.444.7% | |
| INVA (Innoviva Inc) | 51,149 | USD 1,022,469 | USD 19.99 | |
| RLAY (Relay Therapeutics Inc) | 118,569 | USD 1,020,8792.5% | USD 8.612.5% | |
| AGIO (Agios Pharm) | 39,892 | USD 995,3052.0% | USD 24.952.0% | |
| ARDX (Ardelyx Inc) | 166,218 | USD 970,7132.8% | USD 5.842.8% | |
| ANAB (AnaptysBio Inc) | 18,942 | USD 953,3512.5% | USD 50.332.5% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 75,127 | USD 939,0884.0% | USD 12.54.0% | |
| SVRA (Savara Inc) | 139,192 | USD 900,5726.9% | USD 6.476.9% | |
| DVAX (Dynavax Technologies Corporation) | 80,330 | USD 896,4832.8% | USD 11.162.8% | |
| MNMD (Mind Medicine Inc) | 67,390 | USD 896,2874.7% | USD 13.34.7% | |
| PHAT (Phathom Pharmaceuticals Inc) | 48,666 | USD 869,6611.9% | USD 17.871.9% | |
| AMPH (Amphastar P) | 31,436 | USD 858,8322.7% | USD 27.322.7% | |
| SANA (Sana Biotechnology Inc) | 181,221 | USD 828,1804.8% | USD 4.574.8% | |
| CSTL (Castle Biosciences Inc) | 19,955 | USD 825,9374.9% | USD 41.394.9% | |
| XERS (Xeris Pharmaceuticals Inc) | 113,508 | USD 818,393-1.8% | USD 7.21-1.8% | |
| TNGX (Tango Therapeutics Inc) | 92,132 | USD 794,1781.2% | USD 8.621.2% | |
| XNCR (Xencor Inc) | 48,852 | USD 780,1662.7% | USD 15.972.7% | |
| SPRY (Silverback Therapeutics Inc) | 67,622 | USD 768,1868.3% | USD 11.368.3% | |
| PCRX (Pacira BioSciences, Inc.) | 29,431 | USD 765,795-1.3% | USD 26.02-1.3% | |
| NTLA (Intellia Therapeutics Inc) | 78,858 | USD 764,9235.1% | USD 9.700015.1% | |
| NVAX (Novavax Inc) | 110,936 | USD 764,3493.5% | USD 6.893.5% | |
| GRFS (Grifols SA ADR) | 83,456 | USD 757,7800.7% | USD 9.079990.7% | |
| ABCL (Abcellera Biologics Inc) | 203,403 | USD 756,6593.3% | USD 3.723.3% | |
| URGN (UroGen Pharma Ltd) | 32,022 | USD 755,0793.4% | USD 23.583.4% | |
| ELVN (Enliven Therapeutics Inc.) | 40,091 | USD 718,8326.3% | USD 17.936.3% | |
| IOVA (Iovance Biotherapeutics Inc) | 257,611 | USD 716,15912.1% | USD 2.7812.1% | |
| ERAS (Erasca Inc) | 194,086 -2.5% | USD 708,4143.1% | USD 3.655.8% | |
| RAPT (RAPT Therapeutics Inc) | 18,957 | USD 691,3627.9% | USD 36.477.9% | |
| KURA (Kura Oncology Inc) | 59,528 | USD 670,88114.5% | USD 11.2714.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 68,649 | USD 656,9713.6% | USD 9.573.6% | |
| TBPH (Theravance Biopharma Inc) | 34,048 | USD 640,4430.1% | USD 18.810.1% | |
| ABUS (Arbutus Biopharma Corp) | 131,568 | USD 621,0016.5% | USD 4.726.5% | |
| GERN (Geron Corporation) | 426,627 | USD 575,9461.5% | USD 1.351.5% | |
| JANX (Janux Therapeutics Inc) | 40,344 | USD 568,4472.2% | USD 14.092.2% | |
| VIR (Vir Biotechnology Inc) | 92,807 | USD 557,7704.3% | USD 6.014.3% | |
| PAHC (Phibro Animal Health Corporation) | 14,575 | USD 551,3721.6% | USD 37.831.6% | |
| KALV (Kalvista Pharmaceuticals Inc) | 34,579 | USD 547,7314.0% | USD 15.844.0% | |
| ORIC (Oric Pharmaceuticals Inc) | 64,923 | USD 545,3534.5% | USD 8.44.5% | |
| ARVN (Arvinas Inc) | 43,936 | USD 541,2925.5% | USD 12.325.5% | |
| REPL (Replimune Group Inc) | 53,376 | USD 530,0240.5% | USD 9.930010.5% | |
| LYEL (Lyell Immunopharma Inc) | 13,957 | USD 521,57312.1% | USD 37.3712.1% | |
| RGNX (Regenxbio Inc) | 34,631 | USD 518,4262.6% | USD 14.972.6% | |
| ZLAB (Zai Lab Ltd) | 26,785 | USD 474,362-1.8% | USD 17.71-1.8% | |
| FULC (Fulcrum Therapeutics Inc) | 37,022 | USD 473,1414.1% | USD 12.784.1% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,012 | USD 469,9441.6% | USD 3.71.6% | |
| VTYX (Ventyx Biosciences Inc) | 48,816 | USD 455,9416.9% | USD 9.339996.9% | |
| KROS (Keros Therapeutics Inc) | 20,842 | USD 444,7685.3% | USD 21.345.3% | |
| MGTX (MeiraGTx Holdings PLC) | 52,929 | USD 439,3113.4% | USD 8.300013.4% | |
| CGEM (Cullinan Oncology LLC) | 39,717 | USD 410,6746.8% | USD 10.346.8% | |
| PRTA (Prothena Corporation plc) | 39,910 | USD 386,3295.1% | USD 9.680015.1% | |
| PACB (Pacific Biosciences of California) | 206,534 | USD 375,892-1.1% | USD 1.82-1.1% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 111,288 | USD 359,4603.2% | USD 3.233.2% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 99,209 | USD 347,2322.0% | USD 3.500012.0% | |
| SIGA (SIGA Technologies Inc) | 51,181 | USD 319,881-0.3% | USD 6.25-0.3% | |
| EOLS (Evolus Inc) | 44,343 | USD 318,8261.7% | USD 7.191.7% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,378 | USD 316,8520.3% | USD 8.709990.3% | |
| GLPG (Galapagos NV ADR) | 9,548 | USD 310,1190.4% | USD 32.480.4% | |
| VNDA (Vanda Pharmaceuticals Inc) | 40,021 | USD 281,3484.1% | USD 7.030014.1% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,788 | USD 274,5929.3% | USD 3.539.3% | |
| TRDA (Entrada Therapeutics Inc) | 25,764 | USD 273,614-3.3% | USD 10.62-3.3% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,509 | USD 248,1204.7% | USD 7.190014.7% | |
| ALLO (Allogene Therapeutics Inc) | 159,695 | USD 234,7523.5% | USD 1.473.5% | |
| AVXL (Anavex Life Sciences Corp) | 62,557 | USD 234,5892.2% | USD 3.752.2% | |
| ACIU (AC Immune Ltd) | 72,816 | USD 231,5555.0% | USD 3.185.0% | |
| ACRS (Aclaris Therapeutics Inc) | 74,119 | USD 227,545-2.2% | USD 3.07-2.2% | |
| AUTL (Autolus Therapeutics Ltd) | 129,498 | USD 224,0326.1% | USD 1.736.1% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,111 | USD 193,7221.0% | USD 3.171.0% | |
| OABI (OmniAb Inc.) | 89,973 | USD 184,445-1.9% | USD 2.05-1.9% | |
| EDIT (Editas Medicine Inc) | 69,911 | USD 162,893-0.4% | USD 2.33001-0.4% | |
| VYGR (Voyager Therapeutics Inc) | 37,508 | USD 157,9095.3% | USD 4.210015.3% | |
| CABA (Cabaletta Bio Inc) | 65,855 | USD 157,393 | USD 2.38999 | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,777 | USD 136,9200.9% | USD 6.589980.9% | |
| HUMA (Humacyte Inc) | 118,614 | USD 126,917-3.6% | USD 1.07-3.6% | |
| CRBU (Caribou Biosciences Inc) | 63,001 2.2% | USD 108,3624.6% | USD 1.722.4% | |
| FATE (Fate Therapeutics Inc) | 3,563 -70.0% | USD 3,741-70.0% | USD 1.049960.0% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| OKUR (OKUR) | 195 -59.8% | USD 577-60.5% | USD 2.95897-1.7% | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 171,570 9.7% | USD 78,270,23411.8% | USD 456.22.0% | |
| AMGN (Amgen Inc) | 215,349 1.3% | USD 70,500,9562.2% | USD 327.380.9% | |
| REGN (Regeneron Pharmaceuticals Inc) | 70,655 -7.5% | USD 54,260,214-5.1% | USD 767.962.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 90,379 -5.9% | USD 36,172,387-5.0% | USD 400.231.1% | |
| INSM (Insmed Inc) | 145,900 -6.6% | USD 25,509,156-2.0% | USD 174.845.0% | |
| BIIB (Biogen Inc) | 100,358 -7.4% | USD 17,542,578-4.7% | USD 174.82.9% | |
| ARGX (argenx NV ADR) | 19,915 -12.0% | USD 17,027,126-11.2% | USD 854.990.9% | |
| UTHR (United Therapeutics Corporation) | 29,455 -11.9% | USD 15,232,064-10.1% | USD 517.132.0% | |
| ILMN (Illumina Inc) | 104,530 -8.0% | USD 14,088,553-5.0% | USD 134.783.3% | |
| INCY (Incyte Corporation) | 134,304 -7.0% | USD 13,791,678-1.8% | USD 102.695.5% | |
| RPRX (Royalty Pharma Plc) | 292,278 -8.5% | USD 11,281,931-8.1% | USD 38.60.4% | |
| MEDP (Medpace Holdings Inc) | 19,270 -7.2% | USD 10,952,297-5.9% | USD 568.361.5% | |
| ROIV (Roivant Sciences Ltd) | 475,783 -5.5% | USD 10,662,297-2.8% | USD 22.412.8% | |
| RVMD (Revolution Medicines Inc) | 132,249 -4.4% | USD 10,418,576-0.9% | USD 78.783.7% | |
| BBIO (BridgeBio Pharma Inc) | 131,831 -6.8% | USD 10,058,705-4.1% | USD 76.32.9% | |
| NBIX (Neurocrine Biosciences Inc) | 68,208 -7.0% | USD 9,890,160-4.9% | USD 1452.2% | |
| VTRS (Viatris Inc) | 787,921 -8.3% | USD 9,399,898-8.4% | USD 11.93-0.1% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 15,537 -5.5% | USD 9,182,6782.5% | USD 591.028.6% | |
| SMMT (Summit Therapeutics PLC) | 509,270 -7.3% | USD 9,075,191-3.1% | USD 17.824.6% | |
| MRNA (Moderna Inc) | 267,262 -7.1% | USD 9,033,4561.5% | USD 33.89.2% | |
| GH (Guardant Health Inc) | 88,505 -3.9% | USD 8,827,489-1.3% | USD 99.742.7% | |
| IONS (Ionis Pharmaceuticals Inc) | 110,806 -5.7% | USD 8,816,833-3.4% | USD 79.572.5% | |
| SNY (Sanofi ADR) | 181,028 -8.9% | USD 8,721,929-8.5% | USD 48.180.4% | |
| ASND (Ascendis Pharma AS) | 42,001 -6.6% | USD 8,399,780-6.5% | USD 199.990.1% | |
| EXEL (Exelixis Inc) | 183,414 -7.8% | USD 8,125,240-4.1% | USD 44.34.1% | |
| BMRN (Biomarin Pharmaceutical Inc) | 131,425 -7.4% | USD 8,036,6399.0% | USD 61.1517.7% | |
| RNA (Avidity Biosciences Inc) | 103,077 8.2% | USD 7,456,5908.5% | USD 72.340.3% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 41,569 -7.5% | USD 6,941,607-7.0% | USD 166.990.6% | |
| BNTX (BioNTech SE) | 69,164 -7.2% | USD 6,397,670-6.2% | USD 92.51.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 92,907 -8.9% | USD 6,332,541-6.6% | USD 68.162.5% | |
| CYTK (Cytokinetics Inc) | 88,124 | USD 5,524,4940.8% | USD 62.690.8% | |
| HALO (Halozyme Therapeutics Inc) | 80,448 -6.7% | USD 5,418,173-3.5% | USD 67.353.4% | |
| AXSM (Axsome Therapeutics Inc) | 34,487 -6.3% | USD 5,264,441-2.7% | USD 152.653.8% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 45,654 -7.1% | USD 5,119,640-6.8% | USD 112.140.4% | |
| NUVL (Nuvalent Inc) | 49,222 | USD 5,109,2442.4% | USD 103.82.4% | |
| KRYS (Krystal Biotech Inc) | 19,837 -7.3% | USD 4,776,750-4.3% | USD 240.83.2% | |
| PRAX (Praxis Precision Medicines Inc) | 17,107 9.7% | USD 4,668,84211.2% | USD 272.921.4% | |
| PTCT (PTC Therapeutics Inc) | 54,925 -6.6% | USD 4,315,457-1.6% | USD 78.575.3% | |
| PCVX (Vaxcyte Inc) | 89,552 -6.8% | USD 4,157,004-1.0% | USD 46.426.2% | |
| COGT (Cogent Biosciences Inc) | 105,013 1.3% | USD 4,153,2645.8% | USD 39.554.4% | |
| KYMR (Kymera Therapeutics Inc) | 49,220 -7.0% | USD 4,133,988-1.9% | USD 83.995.5% | |
| PTGX (Protagonist Therapeutics Inc) | 42,767 -7.3% | USD 3,680,100-7.0% | USD 86.050.3% | |
| CRSP (Crispr Therapeutics AG) | 65,195 -3.1% | USD 3,641,793-1.3% | USD 55.861.9% | |
| ALKS (Alkermes Plc) | 112,956 -7.7% | USD 3,213,598-5.6% | USD 28.452.3% | |
| IMVT (Immunovant Inc) | 119,906 -6.7% | USD 3,199,092-5.0% | USD 26.681.9% | |
| ADMA (ADMA Biologics Inc) | 162,813 -7.3% | USD 3,187,879-3.5% | USD 19.584.1% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 115,737 -6.7% | USD 3,143,417-4.8% | USD 27.162.1% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 64,915 -7.2% | USD 3,116,569-1.3% | USD 48.016.4% | |
| SRRK (Scholar Rock Holding Corp) | 70,559 | USD 3,097,5402.3% | USD 43.92.3% | |
| FOLD (Amicus Therapeutics Inc) | 211,067 -7.8% | USD 2,992,93020.1% | USD 14.1830.2% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 45,711 4.1% | USD 2,968,4728.2% | USD 64.944.0% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 37,511 9.9% | USD 2,946,11411.6% | USD 78.541.5% | |
| MIRM (Mirum Pharmaceuticals Inc) | 35,158 -4.8% | USD 2,733,1835.3% | USD 77.7410.6% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 215,054 -7.1% | USD 2,703,229-7.6% | USD 12.57-0.6% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 13,464 -6.6% | USD 2,697,243-5.7% | USD 200.331.0% | |
| ACLX (Arcellx Inc) | 39,556 -4.0% | USD 2,530,002-4.2% | USD 63.96-0.3% | |
| GRAL (GRAIL, LLC) | 26,552 | USD 2,418,6223.1% | USD 91.093.1% | |
| TARS (Tarsus Pharmaceuticals Inc) | 29,039 -6.7% | USD 2,363,775-2.0% | USD 81.45.1% | |
| ARQT (Arcutis Biotherapeutics Inc) | 83,796 -5.4% | USD 2,347,126-4.6% | USD 28.010.8% | |
| XENE (Xenon Pharmaceuticals Inc) | 52,864 -6.9% | USD 2,331,302-5.0% | USD 44.12.0% | |
| VCYT (Veracyte Inc) | 54,077 -6.9% | USD 2,320,985-5.0% | USD 42.922.1% | |
| VERA (Vera Therapeutics Inc) | 43,733 -7.8% | USD 2,240,004-1.0% | USD 51.227.4% | |
| RARE (Ultragenyx) | 66,000 -7.1% | USD 2,211,000-5.3% | USD 33.52.0% | |
| CGON (CG Oncology, Inc. Common stock) | 54,916 -2.2% | USD 2,143,3710.5% | USD 39.032.7% | |
| APLS (Apellis Pharmaceuticals Inc) | 86,555 -7.0% | USD 2,133,581-6.3% | USD 24.650.7% | |
| TVTX (Travere Therapeutics Inc) | 61,208 -7.5% | USD 2,112,288-7.4% | USD 34.510.1% | |
| SUPN (Supernus Pharmaceuticals Inc) | 39,226 -5.3% | USD 2,019,354-1.0% | USD 51.484.5% | |
| IDYA (Ideaya Biosciences Inc) | 59,972 -7.4% | USD 2,012,061-6.6% | USD 33.550.9% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 54,139 9.6% | USD 1,993,9399.1% | USD 36.83-0.5% | |
| DYN (Dyne Therapeutics Inc) | 97,706 -6.7% | USD 1,939,464-0.2% | USD 19.857.0% | |
| EWTX (Edgewise Therapeutics Inc) | 72,424 -7.4% | USD 1,850,43311.8% | USD 25.5520.8% | |
| BEAM (Beam Therapeutics Inc) | 69,419 -7.8% | USD 1,844,463-6.4% | USD 26.571.5% | |
| OCUL (Ocular Therapeutix Inc) | 145,745 12.6% | USD 1,830,5578.9% | USD 12.56-3.2% | |
| WVE (Wave Life Sciences Ltd) | 114,368 -3.3% | USD 1,827,601-0.6% | USD 15.982.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 104,438 -7.7% | USD 1,775,446-4.9% | USD 173.0% | |
| SYRE (Spyre Therapeutics Inc.) | 53,080 17.6% | USD 1,772,87217.4% | USD 33.4-0.2% | |
| DNLI (Denali Therapeutics Inc) | 100,331 -7.7% | USD 1,690,577-7.2% | USD 16.850.5% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 66,000 -7.4% | USD 1,640,100-7.4% | USD 24.85 | |
| SRPT (Sarepta Therapeutics Inc) | 72,806 | USD 1,531,8383.4% | USD 21.043.4% | |
| OLMA (Olema Pharmaceuticals Inc) | 53,811 6.0% | USD 1,502,941-4.0% | USD 27.93-9.3% | |
| RXRX (Recursion Pharmaceuticals Inc) | 351,756 11.6% | USD 1,498,4817.1% | USD 4.26-4.1% | |
| HRMY (Harmony Biosciences Holdings) | 39,401 -8.0% | USD 1,489,752-7.2% | USD 37.810.9% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 90,192 -8.8% | USD 1,459,307-7.3% | USD 16.181.7% | |
| IBRX (Immunitybio Inc) | 673,444 -3.1% | USD 1,400,764-3.5% | USD 2.08-0.5% | |
| ZYME (Zymeworks Inc. Common Stock) | 51,195 -8.7% | USD 1,394,040-5.8% | USD 27.233.1% | |
| TWST (Twist Bioscience Corp) | 41,831 -8.0% | USD 1,359,926-6.2% | USD 32.511.8% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 30,864 -3.4% | USD 1,333,016-0.7% | USD 43.192.8% | |
| GMAB (Genmab AS) | 39,987 31.7% | USD 1,294,77935.4% | USD 32.382.8% | |
| NRIX (Nurix Therapeutics Inc) | 69,346 18.9% | USD 1,284,28822.3% | USD 18.522.8% | |
| TXG (10X Genomics Inc) | 79,680 -4.9% | USD 1,278,864-4.6% | USD 16.050.3% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,364 -5.6% | USD 1,272,907-5.6% | USD 82.850.0% | |
| LEGN (Legend Biotech Corp) | 57,602 -6.4% | USD 1,262,636-3.5% | USD 21.923.0% | |
| STOK (Stoke Therapeutics Inc) | 39,074 -3.6% | USD 1,248,805-3.5% | USD 31.960.1% | |
| VCEL (Vericel Corp Ord) | 34,597 -9.0% | USD 1,247,222-9.2% | USD 36.05-0.3% | |
| SNDX (Syndax Pharmaceuticals Inc) | 59,458 -8.1% | USD 1,234,943-5.6% | USD 20.772.7% | |
| MNKD (MannKind Corp) | 210,066 -8.8% | USD 1,226,785-10.8% | USD 5.84-2.2% | |
| HROW (Harrow Health Inc) | 25,337 -9.3% | USD 1,175,637-5.6% | USD 46.44.1% | |
| PHVS (Pharvaris BV) | 43,820 | USD 1,121,354 | USD | New holding detected |
| FTRE (Fortrea Holdings Inc.) | 63,108 -4.2% | USD 1,119,5362.3% | USD 17.746.8% | |
| IMCR (Immunocore Holdings Ltd) | 29,811 | USD 1,073,4940.3% | USD 36.010.3% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 144,032 -8.9% | USD 1,067,277-7.4% | USD 7.411.6% | |
| COLL (Collegium Pharmaceutical Inc) | 21,625 -5.3% | USD 1,057,030-6.1% | USD 48.88-0.9% | |
| PGEN (Precigen Inc) | 242,050 9.5% | USD 1,045,65613.4% | USD 4.323.6% | |
| TSHA (Taysha Gene Therapies Inc) | 187,387 -5.4% | USD 1,028,755-4.7% | USD 5.490.7% | |
| INVA (Innoviva Inc) | 51,149 7.4% | USD 1,022,4697.0% | USD 19.99-0.4% | |
| QURE (Uniqure NV) | 42,613 6.4% | USD 1,022,2866.6% | USD 23.990.3% | |
| RLAY (Relay Therapeutics Inc) | 118,569 -5.2% | USD 995,980-2.1% | USD 8.43.3% | |
| NVCR (Novocure Ltd) | 76,606 -5.5% | USD 983,621-3.4% | USD 12.842.2% | |
| AGIO (Agios Pharm) | 39,892 -8.7% | USD 975,758-9.7% | USD 24.46-1.1% | |
| ARDX (Ardelyx Inc) | 166,218 -4.9% | USD 944,118-4.9% | USD 5.68 | |
| ANAB (AnaptysBio Inc) | 18,942 -6.6% | USD 929,673-3.5% | USD 49.083.3% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 75,127 16.2% | USD 903,02717.1% | USD 12.020.8% | |
| DVAX (Dynavax Technologies Corporation) | 80,330 -5.6% | USD 872,384-5.7% | USD 10.86-0.1% | |
| MNMD (Mind Medicine Inc) | 67,390 19.8% | USD 855,85321.4% | USD 12.71.3% | |
| PHAT (Phathom Pharmaceuticals Inc) | 48,666 -7.3% | USD 853,115-0.2% | USD 17.537.7% | |
| SVRA (Savara Inc) | 139,192 11.4% | USD 842,11211.2% | USD 6.05-0.2% | |
| AMPH (Amphastar P) | 31,436 -6.7% | USD 836,198-6.3% | USD 26.60.4% | |
| XERS (Xeris Pharmaceuticals Inc) | 113,508 -6.0% | USD 833,149-1.5% | USD 7.344.7% | |
| SANA (Sana Biotechnology Inc) | 181,221 -4.9% | USD 790,124-7.9% | USD 4.36-3.1% | |
| CSTL (Castle Biosciences Inc) | 19,955 -5.4% | USD 787,025-5.8% | USD 39.44-0.4% | |
| TNGX (Tango Therapeutics Inc) | 92,132 14.2% | USD 784,96515.0% | USD 8.520.7% | |
| PCRX (Pacira BioSciences, Inc.) | 29,431 -9.6% | USD 775,507-8.0% | USD 26.351.8% | |
| XNCR (Xencor Inc) | 48,852 -5.6% | USD 759,649-6.4% | USD 15.55-0.9% | |
| GRFS (Grifols SA ADR) | 83,456 -5.8% | USD 752,773-4.7% | USD 9.021.1% | |
| NVAX (Novavax Inc) | 110,936 -5.9% | USD 738,834-6.1% | USD 6.66-0.3% | |
| ABCL (Abcellera Biologics Inc) | 203,403 -6.2% | USD 732,251-4.3% | USD 3.62.0% | |
| URGN (UroGen Pharma Ltd) | 32,022 -7.8% | USD 730,102-3.3% | USD 22.85.0% | |
| NTLA (Intellia Therapeutics Inc) | 78,858 | USD 727,8593.9% | USD 9.233.9% | |
| SPRY (Silverback Therapeutics Inc) | 67,622 -10.2% | USD 709,355-4.1% | USD 10.496.8% | |
| ERAS (Erasca Inc) | 199,154 -9.6% | USD 687,081-13.4% | USD 3.45-4.2% | |
| ELVN (Enliven Therapeutics Inc.) | 40,091 -6.6% | USD 676,335-5.5% | USD 16.871.1% | |
| RAPT (RAPT Therapeutics Inc) | 18,957 | USD 640,936 | USD | New holding detected |
| TBPH (Theravance Biopharma Inc) | 34,048 -6.9% | USD 639,762-3.8% | USD 18.793.4% | |
| IOVA (Iovance Biotherapeutics Inc) | 257,611 | USD 638,8750.8% | USD 2.480.8% | |
| DAWN (Day One Biopharmaceuticals Inc) | 68,649 -7.0% | USD 634,317-13.8% | USD 9.24-7.3% | |
| KURA (Kura Oncology Inc) | 59,528 -9.3% | USD 585,756-9.4% | USD 9.84001-0.1% | |
| ABUS (Arbutus Biopharma Corp) | 131,568 -7.2% | USD 582,846-9.4% | USD 4.43-2.4% | |
| GERN (Geron Corporation) | 426,627 -7.0% | USD 567,414-7.7% | USD 1.33-0.7% | |
| JANX (Janux Therapeutics Inc) | 40,344 -7.3% | USD 556,344-9.0% | USD 13.79-1.8% | |
| PAHC (Phibro Animal Health Corporation) | 14,575 | USD 542,919-7.8% | USD 37.25-7.8% | |
| VIR (Vir Biotechnology Inc) | 92,807 -7.3% | USD 534,568-10.0% | USD 5.76-2.9% | |
| REPL (Replimune Group Inc) | 53,376 -8.0% | USD 527,355-6.2% | USD 9.882.0% | |
| KALV (Kalvista Pharmaceuticals Inc) | 34,579 -11.1% | USD 526,638-9.7% | USD 15.231.5% | |
| ORIC (Oric Pharmaceuticals Inc) | 64,923 -7.8% | USD 521,981-8.3% | USD 8.04-0.6% | |
| ARVN (Arvinas Inc) | 43,936 -21.7% | USD 513,172-19.0% | USD 11.683.5% | |
| RGNX (Regenxbio Inc) | 34,631 -9.2% | USD 505,266-2.0% | USD 14.598.0% | |
| ZLAB (Zai Lab Ltd) | 26,785 -22.8% | USD 483,201-18.9% | USD 18.045.0% | |
| LYEL (Lyell Immunopharma Inc) | 13,957 | USD 465,1872.9% | USD 33.332.9% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,012 | USD 462,3241.1% | USD 3.641.1% | |
| FULC (Fulcrum Therapeutics Inc) | 37,022 | USD 454,630 | USD | New holding detected |
| VTYX (Ventyx Biosciences Inc) | 48,816 | USD 426,652 | USD | New holding detected |
| MGTX (MeiraGTx Holdings PLC) | 52,929 -9.5% | USD 425,020-8.7% | USD 8.030.9% | |
| KROS (Keros Therapeutics Inc) | 20,842 -33.0% | USD 422,259-32.6% | USD 20.260.6% | |
| CGEM (Cullinan Oncology LLC) | 39,717 -10.6% | USD 384,461-13.3% | USD 9.68001-3.0% | |
| PACB (Pacific Biosciences of California) | 206,534 -10.3% | USD 380,023-12.2% | USD 1.84-2.1% | |
| PRTA (Prothena Corporation plc) | 39,910 | USD 367,571-1.8% | USD 9.21-1.8% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 111,288 -12.0% | USD 348,331-15.5% | USD 3.13-4.0% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 99,209 -12.6% | USD 340,287-14.9% | USD 3.43-2.6% | |
| SIGA (SIGA Technologies Inc) | 51,181 | USD 320,905-0.6% | USD 6.27-0.6% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,378 | USD 315,761-0.1% | USD 8.68-0.1% | |
| EOLS (Evolus Inc) | 44,343 -13.0% | USD 313,505-14.3% | USD 7.07-1.5% | |
| GLPG (Galapagos NV ADR) | 9,548 -13.0% | USD 308,973-11.0% | USD 32.362.3% | |
| TRDA (Entrada Therapeutics Inc) | 25,764 -13.5% | USD 282,889-13.3% | USD 10.980.2% | |
| VNDA (Vanda Pharmaceuticals Inc) | 40,021 -14.2% | USD 270,142-13.1% | USD 6.750011.2% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,788 | USD 251,255 | USD 3.23 | |
| BCYC (Bicycle Therapeutics Ltd) | 34,509 | USD 237,0771.5% | USD 6.870011.5% | |
| ACRS (Aclaris Therapeutics Inc) | 74,119 | USD 232,734 | USD | New holding detected |
| AVXL (Anavex Life Sciences Corp) | 62,557 | USD 229,584-5.7% | USD 3.67-5.7% | |
| ALLO (Allogene Therapeutics Inc) | 159,695 | USD 226,767 | USD 1.42 | |
| ACIU (AC Immune Ltd) | 72,816 | USD 220,6322.7% | USD 3.029992.7% | |
| AUTL (Autolus Therapeutics Ltd) | 129,498 -18.2% | USD 211,082-15.1% | USD 1.633.8% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,111 | USD 191,8890.3% | USD 3.140010.3% | |
| OABI (OmniAb Inc.) | 89,973 | USD 188,0444.0% | USD 2.094.0% | |
| EDIT (Editas Medicine Inc) | 69,911 | USD 163,592-0.4% | USD 2.34-0.4% | |
| CABA (Cabaletta Bio Inc) | 65,855 | USD 157,393 | USD | New holding detected |
| VYGR (Voyager Therapeutics Inc) | 37,508 | USD 150,032-2.9% | USD 4-2.9% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,777 | USD 135,6741.6% | USD 6.530011.6% | |
| HUMA (Humacyte Inc) | 118,614 | USD 131,662 | USD 1.11 | |
| CRBU (Caribou Biosciences Inc) | 61,669 | USD 103,604 | USD | New holding detected |
| FATE (Fate Therapeutics Inc) | 11,879 -85.0% | USD 12,473-85.0% | USD 1.05 | |
| OKUR (OKUR) | 485 -94.5% | USD 1,460-94.7% | USD 3.01031-3.2% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 156,431 | USD 69,984,101-0.5% | USD 447.38-0.5% | |
| AMGN (Amgen Inc) | 212,607 | USD 68,973,963-0.5% | USD 324.42-0.5% | |
| REGN (Regeneron Pharmaceuticals Inc) | 76,363 | USD 57,173,742-0.1% | USD 748.71-0.1% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 96,093 | USD 38,056,6721.0% | USD 396.041.0% | |
| INSM (Insmed Inc) | 156,244 | USD 26,022,438-16.1% | USD 166.55-16.1% | |
| ARGX (argenx NV ADR) | 22,631 | USD 19,169,589-1.7% | USD 847.05-1.7% | |
| BIIB (Biogen Inc) | 108,376 | USD 18,414,166-1.3% | USD 169.91-1.3% | |
| UTHR (United Therapeutics Corporation) | 33,431 | USD 16,949,517-0.8% | USD 507-0.8% | |
| ILMN (Illumina Inc) | 113,612 | USD 14,827,5020.7% | USD 130.510.7% | |
| INCY (Incyte Corporation) | 144,344 | USD 14,046,115-0.3% | USD 97.31-0.3% | |
| RPRX (Royalty Pharma Plc) | 319,542 | USD 12,279,9990.3% | USD 38.430.3% | |
| MEDP (Medpace Holdings Inc) | 20,771 | USD 11,636,1220.6% | USD 560.210.6% | |
| ROIV (Roivant Sciences Ltd) | 503,394 | USD 10,968,955-4.0% | USD 21.79-4.0% | |
| RVMD (Revolution Medicines Inc) | 138,380 | USD 10,511,345-1.0% | USD 75.96-1.0% | |
| BBIO (BridgeBio Pharma Inc) | 141,509 | USD 10,491,4770.2% | USD 74.140.2% | |
| NBIX (Neurocrine Biosciences Inc) | 73,331 | USD 10,401,2690.1% | USD 141.840.1% | |
| VTRS (Viatris Inc) | 859,562 | USD 10,263,1702.1% | USD 11.942.1% | |
| SNY (Sanofi ADR) | 198,634 | USD 9,532,446-0.3% | USD 47.99-0.3% | |
| SMMT (Summit Therapeutics PLC) | 549,587 | USD 9,364,9620.2% | USD 17.040.2% | |
| IONS (Ionis Pharmaceuticals Inc) | 117,547 | USD 9,125,1740.7% | USD 77.630.7% | |
| ASND (Ascendis Pharma AS) | 44,982 | USD 8,987,404-1.5% | USD 199.8-1.5% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,448 | USD 8,954,456-0.3% | USD 544.41-0.3% | |
| GH (Guardant Health Inc) | 92,086 | USD 8,941,551-0.4% | USD 97.1-0.4% | |
| MRNA (Moderna Inc) | 287,594 | USD 8,901,0341.4% | USD 30.951.4% | |
| EXEL (Exelixis Inc) | 198,986 | USD 8,470,8341.4% | USD 42.571.4% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 44,948 | USD 7,461,3680.7% | USD 1660.7% | |
| BMRN (Biomarin Pharmaceutical Inc) | 141,930 | USD 7,373,2640.3% | USD 51.950.3% | |
| RNA (Avidity Biosciences Inc) | 95,235 | USD 6,869,7770.4% | USD 72.1350.4% | |
| BNTX (BioNTech SE) | 74,561 | USD 6,819,349-0.2% | USD 91.46-0.2% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 101,970 | USD 6,777,9462.6% | USD 66.472.6% | |
| HALO (Halozyme Therapeutics Inc) | 86,198 | USD 5,612,352-1.0% | USD 65.11-1.0% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 49,160 | USD 5,492,647-0.1% | USD 111.73-0.1% | |
| CYTK (Cytokinetics Inc) | 88,124 | USD 5,481,3134.0% | USD 62.24.0% | |
| AXSM (Axsome Therapeutics Inc) | 36,804 | USD 5,410,188-0.7% | USD 147-0.7% | |
| KRYS (Krystal Biotech Inc) | 21,390 | USD 4,991,784-1.0% | USD 233.37-1.0% | |
| NUVL (Nuvalent Inc) | 49,222 | USD 4,991,6030.2% | USD 101.410.2% | |
| PTCT (PTC Therapeutics Inc) | 58,802 | USD 4,386,041-0.5% | USD 74.59-0.5% | |
| KYMR (Kymera Therapeutics Inc) | 52,942 | USD 4,215,771-3.0% | USD 79.63-3.0% | |
| PCVX (Vaxcyte Inc) | 96,108 | USD 4,200,8811.5% | USD 43.711.5% | |
| PRAX (Praxis Precision Medicines Inc) | 15,593 | USD 4,198,5711.3% | USD 269.261.3% | |
| PTGX (Protagonist Therapeutics Inc) | 46,121 | USD 3,956,721-4.0% | USD 85.79-4.0% | |
| COGT (Cogent Biosciences Inc) | 103,616 | USD 3,927,046-3.9% | USD 37.9-3.9% | |
| CRSP (Crispr Therapeutics AG) | 67,312 | USD 3,691,3900.2% | USD 54.840.2% | |
| ALKS (Alkermes Plc) | 122,352 | USD 3,402,609-0.8% | USD 27.81-0.8% | |
| IMVT (Immunovant Inc) | 128,576 | USD 3,366,120-3.0% | USD 26.18-3.0% | |
| ADMA (ADMA Biologics Inc) | 175,546 | USD 3,302,020-0.1% | USD 18.81-0.1% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 124,104 | USD 3,301,166-1.2% | USD 26.6-1.2% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 69,980 | USD 3,158,897-5.3% | USD 45.14-5.3% | |
| SRRK (Scholar Rock Holding Corp) | 70,559 | USD 3,029,098-2.5% | USD 42.93-2.5% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 231,411 | USD 2,925,0352.5% | USD 12.642.5% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,411 | USD 2,859,2872.0% | USD 198.412.0% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 43,917 | USD 2,742,6174.1% | USD 62.454.1% | |
| ACLX (Arcellx Inc) | 41,187 | USD 2,641,322-0.9% | USD 64.13-0.9% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,137 | USD 2,640,4972.5% | USD 77.352.5% | |
| MIRM (Mirum Pharmaceuticals Inc) | 36,921 | USD 2,594,8081.9% | USD 70.281.9% | |
| FOLD (Amicus Therapeutics Inc) | 228,837 | USD 2,492,035-1.0% | USD 10.89-1.0% | |
| ARQT (Arcutis Biotherapeutics Inc) | 88,605 | USD 2,461,447-2.0% | USD 27.78-2.0% | |
| XENE (Xenon Pharmaceuticals Inc) | 56,793 | USD 2,455,1610.5% | USD 43.230.5% | |
| VCYT (Veracyte Inc) | 58,110 | USD 2,442,944-0.4% | USD 42.04-0.4% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,127 | USD 2,411,720-0.4% | USD 77.48-0.4% | |
| GRAL (GRAIL, LLC) | 26,552 | USD 2,344,9402.8% | USD 88.3152.8% | |
| RARE (Ultragenyx) | 71,079 | USD 2,334,234-1.1% | USD 32.84-1.1% | |
| TVTX (Travere Therapeutics Inc) | 66,141 | USD 2,281,2031.8% | USD 34.491.8% | |
| APLS (Apellis Pharmaceuticals Inc) | 93,034 | USD 2,277,472-2.9% | USD 24.48-2.9% | |
| VERA (Vera Therapeutics Inc) | 47,428 | USD 2,261,841-1.7% | USD 47.69-1.7% | |
| IDYA (Ideaya Biosciences Inc) | 64,771 | USD 2,154,283-1.4% | USD 33.26-1.4% | |
| CGON (CG Oncology, Inc. Common stock) | 56,123 | USD 2,132,6741.7% | USD 381.7% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,401 | USD 2,040,2411.1% | USD 49.281.1% | |
| BEAM (Beam Therapeutics Inc) | 75,274 | USD 1,969,9212.2% | USD 26.172.2% | |
| DYN (Dyne Therapeutics Inc) | 104,735 | USD 1,942,834-1.9% | USD 18.55-1.9% | |
| ADPT (Adaptive Biotechnologies Corp) | 113,176 | USD 1,867,4042.4% | USD 16.52.4% | |
| WVE (Wave Life Sciences Ltd) | 118,328 | USD 1,838,817-4.9% | USD 15.54-4.9% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 49,402 | USD 1,827,874-0.1% | USD 37-0.1% | |
| DNLI (Denali Therapeutics Inc) | 108,683 | USD 1,822,614-0.2% | USD 16.77-0.2% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 71,306 | USD 1,771,954-0.5% | USD 24.85-0.5% | |
| OCUL (Ocular Therapeutix Inc) | 129,450 | USD 1,680,261-5.4% | USD 12.98-5.4% | |
| EWTX (Edgewise Therapeutics Inc) | 78,231 | USD 1,654,586-5.2% | USD 21.15-5.2% | |
| HRMY (Harmony Biosciences Holdings) | 42,826 | USD 1,604,690-3.4% | USD 37.47-3.4% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 98,916 | USD 1,573,7540.8% | USD 15.910.8% | |
| OLMA (Olema Pharmaceuticals Inc) | 50,789 | USD 1,564,809-5.5% | USD 30.81-5.5% | |
| SYRE (Spyre Therapeutics Inc.) | 45,122 | USD 1,510,2331.2% | USD 33.471.2% | |
| AVDL (Avadel Pharmaceuticals PLC) | 70,379 | USD 1,507,5180.1% | USD 21.420.1% | |
| SRPT (Sarepta Therapeutics Inc) | 72,806 | USD 1,480,874-3.8% | USD 20.34-3.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,084 | USD 1,480,6183.2% | USD 26.43.2% | |
| IBRX (Immunitybio Inc) | 694,806 | USD 1,452,145-0.9% | USD 2.09-0.9% | |
| TWST (Twist Bioscience Corp) | 45,444 | USD 1,450,572-0.7% | USD 31.92-0.7% | |
| RXRX (Recursion Pharmaceuticals Inc) | 315,213 | USD 1,399,546-5.1% | USD 4.44-5.1% | |
| MNKD (MannKind Corp) | 230,268 | USD 1,374,700 | USD 5.97 | |
| VCEL (Vericel Corp Ord) | 38,002 | USD 1,374,152-0.7% | USD 36.16-0.7% | |
| ANIP (ANI Pharmaceuticals Inc) | 16,281 | USD 1,348,5550.6% | USD 82.830.6% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 31,951 | USD 1,341,9421.3% | USD 421.3% | |
| TXG (10X Genomics Inc) | 83,804 | USD 1,340,8641.6% | USD 161.6% | |
| LEGN (Legend Biotech Corp) | 61,510 | USD 1,308,933-0.7% | USD 21.28-0.7% | |
| SNDX (Syndax Pharmaceuticals Inc) | 64,665 | USD 1,308,173-0.7% | USD 20.23-0.7% | |
| STOK (Stoke Therapeutics Inc) | 40,528 | USD 1,294,059-2.8% | USD 31.93-2.8% | |
| HROW (Harrow Health Inc) | 27,939 | USD 1,244,9620.4% | USD 44.560.4% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 158,135 | USD 1,152,8042.2% | USD 7.292.2% | |
| COLL (Collegium Pharmaceutical Inc) | 22,825 | USD 1,125,9570.9% | USD 49.330.9% | |
| FTRE (Fortrea Holdings Inc.) | 65,893 | USD 1,094,4832.6% | USD 16.612.6% | |
| AGIO (Agios Pharm) | 43,693 | USD 1,080,528-2.8% | USD 24.73-2.8% | |
| TSHA (Taysha Gene Therapies Inc) | 198,026 | USD 1,079,2420.2% | USD 5.450.2% | |
| IMCR (Immunocore Holdings Ltd) | 29,811 | USD 1,070,2150.2% | USD 35.90.2% | |
| NRIX (Nurix Therapeutics Inc) | 58,306 | USD 1,050,091-1.1% | USD 18.01-1.1% | |
| NVCR (Novocure Ltd) | 81,063 | USD 1,018,1511.9% | USD 12.561.9% | |
| RLAY (Relay Therapeutics Inc) | 125,138 | USD 1,017,3721.2% | USD 8.131.2% | |
| ARDX (Ardelyx Inc) | 174,845 | USD 993,120-1.9% | USD 5.68-1.9% | |
| ANAB (AnaptysBio Inc) | 20,278 | USD 963,8134.0% | USD 47.534.0% | |
| QURE (Uniqure NV) | 40,057 | USD 958,5643.9% | USD 23.933.9% | |
| GMAB (Genmab AS) | 30,360 | USD 956,340-0.7% | USD 31.5-0.7% | |
| INVA (Innoviva Inc) | 47,626 | USD 955,8540.1% | USD 20.070.1% | |
| DVAX (Dynavax Technologies Corporation) | 85,069 | USD 924,7000.7% | USD 10.870.7% | |
| PGEN (Precigen Inc) | 221,132 | USD 922,1204.8% | USD 4.174.8% | |
| AMPH (Amphastar P) | 33,694 | USD 892,8911.6% | USD 26.51.6% | |
| SANA (Sana Biotechnology Inc) | 190,651 | USD 857,930-5.9% | USD 4.5-5.9% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,514 | USD 854,9286.0% | USD 16.286.0% | |
| XERS (Xeris Pharmaceuticals Inc) | 120,709 | USD 846,1700.3% | USD 7.010.3% | |
| PCRX (Pacira BioSciences, Inc.) | 32,568 | USD 842,860-2.5% | USD 25.88-2.5% | |
| CSTL (Castle Biosciences Inc) | 21,092 | USD 835,243-0.2% | USD 39.6-0.2% | |
| XNCR (Xencor Inc) | 51,738 | USD 811,769-0.7% | USD 15.69-0.7% | |
| ERAS (Erasca Inc) | 220,276 | USD 792,994-1.1% | USD 3.6-1.1% | |
| GRFS (Grifols SA ADR) | 88,559 | USD 789,9460.1% | USD 8.920.1% | |
| NVAX (Novavax Inc) | 117,839 | USD 787,1652.3% | USD 6.682.3% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 64,667 | USD 770,8310.4% | USD 11.920.4% | |
| ABCL (Abcellera Biologics Inc) | 216,858 | USD 765,5095.4% | USD 3.535.4% | |
| SVRA (Savara Inc) | 124,920 | USD 757,015-0.8% | USD 6.06-0.8% | |
| URGN (UroGen Pharma Ltd) | 34,748 | USD 754,727-4.0% | USD 21.72-4.0% | |
| SPRY (Silverback Therapeutics Inc) | 75,291 | USD 739,358-2.5% | USD 9.82001-2.5% | |
| DAWN (Day One Biopharmaceuticals Inc) | 73,795 | USD 735,73613.8% | USD 9.9713.8% | |
| ELVN (Enliven Therapeutics Inc.) | 42,905 | USD 715,6554.1% | USD 16.684.1% | |
| MNMD (Mind Medicine Inc) | 56,242 | USD 705,2753.4% | USD 12.543.4% | |
| NTLA (Intellia Therapeutics Inc) | 78,858 | USD 700,2591.0% | USD 8.881.0% | |
| TNGX (Tango Therapeutics Inc) | 80,661 | USD 682,392-3.6% | USD 8.46-3.6% | |
| TBPH (Theravance Biopharma Inc) | 36,565 | USD 664,7521.5% | USD 18.181.5% | |
| KURA (Kura Oncology Inc) | 65,622 | USD 646,377-3.2% | USD 9.85-3.2% | |
| ABUS (Arbutus Biopharma Corp) | 141,748 | USD 643,536-2.2% | USD 4.54-2.2% | |
| IOVA (Iovance Biotherapeutics Inc) | 257,611 | USD 633,723-2.4% | USD 2.46-2.4% | |
| ARVN (Arvinas Inc) | 56,148 | USD 633,349-3.8% | USD 11.28-3.8% | |
| KROS (Keros Therapeutics Inc) | 31,102 | USD 626,083-3.4% | USD 20.13-3.4% | |
| GERN (Geron Corporation) | 458,823 | USD 614,823-4.3% | USD 1.34-4.3% | |
| JANX (Janux Therapeutics Inc) | 43,541 | USD 611,316-0.4% | USD 14.04-0.4% | |
| ZLAB (Zai Lab Ltd) | 34,678 | USD 595,768-0.2% | USD 17.18-0.2% | |
| VIR (Vir Biotechnology Inc) | 100,148 | USD 593,878-3.4% | USD 5.93-3.4% | |
| PAHC (Phibro Animal Health Corporation) | 14,575 | USD 588,976-0.5% | USD 40.41-0.5% | |
| KALV (Kalvista Pharmaceuticals Inc) | 38,901 | USD 583,5151.0% | USD 151.0% | |
| ORIC (Oric Pharmaceuticals Inc) | 70,407 | USD 569,241-1.6% | USD 8.08501-1.6% | |
| REPL (Replimune Group Inc) | 58,042 | USD 562,4270.3% | USD 9.690.3% | |
| RGNX (Regenxbio Inc) | 38,147 | USD 515,3662.6% | USD 13.512.6% | |
| MGTX (MeiraGTx Holdings PLC) | 58,487 | USD 465,557-1.8% | USD 7.96001-1.8% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,012 | USD 457,243-3.7% | USD 3.6-3.7% | |
| LYEL (Lyell Immunopharma Inc) | 13,957 | USD 451,9281.0% | USD 32.381.0% | |
| CGEM (Cullinan Oncology LLC) | 44,418 | USD 443,2924.1% | USD 9.980014.1% | |
| PACB (Pacific Biosciences of California) | 230,162 | USD 432,705-2.6% | USD 1.88-2.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 126,480 | USD 412,325-3.3% | USD 3.26-3.3% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 113,559 | USD 399,7281.7% | USD 3.521.7% | |
| PRTA (Prothena Corporation plc) | 39,910 | USD 374,356-0.5% | USD 9.38-0.5% | |
| EOLS (Evolus Inc) | 50,962 | USD 365,9071.4% | USD 7.181.4% | |
| GLPG (Galapagos NV ADR) | 10,978 | USD 347,2340.3% | USD 31.630.3% | |
| TRDA (Entrada Therapeutics Inc) | 29,782 | USD 326,411-2.3% | USD 10.96-2.3% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 274,688 | USD 324,1322.6% | USD 1.182.6% | |
| SIGA (SIGA Technologies Inc) | 51,181 | USD 322,952-1.1% | USD 6.31-1.1% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,378 -1.2% | USD 316,125-6.7% | USD 8.69001-5.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 46,631 | USD 311,029-2.2% | USD 6.67-2.2% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,788 | USD 251,255-1.2% | USD 3.23-1.2% | |
| AUTL (Autolus Therapeutics Ltd) | 158,392 | USD 248,6750.6% | USD 1.570.6% | |
| AVXL (Anavex Life Sciences Corp) | 62,557 | USD 243,347-0.8% | USD 3.89-0.8% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,509 | USD 233,626-2.6% | USD 6.77-2.6% | |
| ALLO (Allogene Therapeutics Inc) | 159,695 | USD 226,767 | USD 1.42 | |
| ACIU (AC Immune Ltd) | 72,816 | USD 214,8070.3% | USD 2.950.3% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,111 | USD 191,277-1.6% | USD 3.12999-1.6% | |
| OABI (OmniAb Inc.) | 89,973 | USD 180,846-2.4% | USD 2.01-2.4% | |
| EDIT (Editas Medicine Inc) | 69,911 | USD 164,291-0.8% | USD 2.35-0.8% | |
| VYGR (Voyager Therapeutics Inc) | 37,508 | USD 154,533-3.3% | USD 4.12-3.3% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,777 | USD 133,596-1.4% | USD 6.42999-1.4% | |
| HUMA (Humacyte Inc) | 118,614 | USD 131,6623.7% | USD 1.113.7% | |
| ALEC (Alector Inc) | 77,495 | USD 107,7183.0% | USD 1.393.0% | |
| MRSN (Mersana Therapeutics Inc) | 3,432 | USD 99,8710.1% | USD 29.09990.1% | |
| FATE (Fate Therapeutics Inc) | 79,418 | USD 83,389 | USD 1.05 | |
| MGNX (MacroGenics Inc) | 44,990 | USD 70,634-2.5% | USD 1.56999-2.5% | |
| BMEA (Biomea Fusion Inc) | 50,551 | USD 68,244 | USD 1.35 | |
| PLRX (Pliant Therapeutics Inc) | 42,399 | USD 51,303-0.8% | USD 1.21-0.8% | |
| STRO (Sutro Biopharma) | 5,534 | USD 49,419-2.2% | USD 8.93007-2.2% | |
| OKUR (OKUR) | 8,857 | USD 27,5455.8% | USD 3.109975.8% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 156,431 -1.1% | USD 70,318,863-2.3% | USD 449.52-1.2% | |
| AMGN (Amgen Inc) | 212,607 -1.1% | USD 69,312,008-1.3% | USD 326.01-0.2% | |
| REGN (Regeneron Pharmaceuticals Inc) | 76,363 -1.1% | USD 57,256,214-0.7% | USD 749.790.5% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 96,093 -1.1% | USD 37,678,065-0.9% | USD 392.10.2% | |
| INSM (Insmed Inc) | 156,244 -1.1% | USD 31,008,184-2.2% | USD 198.46-1.1% | |
| ARGX (argenx NV ADR) | 22,631 -1.1% | USD 19,509,0540.1% | USD 862.051.2% | |
| BIIB (Biogen Inc) | 108,376 -1.1% | USD 18,651,510-0.8% | USD 172.10.3% | |
| UTHR (United Therapeutics Corporation) | 33,431 -1.1% | USD 17,081,2351.0% | USD 510.942.2% | |
| ILMN (Illumina Inc) | 113,612 -1.1% | USD 14,719,571-2.6% | USD 129.56-1.5% | |
| INCY (Incyte Corporation) | 144,344 -1.1% | USD 14,092,305-0.5% | USD 97.630.6% | |
| RPRX (Royalty Pharma Plc) | 319,542 -1.1% | USD 12,241,654-1.3% | USD 38.31-0.2% | |
| MEDP (Medpace Holdings Inc) | 20,771 -1.1% | USD 11,570,901-1.4% | USD 557.07-0.3% | |
| ROIV (Roivant Sciences Ltd) | 503,394 -1.1% | USD 11,427,044-2.2% | USD 22.7-1.0% | |
| RVMD (Revolution Medicines Inc) | 138,380 -1.1% | USD 10,619,281-2.2% | USD 76.74-1.1% | |
| BBIO (BridgeBio Pharma Inc) | 141,509 -1.1% | USD 10,474,496-3.3% | USD 74.02-2.2% | |
| NBIX (Neurocrine Biosciences Inc) | 73,331 -1.1% | USD 10,391,003-5.8% | USD 141.7-4.7% | |
| VTRS (Viatris Inc) | 859,562 -1.1% | USD 10,056,8750.9% | USD 11.72.1% | |
| SNY (Sanofi ADR) | 198,634 -1.1% | USD 9,562,2410.3% | USD 48.141.5% | |
| SMMT (Summit Therapeutics PLC) | 549,587 -1.1% | USD 9,348,475-2.4% | USD 17.01-1.3% | |
| ASND (Ascendis Pharma AS) | 44,982 -1.1% | USD 9,123,249-5.5% | USD 202.82-4.4% | |
| IONS (Ionis Pharmaceuticals Inc) | 117,547 -1.1% | USD 9,060,523-2.8% | USD 77.08-1.6% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,448 -1.1% | USD 8,983,733-2.6% | USD 546.19-1.5% | |
| GH (Guardant Health Inc) | 92,086 -1.1% | USD 8,975,622-3.6% | USD 97.47-2.5% | |
| MRNA (Moderna Inc) | 287,594 -1.1% | USD 8,774,4930.9% | USD 30.512.1% | |
| EXEL (Exelixis Inc) | 198,986 -1.1% | USD 8,357,412-0.2% | USD 421.0% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 44,948 -1.1% | USD 7,412,599-3.9% | USD 164.915-2.8% | |
| BMRN (Biomarin Pharmaceutical Inc) | 141,930 -1.1% | USD 7,351,974-1.1% | USD 51.80.1% | |
| RNA (Avidity Biosciences Inc) | 95,235 -1.1% | USD 6,844,539-1.3% | USD 71.87-0.1% | |
| BNTX (BioNTech SE) | 74,561 -1.1% | USD 6,829,788-1.8% | USD 91.6-0.7% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 101,970 -1.1% | USD 6,607,656-0.9% | USD 64.80.2% | |
| HALO (Halozyme Therapeutics Inc) | 86,198 -1.1% | USD 5,669,2420.9% | USD 65.772.0% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 49,160 -1.1% | USD 5,499,038-1.6% | USD 111.86-0.5% | |
| AXSM (Axsome Therapeutics Inc) | 36,804 -1.1% | USD 5,446,992-0.4% | USD 1480.8% | |
| CYTK (Cytokinetics Inc) | 88,124 -1.1% | USD 5,271,578-4.6% | USD 59.82-3.5% | |
| KRYS (Krystal Biotech Inc) | 21,390 -1.1% | USD 5,043,762-2.3% | USD 235.8-1.2% | |
| NUVL (Nuvalent Inc) | 49,222 -1.1% | USD 4,983,728-2.5% | USD 101.25-1.3% | |
| PTCT (PTC Therapeutics Inc) | 58,802 -1.1% | USD 4,406,622-1.8% | USD 74.94-0.6% | |
| KYMR (Kymera Therapeutics Inc) | 52,942 -1.1% | USD 4,344,950-3.6% | USD 82.07-2.5% | |
| PRAX (Praxis Precision Medicines Inc) | 15,593 -1.1% | USD 4,145,555-4.2% | USD 265.86-3.2% | |
| PCVX (Vaxcyte Inc) | 96,108 -1.1% | USD 4,138,410-2.5% | USD 43.06-1.4% | |
| PTGX (Protagonist Therapeutics Inc) | 46,121 -1.1% | USD 4,120,450-3.5% | USD 89.34-2.4% | |
| COGT (Cogent Biosciences Inc) | 103,616 -1.1% | USD 4,087,651-2.5% | USD 39.45-1.4% | |
| CRSP (Crispr Therapeutics AG) | 67,312 -1.1% | USD 3,684,659-3.3% | USD 54.74-2.2% | |
| IMVT (Immunovant Inc) | 128,576 -1.1% | USD 3,468,9800.2% | USD 26.981.4% | |
| ALKS (Alkermes Plc) | 122,352 -1.1% | USD 3,430,750-1.2% | USD 28.04-0.1% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 124,104 -1.1% | USD 3,342,121-0.6% | USD 26.930.5% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 69,980 -1.1% | USD 3,337,346-3.0% | USD 47.69-1.9% | |
| ADMA (ADMA Biologics Inc) | 175,546 -1.1% | USD 3,305,531-2.9% | USD 18.83-1.8% | |
| SRRK (Scholar Rock Holding Corp) | 70,559 -1.1% | USD 3,105,302-1.8% | USD 44.01-0.7% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 231,411 -1.1% | USD 2,853,2980.2% | USD 12.331.3% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,411 -1.1% | USD 2,804,236-0.1% | USD 194.591.0% | |
| ACLX (Arcellx Inc) | 41,187 -1.1% | USD 2,665,623-3.5% | USD 64.72-2.4% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 43,917 -1.1% | USD 2,633,702-3.9% | USD 59.97-2.8% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,137 -1.1% | USD 2,577,344-0.2% | USD 75.51.0% | |
| MIRM (Mirum Pharmaceuticals Inc) | 36,921 -1.1% | USD 2,547,5491.8% | USD 692.9% | |
| FOLD (Amicus Therapeutics Inc) | 228,837 -1.1% | USD 2,517,207-0.1% | USD 111.0% | |
| ARQT (Arcutis Biotherapeutics Inc) | 88,605 -1.1% | USD 2,511,066-1.8% | USD 28.34-0.7% | |
| VCYT (Veracyte Inc) | 58,110 -1.1% | USD 2,452,823-3.4% | USD 42.21-2.3% | |
| XENE (Xenon Pharmaceuticals Inc) | 56,793 -1.1% | USD 2,442,667-1.1% | USD 43.010.0% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,127 -1.1% | USD 2,420,747-1.8% | USD 77.77-0.7% | |
| RARE (Ultragenyx) | 71,079 -1.1% | USD 2,360,534-4.4% | USD 33.21-3.3% | |
| APLS (Apellis Pharmaceuticals Inc) | 93,034 -1.1% | USD 2,344,457-1.6% | USD 25.2-0.4% | |
| VERA (Vera Therapeutics Inc) | 47,428 -1.1% | USD 2,301,681-0.7% | USD 48.530.5% | |
| GRAL (GRAIL, LLC) | 26,552 -1.1% | USD 2,280,020-2.4% | USD 85.87-1.3% | |
| TVTX (Travere Therapeutics Inc) | 66,141 -1.1% | USD 2,241,518-6.5% | USD 33.89-5.5% | |
| IDYA (Ideaya Biosciences Inc) | 64,771 -1.1% | USD 2,184,726-1.4% | USD 33.73-0.2% | |
| CGON (CG Oncology, Inc. Common stock) | 56,123 -1.1% | USD 2,097,317-2.4% | USD 37.37-1.3% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,401 -1.1% | USD 2,018,299-0.2% | USD 48.750.9% | |
| DYN (Dyne Therapeutics Inc) | 104,735 -1.1% | USD 1,979,492-4.4% | USD 18.9-3.3% | |
| WVE (Wave Life Sciences Ltd) | 118,328 -1.1% | USD 1,933,480-1.6% | USD 16.34-0.4% | |
| BEAM (Beam Therapeutics Inc) | 75,274 -1.1% | USD 1,927,014-5.4% | USD 25.6-4.3% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 49,402 -1.1% | USD 1,828,8621.6% | USD 37.022.7% | |
| DNLI (Denali Therapeutics Inc) | 108,683 -1.1% | USD 1,826,961-2.4% | USD 16.81-1.2% | |
| ADPT (Adaptive Biotechnologies Corp) | 113,176 -1.1% | USD 1,824,3970.0% | USD 16.121.2% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 71,306 -1.1% | USD 1,781,224-4.0% | USD 24.98-2.9% | |
| OCUL (Ocular Therapeutix Inc) | 129,450 -1.1% | USD 1,776,054-5.7% | USD 13.72-4.7% | |
| EWTX (Edgewise Therapeutics Inc) | 78,231 -1.1% | USD 1,745,334-3.1% | USD 22.31-2.0% | |
| HRMY (Harmony Biosciences Holdings) | 42,826 -1.1% | USD 1,660,792-1.3% | USD 38.78-0.1% | |
| OLMA (Olema Pharmaceuticals Inc) | 50,789 -1.1% | USD 1,655,721-6.0% | USD 32.6-4.9% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 98,916 -1.1% | USD 1,561,884-1.5% | USD 15.79-0.4% | |
| SRPT (Sarepta Therapeutics Inc) | 72,806 -1.1% | USD 1,539,119-6.3% | USD 21.14-5.2% | |
| AVDL (Avadel Pharmaceuticals PLC) | 70,379 -1.1% | USD 1,506,111-1.0% | USD 21.40.1% | |
| SYRE (Spyre Therapeutics Inc.) | 45,122 -1.1% | USD 1,491,733-0.9% | USD 33.060.3% | |
| RXRX (Recursion Pharmaceuticals Inc) | 315,213 -1.1% | USD 1,475,19710.2% | USD 4.6811.4% | |
| IBRX (Immunitybio Inc) | 694,806 -1.1% | USD 1,466,041-3.4% | USD 2.11-2.3% | |
| TWST (Twist Bioscience Corp) | 45,444 -1.1% | USD 1,460,1162.0% | USD 32.133.2% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,084 -1.1% | USD 1,435,190-2.1% | USD 25.59-1.0% | |
| VCEL (Vericel Corp Ord) | 38,002 -1.1% | USD 1,383,2731.4% | USD 36.42.5% | |
| MNKD (MannKind Corp) | 230,268 -1.1% | USD 1,374,700-0.1% | USD 5.971.0% | |
| ANIP (ANI Pharmaceuticals Inc) | 16,281 -1.1% | USD 1,340,7400.4% | USD 82.351.5% | |
| STOK (Stoke Therapeutics Inc) | 40,528 -1.1% | USD 1,331,750-3.3% | USD 32.86-2.2% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 31,951 -1.1% | USD 1,325,008-0.9% | USD 41.470.2% | |
| TXG (10X Genomics Inc) | 83,804 -1.1% | USD 1,319,913-0.9% | USD 15.750.3% | |
| LEGN (Legend Biotech Corp) | 61,510 -1.1% | USD 1,317,544-2.2% | USD 21.42-1.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 64,665 -1.1% | USD 1,317,226-2.8% | USD 20.37-1.7% | |
| HROW (Harrow Health Inc) | 27,939 -1.1% | USD 1,240,212-2.0% | USD 44.39-0.8% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 158,135 -1.1% | USD 1,127,503-5.6% | USD 7.13-4.6% | |
| COLL (Collegium Pharmaceutical Inc) | 22,825 -1.1% | USD 1,116,143-0.7% | USD 48.90.4% | |
| AGIO (Agios Pharm) | 43,693 -1.1% | USD 1,111,987-3.6% | USD 25.45-2.5% | |
| TSHA (Taysha Gene Therapies Inc) | 198,026 -1.1% | USD 1,077,261-7.6% | USD 5.44-6.5% | |
| IMCR (Immunocore Holdings Ltd) | 29,811 -1.1% | USD 1,067,830-2.2% | USD 35.82-1.1% | |
| FTRE (Fortrea Holdings Inc.) | 65,893 -1.1% | USD 1,066,8080.1% | USD 16.191.3% | |
| NRIX (Nurix Therapeutics Inc) | 58,306 -1.1% | USD 1,061,752-4.4% | USD 18.21-3.3% | |
| ARDX (Ardelyx Inc) | 174,845 -1.1% | USD 1,012,353-4.6% | USD 5.79-3.5% | |
| RLAY (Relay Therapeutics Inc) | 125,138 -1.1% | USD 1,004,858-6.4% | USD 8.03-5.3% | |
| NVCR (Novocure Ltd) | 81,063 -1.1% | USD 999,507-5.7% | USD 12.33-4.6% | |
| GMAB (Genmab AS) | 30,360 -1.1% | USD 962,7160.0% | USD 31.711.1% | |
| INVA (Innoviva Inc) | 47,626 -1.1% | USD 954,901-0.5% | USD 20.050.7% | |
| ANAB (AnaptysBio Inc) | 20,278 -1.1% | USD 926,5020.3% | USD 45.691.5% | |
| QURE (Uniqure NV) | 40,057 -1.1% | USD 922,5134.0% | USD 23.035.2% | |
| DVAX (Dynavax Technologies Corporation) | 85,069 -1.1% | USD 917,895-1.0% | USD 10.790.1% | |
| SANA (Sana Biotechnology Inc) | 190,651 -1.1% | USD 911,312-5.5% | USD 4.78-4.4% | |
| PGEN (Precigen Inc) | 221,132 -1.1% | USD 880,1051.7% | USD 3.982.8% | |
| AMPH (Amphastar P) | 33,694 -1.1% | USD 878,4030.6% | USD 26.071.8% | |
| PCRX (Pacira BioSciences, Inc.) | 32,568 -1.1% | USD 864,6800.3% | USD 26.551.4% | |
| XERS (Xeris Pharmaceuticals Inc) | 120,709 -1.1% | USD 843,756-2.7% | USD 6.99-1.5% | |
| CSTL (Castle Biosciences Inc) | 21,092 -1.1% | USD 836,5090.4% | USD 39.661.6% | |
| XNCR (Xencor Inc) | 51,738 -1.1% | USD 817,460-5.6% | USD 15.8-4.5% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,514 -1.1% | USD 806,615-0.4% | USD 15.360.8% | |
| ERAS (Erasca Inc) | 220,276 -1.1% | USD 801,8052.2% | USD 3.643.4% | |
| GRFS (Grifols SA ADR) | 88,559 -1.1% | USD 789,061-1.7% | USD 8.91-0.6% | |
| URGN (UroGen Pharma Ltd) | 34,748 -1.1% | USD 786,000-4.7% | USD 22.62-3.6% | |
| NVAX (Novavax Inc) | 117,839 -1.1% | USD 769,489-1.3% | USD 6.53-0.2% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 64,667 -1.1% | USD 767,597-4.7% | USD 11.87-3.6% | |
| SVRA (Savara Inc) | 124,920 -1.1% | USD 763,261-6.1% | USD 6.11-5.0% | |
| SPRY (Silverback Therapeutics Inc) | 75,291 -1.1% | USD 758,180-6.6% | USD 10.07-5.5% | |
| ABCL (Abcellera Biologics Inc) | 216,858 -1.1% | USD 726,474-4.3% | USD 3.35-3.2% | |
| TNGX (Tango Therapeutics Inc) | 80,661 -1.1% | USD 708,204-3.1% | USD 8.78001-2.0% | |
| NTLA (Intellia Therapeutics Inc) | 78,858 -1.1% | USD 693,162-4.7% | USD 8.79-3.6% | |
| ELVN (Enliven Therapeutics Inc.) | 42,905 -1.1% | USD 687,338-6.3% | USD 16.02-5.3% | |
| MNMD (Mind Medicine Inc) | 56,242 -1.1% | USD 682,215-2.2% | USD 12.13-1.1% | |
| KURA (Kura Oncology Inc) | 65,622 -1.1% | USD 668,032-5.3% | USD 10.18-4.2% | |
| ARVN (Arvinas Inc) | 56,148 -1.1% | USD 658,055-2.6% | USD 11.72-1.5% | |
| ABUS (Arbutus Biopharma Corp) | 141,748 -1.1% | USD 657,711-0.1% | USD 4.641.1% | |
| TBPH (Theravance Biopharma Inc) | 36,565 -1.1% | USD 654,8791.0% | USD 17.912.2% | |
| IOVA (Iovance Biotherapeutics Inc) | 257,611 -1.2% | USD 649,18010.7% | USD 2.5212.0% | |
| KROS (Keros Therapeutics Inc) | 31,102 -1.1% | USD 647,855-4.4% | USD 20.83-3.3% | |
| DAWN (Day One Biopharmaceuticals Inc) | 73,795 -1.1% | USD 646,4445.0% | USD 8.766.2% | |
| GERN (Geron Corporation) | 458,823 -1.1% | USD 642,3523.3% | USD 1.44.5% | |
| VIR (Vir Biotechnology Inc) | 100,148 -1.1% | USD 614,909-6.3% | USD 6.14-5.2% | |
| JANX (Janux Therapeutics Inc) | 43,541 -1.1% | USD 613,928-4.9% | USD 14.1-3.8% | |
| ZLAB (Zai Lab Ltd) | 34,678 -1.1% | USD 597,1550.1% | USD 17.221.3% | |
| PAHC (Phibro Animal Health Corporation) | 14,575 -1.1% | USD 591,745-0.6% | USD 40.60.5% | |
| ORIC (Oric Pharmaceuticals Inc) | 70,407 -1.1% | USD 578,746-10.9% | USD 8.22001-9.9% | |
| KALV (Kalvista Pharmaceuticals Inc) | 38,901 -1.1% | USD 577,680-7.7% | USD 14.85-6.6% | |
| REPL (Replimune Group Inc) | 58,042 -1.1% | USD 560,686-0.6% | USD 9.660.5% | |
| RGNX (Regenxbio Inc) | 38,147 -1.2% | USD 502,396-7.7% | USD 13.17-6.7% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,012 -1.2% | USD 475,025-4.7% | USD 3.74-3.6% | |
| MGTX (MeiraGTx Holdings PLC) | 58,487 -1.1% | USD 474,330-6.8% | USD 8.11001-5.7% | |
| LYEL (Lyell Immunopharma Inc) | 13,957 -1.1% | USD 447,601-2.9% | USD 32.07-1.7% | |
| PACB (Pacific Biosciences of California) | 230,162 -1.2% | USD 444,213-5.6% | USD 1.93-4.5% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 126,480 -1.2% | USD 426,238-5.9% | USD 3.37-4.8% | |
| CGEM (Cullinan Oncology LLC) | 44,418 -1.2% | USD 425,969-7.3% | USD 9.59001-6.2% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 113,559 -1.2% | USD 392,914-4.7% | USD 3.46-3.6% | |
| PRTA (Prothena Corporation plc) | 39,910 -1.2% | USD 376,351-4.4% | USD 9.42999-3.3% | |
| EOLS (Evolus Inc) | 50,962 -1.2% | USD 360,811-3.1% | USD 7.08-1.9% | |
| GLPG (Galapagos NV ADR) | 10,978 -1.2% | USD 346,1360.3% | USD 31.531.4% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,803 | USD 338,956-20.1% | USD 9.21001-20.1% | |
| TRDA (Entrada Therapeutics Inc) | 29,782 -1.2% | USD 334,154-2.5% | USD 11.22-1.3% | |
| SIGA (SIGA Technologies Inc) | 51,181 -1.2% | USD 326,5350.4% | USD 6.381.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 46,631 -1.2% | USD 318,0231.4% | USD 6.819992.6% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 274,688 -1.2% | USD 315,891-5.3% | USD 1.15-4.2% | |
| RCKT (Rocket Pharmaceuticals Inc) | 77,788 -1.2% | USD 254,367-5.8% | USD 3.27-4.7% | |
| AUTL (Autolus Therapeutics Ltd) | 158,392 -1.2% | USD 247,092-3.6% | USD 1.56-2.5% | |
| AVXL (Anavex Life Sciences Corp) | 62,557 -1.2% | USD 245,223-3.6% | USD 3.91999-2.5% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,509 -1.2% | USD 239,838-6.0% | USD 6.95001-4.9% | |
| ALLO (Allogene Therapeutics Inc) | 159,695 -1.2% | USD 226,767-8.9% | USD 1.42-7.8% | |
| ACIU (AC Immune Ltd) | 72,816 -1.2% | USD 214,079-11.7% | USD 2.94-10.6% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,111 -1.2% | USD 194,333-2.4% | USD 3.18-1.2% | |
| OABI (OmniAb Inc.) | 89,973 -1.2% | USD 185,344-0.7% | USD 2.060.5% | |
| EDIT (Editas Medicine Inc) | 69,911 -1.2% | USD 165,689-6.7% | USD 2.37-5.6% | |
| VYGR (Voyager Therapeutics Inc) | 37,508 -1.2% | USD 159,784-4.7% | USD 4.26-3.6% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,777 -1.2% | USD 135,466-9.6% | USD 6.52-8.6% | |
| HUMA (Humacyte Inc) | 118,614 -1.2% | USD 126,917-5.6% | USD 1.07-4.5% | |
| ALEC (Alector Inc) | 77,495 -1.2% | USD 104,618-4.0% | USD 1.35-2.9% | |
| MRSN (Mersana Therapeutics Inc) | 3,432 -1.2% | USD 99,734-1.1% | USD 29.060.1% | |
| FATE (Fate Therapeutics Inc) | 79,418 -1.2% | USD 83,389-4.8% | USD 1.05-3.7% | |
| MGNX (MacroGenics Inc) | 44,990 -1.2% | USD 72,43417.9% | USD 1.6119.3% | |
| BMEA (Biomea Fusion Inc) | 50,551 -1.2% | USD 68,244-2.6% | USD 1.35-1.5% | |
| PLRX (Pliant Therapeutics Inc) | 42,399 -1.2% | USD 51,727-3.5% | USD 1.22001-2.4% | |
| STRO (Sutro Biopharma) | 5,534 -1.2% | USD 50,525-8.0% | USD 9.12992-6.9% | |
| OKUR (OKUR) | 8,857 -1.2% | USD 26,040-3.8% | USD 2.94005-2.6% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 158,211 -0.2% | USD 71,979,677-0.4% | USD 454.96-0.2% | |
| AMGN (Amgen Inc) | 215,022 -0.2% | USD 70,256,2880.2% | USD 326.740.4% | |
| REGN (Regeneron Pharmaceuticals Inc) | 77,233 -0.2% | USD 57,643,622-1.1% | USD 746.36-0.8% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 97,183 -0.2% | USD 38,015,074-0.3% | USD 391.17-0.1% | |
| INSM (Insmed Inc) | 158,019 -0.2% | USD 31,709,6731.7% | USD 200.671.9% | |
| ARGX (argenx NV ADR) | 22,886 -0.2% | USD 19,485,598-0.2% | USD 851.420.1% | |
| BIIB (Biogen Inc) | 109,606 -0.2% | USD 18,797,429-2.6% | USD 171.5-2.4% | |
| UTHR (United Therapeutics Corporation) | 33,811 -0.2% | USD 16,905,500-0.3% | USD 500-0.1% | |
| ILMN (Illumina Inc) | 114,902 -0.2% | USD 15,116,507-2.7% | USD 131.56-2.5% | |
| INCY (Incyte Corporation) | 145,984 -0.2% | USD 14,164,828-1.9% | USD 97.03-1.6% | |
| RPRX (Royalty Pharma Plc) | 323,177 -0.2% | USD 12,403,533-0.6% | USD 38.38-0.4% | |
| MEDP (Medpace Holdings Inc) | 21,006 -0.2% | USD 11,736,892-0.3% | USD 558.74-0.1% | |
| ROIV (Roivant Sciences Ltd) | 509,119 -0.2% | USD 11,679,1904.5% | USD 22.944.7% | |
| NBIX (Neurocrine Biosciences Inc) | 74,166 -0.2% | USD 11,031,451-3.7% | USD 148.74-3.5% | |
| RVMD (Revolution Medicines Inc) | 139,955 -0.2% | USD 10,854,910-2.0% | USD 77.56-1.8% | |
| BBIO (BridgeBio Pharma Inc) | 143,119 -0.2% | USD 10,832,6771.4% | USD 75.691.6% | |
| VTRS (Viatris Inc) | 869,342 -0.2% | USD 9,962,659-1.9% | USD 11.46-1.7% | |
| ASND (Ascendis Pharma AS) | 45,492 -0.2% | USD 9,649,308-0.8% | USD 212.11-0.5% | |
| SMMT (Summit Therapeutics PLC) | 555,837 -0.2% | USD 9,577,072-1.1% | USD 17.23-0.9% | |
| SNY (Sanofi ADR) | 200,894 -0.2% | USD 9,530,411-1.0% | USD 47.44-0.8% | |
| IONS (Ionis Pharmaceuticals Inc) | 118,882 -0.2% | USD 9,316,782-2.0% | USD 78.37-1.7% | |
| GH (Guardant Health Inc) | 93,131 -0.2% | USD 9,313,100-2.8% | USD 100-2.6% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,633 -0.2% | USD 9,224,163-1.3% | USD 554.57-1.1% | |
| MRNA (Moderna Inc) | 290,869 -0.2% | USD 8,694,074-0.3% | USD 29.89-0.1% | |
| EXEL (Exelixis Inc) | 201,251 -0.2% | USD 8,372,0420.3% | USD 41.60.5% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 45,458 -0.2% | USD 7,715,586-0.1% | USD 169.730.1% | |
| BMRN (Biomarin Pharmaceutical Inc) | 143,545 -0.2% | USD 7,431,325-0.9% | USD 51.77-0.7% | |
| BNTX (BioNTech SE) | 75,411 -0.2% | USD 6,955,157-1.9% | USD 92.23-1.7% | |
| RNA (Avidity Biosciences Inc) | 96,320 -0.2% | USD 6,932,150-0.1% | USD 71.970.2% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 103,130 -0.2% | USD 6,668,386-5.7% | USD 64.66-5.5% | |
| HALO (Halozyme Therapeutics Inc) | 87,178 -0.2% | USD 5,620,3661.4% | USD 64.471.6% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 49,720 -0.2% | USD 5,591,014-0.3% | USD 112.45-0.1% | |
| CYTK (Cytokinetics Inc) | 89,124 -0.2% | USD 5,527,470-0.4% | USD 62.02-0.2% | |
| AXSM (Axsome Therapeutics Inc) | 37,224 -0.2% | USD 5,467,0890.2% | USD 146.870.4% | |
| KRYS (Krystal Biotech Inc) | 21,635 -0.2% | USD 5,161,029-2.0% | USD 238.55-1.8% | |
| NUVL (Nuvalent Inc) | 49,782 -0.2% | USD 5,109,127-2.4% | USD 102.63-2.2% | |
| KYMR (Kymera Therapeutics Inc) | 53,542 -0.2% | USD 4,507,701-2.0% | USD 84.19-1.7% | |
| PTCT (PTC Therapeutics Inc) | 59,472 -0.2% | USD 4,485,378-1.3% | USD 75.42-1.1% | |
| PRAX (Praxis Precision Medicines Inc) | 15,768 -0.2% | USD 4,328,474-0.9% | USD 274.51-0.7% | |
| PTGX (Protagonist Therapeutics Inc) | 46,646 -0.2% | USD 4,269,975-3.6% | USD 91.54-3.4% | |
| PCVX (Vaxcyte Inc) | 97,203 -0.2% | USD 4,244,855-1.7% | USD 43.67-1.5% | |
| COGT (Cogent Biosciences Inc) | 104,796 -0.2% | USD 4,190,792-0.8% | USD 39.99-0.6% | |
| CRSP (Crispr Therapeutics AG) | 68,077 -0.2% | USD 3,810,270-0.7% | USD 55.97-0.5% | |
| ALKS (Alkermes Plc) | 123,747 -0.2% | USD 3,472,341-0.6% | USD 28.06-0.4% | |
| IMVT (Immunovant Inc) | 130,041 -0.2% | USD 3,460,3912.1% | USD 26.612.3% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 70,775 -0.2% | USD 3,440,373-1.7% | USD 48.61-1.4% | |
| ADMA (ADMA Biologics Inc) | 177,546 -0.2% | USD 3,403,557-3.1% | USD 19.17-2.8% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 125,519 -0.2% | USD 3,363,909-1.9% | USD 26.8-1.7% | |
| SRRK (Scholar Rock Holding Corp) | 71,364 -0.2% | USD 3,162,852-2.3% | USD 44.32-2.0% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 234,051 -0.2% | USD 2,848,401-2.5% | USD 12.17-2.3% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,576 -0.2% | USD 2,807,775-0.4% | USD 192.63-0.1% | |
| ACLX (Arcellx Inc) | 41,657 -0.2% | USD 2,763,109-3.2% | USD 66.33-2.9% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,417 -0.2% | USD 2,740,973-5.0% | USD 61.71-4.8% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,527 -0.2% | USD 2,581,929-2.9% | USD 74.78-2.6% | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,615 -0.2% | USD 2,556,716-1.7% | USD 28.53-1.5% | |
| VCYT (Veracyte Inc) | 58,770 -0.2% | USD 2,540,039-0.9% | USD 43.22-0.7% | |
| FOLD (Amicus Therapeutics Inc) | 231,452 -0.2% | USD 2,520,512-0.1% | USD 10.890.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,341 -0.2% | USD 2,503,7144.4% | USD 67.054.6% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,438 -0.2% | USD 2,469,834-1.6% | USD 43-1.4% | |
| RARE (Ultragenyx) | 71,889 -0.2% | USD 2,468,668-5.4% | USD 34.34-5.2% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,482 -0.2% | USD 2,464,411-3.0% | USD 78.28-2.7% | |
| TVTX (Travere Therapeutics Inc) | 66,896 -0.2% | USD 2,398,2222.9% | USD 35.853.1% | |
| APLS (Apellis Pharmaceuticals Inc) | 94,094 -0.2% | USD 2,381,5192.8% | USD 25.313.1% | |
| GRAL (GRAIL, LLC) | 26,852 -0.2% | USD 2,336,661-4.6% | USD 87.02-4.4% | |
| VERA (Vera Therapeutics Inc) | 47,968 -0.2% | USD 2,316,854-2.1% | USD 48.3-1.8% | |
| IDYA (Ideaya Biosciences Inc) | 65,511 -0.2% | USD 2,214,9271.1% | USD 33.811.3% | |
| CGON (CG Oncology, Inc. Common stock) | 56,763 -0.2% | USD 2,148,480-5.0% | USD 37.85-4.8% | |
| DYN (Dyne Therapeutics Inc) | 105,930 -0.2% | USD 2,070,932-0.4% | USD 19.55-0.2% | |
| BEAM (Beam Therapeutics Inc) | 76,134 -0.2% | USD 2,037,346-0.5% | USD 26.76-0.3% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,871 -0.2% | USD 2,023,2072.0% | USD 48.322.2% | |
| WVE (Wave Life Sciences Ltd) | 119,683 -0.2% | USD 1,963,9981.6% | USD 16.411.9% | |
| OCUL (Ocular Therapeutix Inc) | 130,930 -0.2% | USD 1,884,0831.3% | USD 14.391.6% | |
| DNLI (Denali Therapeutics Inc) | 109,928 -0.2% | USD 1,870,975-2.1% | USD 17.02-1.8% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 72,121 -0.2% | USD 1,854,952-1.9% | USD 25.72-1.6% | |
| ADPT (Adaptive Biotechnologies Corp) | 114,471 -0.2% | USD 1,823,5231.3% | USD 15.931.5% | |
| EWTX (Edgewise Therapeutics Inc) | 79,126 -0.2% | USD 1,801,699-5.1% | USD 22.77-4.9% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 49,967 -0.2% | USD 1,800,811-0.2% | USD 36.040.1% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,369 -0.2% | USD 1,760,929-4.5% | USD 34.28-4.3% | |
| HRMY (Harmony Biosciences Holdings) | 43,316 -0.2% | USD 1,681,960-0.5% | USD 38.83-0.2% | |
| SRPT (Sarepta Therapeutics Inc) | 73,636 -0.2% | USD 1,642,8193.3% | USD 22.313.5% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 100,046 -0.2% | USD 1,585,7290.8% | USD 15.851.0% | |
| AVDL (Avadel Pharmaceuticals PLC) | 71,184 -0.2% | USD 1,521,202-0.5% | USD 21.37-0.2% | |
| IBRX (Immunitybio Inc) | 702,776 -0.2% | USD 1,517,996-2.9% | USD 2.16-2.7% | |
| SYRE (Spyre Therapeutics Inc.) | 45,637 -0.2% | USD 1,504,652-1.3% | USD 32.97-1.1% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,724 -0.2% | USD 1,466,315-0.7% | USD 25.85-0.5% | |
| TWST (Twist Bioscience Corp) | 45,964 -0.2% | USD 1,430,8590.0% | USD 31.130.2% | |
| STOK (Stoke Therapeutics Inc) | 40,993 -0.2% | USD 1,377,7751.7% | USD 33.611.9% | |
| MNKD (MannKind Corp) | 232,913 -0.2% | USD 1,376,516-0.7% | USD 5.91-0.5% | |
| VCEL (Vericel Corp Ord) | 38,437 -0.2% | USD 1,364,514-2.9% | USD 35.5-2.7% | |
| SNDX (Syndax Pharmaceuticals Inc) | 65,405 -0.2% | USD 1,355,192-1.0% | USD 20.72-0.8% | |
| LEGN (Legend Biotech Corp) | 62,215 -0.2% | USD 1,346,955-1.9% | USD 21.65-1.6% | |
| RXRX (Recursion Pharmaceuticals Inc) | 318,833 -0.2% | USD 1,339,099-0.2% | USD 4.2 | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,316 -0.2% | USD 1,336,913-0.7% | USD 41.37-0.4% | |
| ANIP (ANI Pharmaceuticals Inc) | 16,466 -0.2% | USD 1,335,393-0.7% | USD 81.1-0.5% | |
| TXG (10X Genomics Inc) | 84,764 -0.2% | USD 1,331,642-0.5% | USD 15.71-0.3% | |
| HROW (Harrow Health Inc) | 28,259 -0.2% | USD 1,265,155-2.3% | USD 44.77-2.0% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 159,950 -0.2% | USD 1,194,827-1.8% | USD 7.47-1.6% | |
| TSHA (Taysha Gene Therapies Inc) | 200,301 -0.2% | USD 1,165,7520.8% | USD 5.821.0% | |
| AGIO (Agios Pharm) | 44,193 -0.2% | USD 1,152,995-3.0% | USD 26.09-2.8% | |
| COLL (Collegium Pharmaceutical Inc) | 23,085 -0.2% | USD 1,124,470-0.8% | USD 48.71-0.6% | |
| NRIX (Nurix Therapeutics Inc) | 58,976 -0.2% | USD 1,111,108-1.1% | USD 18.84-0.9% | |
| IMCR (Immunocore Holdings Ltd) | 30,151 -0.2% | USD 1,091,7680.3% | USD 36.210.5% | |
| RLAY (Relay Therapeutics Inc) | 126,578 -0.2% | USD 1,073,381-0.2% | USD 8.48 | |
| FTRE (Fortrea Holdings Inc.) | 66,648 -0.2% | USD 1,065,702-0.7% | USD 15.99-0.4% | |
| ARDX (Ardelyx Inc) | 176,855 -0.2% | USD 1,061,130-3.4% | USD 6-3.2% | |
| NVCR (Novocure Ltd) | 81,993 -0.2% | USD 1,060,169-0.5% | USD 12.93-0.3% | |
| SANA (Sana Biotechnology Inc) | 192,851 -0.2% | USD 964,255-1.8% | USD 5-1.6% | |
| GMAB (Genmab AS) | 30,710 -0.2% | USD 962,759-0.9% | USD 31.35-0.7% | |
| INVA (Innoviva Inc) | 48,171 -0.2% | USD 959,566-1.3% | USD 19.92-1.1% | |
| DVAX (Dynavax Technologies Corporation) | 86,049 -0.2% | USD 927,608-0.9% | USD 10.78-0.6% | |
| ANAB (AnaptysBio Inc) | 20,508 -0.2% | USD 923,475-1.4% | USD 45.03-1.2% | |
| QURE (Uniqure NV) | 40,517 -0.2% | USD 886,9176.9% | USD 21.897.1% | |
| AMPH (Amphastar P) | 34,079 -0.2% | USD 872,763-2.9% | USD 25.61-2.7% | |
| XERS (Xeris Pharmaceuticals Inc) | 122,104 -0.2% | USD 866,9380.5% | USD 7.10.7% | |
| XNCR (Xencor Inc) | 52,333 -0.2% | USD 866,111-1.7% | USD 16.55-1.4% | |
| PGEN (Precigen Inc) | 223,687 -0.2% | USD 865,6691.3% | USD 3.871.6% | |
| PCRX (Pacira BioSciences, Inc.) | 32,943 -0.2% | USD 862,448-2.1% | USD 26.18-1.9% | |
| CSTL (Castle Biosciences Inc) | 21,332 -0.2% | USD 833,0150.2% | USD 39.050.4% | |
| URGN (UroGen Pharma Ltd) | 35,148 -0.2% | USD 824,9242.5% | USD 23.472.7% | |
| SVRA (Savara Inc) | 126,365 -0.2% | USD 812,527-2.9% | USD 6.43-2.7% | |
| SPRY (Silverback Therapeutics Inc) | 76,161 -0.2% | USD 811,8760.4% | USD 10.660.7% | |
| PHAT (Phathom Pharmaceuticals Inc) | 53,119 -0.2% | USD 809,5343.5% | USD 15.243.7% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 65,412 -0.2% | USD 805,222-2.2% | USD 12.31-2.0% | |
| GRFS (Grifols SA ADR) | 89,579 -0.2% | USD 802,628-1.0% | USD 8.96-0.8% | |
| ERAS (Erasca Inc) | 222,826 -0.2% | USD 784,3482.4% | USD 3.522.6% | |
| NVAX (Novavax Inc) | 119,199 -0.2% | USD 779,561-0.8% | USD 6.54-0.6% | |
| ABCL (Abcellera Biologics Inc) | 219,368 -0.2% | USD 759,013-1.6% | USD 3.46-1.4% | |
| ELVN (Enliven Therapeutics Inc.) | 43,400 -0.2% | USD 733,894-1.7% | USD 16.91-1.5% | |
| TNGX (Tango Therapeutics Inc) | 81,596 -0.2% | USD 731,100-2.0% | USD 8.96-1.8% | |
| NTLA (Intellia Therapeutics Inc) | 79,768 -0.2% | USD 727,484-0.4% | USD 9.12-0.2% | |
| KURA (Kura Oncology Inc) | 66,382 -0.2% | USD 705,6410.4% | USD 10.630.7% | |
| MNMD (Mind Medicine Inc) | 56,892 -0.2% | USD 697,4961.3% | USD 12.261.5% | |
| KROS (Keros Therapeutics Inc) | 31,462 -0.2% | USD 677,3771.2% | USD 21.531.4% | |
| ARVN (Arvinas Inc) | 56,798 -0.2% | USD 675,896-3.8% | USD 11.9-3.6% | |
| ABUS (Arbutus Biopharma Corp) | 143,393 -0.2% | USD 658,174-7.5% | USD 4.59-7.3% | |
| VIR (Vir Biotechnology Inc) | 101,308 -0.2% | USD 656,476-3.8% | USD 6.48-3.6% | |
| ORIC (Oric Pharmaceuticals Inc) | 71,222 -0.2% | USD 649,545-1.4% | USD 9.12-1.2% | |
| TBPH (Theravance Biopharma Inc) | 36,985 -0.2% | USD 648,347-1.6% | USD 17.53-1.4% | |
| JANX (Janux Therapeutics Inc) | 44,046 -0.2% | USD 645,274-3.3% | USD 14.65-3.1% | |
| KALV (Kalvista Pharmaceuticals Inc) | 39,351 -0.2% | USD 625,681-6.1% | USD 15.9-5.9% | |
| GERN (Geron Corporation) | 464,153 -0.2% | USD 621,9650.5% | USD 1.340.8% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,650 -0.2% | USD 615,863-0.5% | USD 8.25001-0.2% | |
| ZLAB (Zai Lab Ltd) | 35,078 -0.2% | USD 596,326-2.2% | USD 17-2.0% | |
| PAHC (Phibro Animal Health Corporation) | 14,740 -0.2% | USD 595,496-0.9% | USD 40.4-0.7% | |
| IOVA (Iovance Biotherapeutics Inc) | 260,611 -0.2% | USD 586,3753.9% | USD 2.254.2% | |
| REPL (Replimune Group Inc) | 58,717 -0.2% | USD 564,270-3.6% | USD 9.60999-3.4% | |
| RGNX (Regenxbio Inc) | 38,592 -0.2% | USD 544,5331.8% | USD 14.112.0% | |
| MGTX (MeiraGTx Holdings PLC) | 59,167 -0.2% | USD 508,836-3.6% | USD 8.6-3.4% | |
| PRME (Prime Medicine, Inc. Common Stock) | 128,497 -0.2% | USD 498,568-4.2% | USD 3.88-4.0% | |
| PACB (Pacific Biosciences of California) | 232,857 -0.2% | USD 470,371-4.9% | USD 2.02-4.7% | |
| LYEL (Lyell Immunopharma Inc) | 14,117 -0.2% | USD 460,7790.5% | USD 32.640.7% | |
| CGEM (Cullinan Oncology LLC) | 44,938 -0.2% | USD 459,266-5.8% | USD 10.22-5.5% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 127,960 -0.2% | USD 452,978-1.6% | USD 3.54-1.4% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,803 -0.2% | USD 423,9715.0% | USD 11.525.2% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 114,894 -0.2% | USD 412,469-2.4% | USD 3.59-2.2% | |
| PRTA (Prothena Corporation plc) | 40,380 -0.2% | USD 393,705-2.4% | USD 9.75-2.2% | |
| EOLS (Evolus Inc) | 51,562 -0.2% | USD 372,2780.9% | USD 7.220011.1% | |
| GLPG (Galapagos NV ADR) | 11,108 -0.2% | USD 345,237-0.3% | USD 31.08-0.1% | |
| TRDA (Entrada Therapeutics Inc) | 30,132 -0.2% | USD 342,6012.8% | USD 11.373.1% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 277,943 -0.2% | USD 333,532-2.7% | USD 1.2-2.4% | |
| SIGA (SIGA Technologies Inc) | 51,786 -0.2% | USD 325,216-0.9% | USD 6.28-0.6% | |
| VNDA (Vanda Pharmaceuticals Inc) | 47,181 -0.2% | USD 313,7540.1% | USD 6.650010.3% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,713 -0.2% | USD 269,9860.4% | USD 3.430010.6% | |
| AUTL (Autolus Therapeutics Ltd) | 160,282 -0.2% | USD 256,451-1.5% | USD 1.6-1.2% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,914 -0.2% | USD 255,221-0.5% | USD 7.30999-0.3% | |
| AVXL (Anavex Life Sciences Corp) | 63,302 -0.2% | USD 254,474-3.1% | USD 4.02-2.9% | |
| ALLO (Allogene Therapeutics Inc) | 161,600 -0.2% | USD 248,8644.5% | USD 1.544.8% | |
| ACIU (AC Immune Ltd) | 73,686 -0.2% | USD 242,4271.3% | USD 3.291.5% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,836 -0.2% | USD 199,1122.0% | USD 3.222.2% | |
| OABI (OmniAb Inc.) | 91,048 -0.2% | USD 186,6480.7% | USD 2.051.0% | |
| EDIT (Editas Medicine Inc) | 70,741 -0.2% | USD 177,5602.6% | USD 2.512.9% | |
| VYGR (Voyager Therapeutics Inc) | 37,953 -0.2% | USD 167,7521.1% | USD 4.419991.4% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 21,022 -0.2% | USD 149,887-1.9% | USD 7.13001-1.7% | |
| HUMA (Humacyte Inc) | 120,029 -0.2% | USD 134,432-5.3% | USD 1.12-5.1% | |
| ALEC (Alector Inc) | 78,415 -0.2% | USD 108,997-2.3% | USD 1.39-2.1% | |
| MRSN (Mersana Therapeutics Inc) | 3,472 -0.2% | USD 100,8441.4% | USD 29.04491.6% | |
| FATE (Fate Therapeutics Inc) | 80,368 -0.2% | USD 87,601-2.9% | USD 1.09-2.7% | |
| BMEA (Biomea Fusion Inc) | 51,151 -0.2% | USD 70,0772.0% | USD 1.372.2% | |
| MGNX (MacroGenics Inc) | 45,525 -0.2% | USD 61,459-1.7% | USD 1.35001-1.5% | |
| STRO (Sutro Biopharma) | 5,599 -0.2% | USD 54,926-1.4% | USD 9.80997-1.2% | |
| PLRX (Pliant Therapeutics Inc) | 42,899 -0.2% | USD 53,6240.6% | USD 1.250010.8% | |
| OKUR (OKUR) | 8,962 -0.2% | USD 27,065-5.8% | USD 3.01997-5.6% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 158,567 0.5% | USD 72,260,5681.3% | USD 455.710.8% | |
| AMGN (Amgen Inc) | 215,505 0.5% | USD 70,105,9322.8% | USD 325.312.4% | |
| REGN (Regeneron Pharmaceuticals Inc) | 77,407 0.5% | USD 58,258,0562.0% | USD 752.621.5% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 97,401 0.4% | USD 38,132,492-1.1% | USD 391.5-1.5% | |
| INSM (Insmed Inc) | 158,374 0.5% | USD 31,187,0080.4% | USD 196.920.0% | |
| ARGX (argenx NV ADR) | 22,937 0.4% | USD 19,518,240-2.6% | USD 850.95-3.1% | |
| BIIB (Biogen Inc) | 109,852 0.4% | USD 19,305,3901.4% | USD 175.740.9% | |
| UTHR (United Therapeutics Corporation) | 33,887 0.5% | USD 16,953,6661.7% | USD 500.31.3% | |
| ILMN (Illumina Inc) | 115,160 0.5% | USD 15,537,3870.5% | USD 134.920.0% | |
| INCY (Incyte Corporation) | 146,312 0.5% | USD 14,432,2163.9% | USD 98.643.4% | |
| RPRX (Royalty Pharma Plc) | 323,904 0.5% | USD 12,480,0210.8% | USD 38.530.4% | |
| MEDP (Medpace Holdings Inc) | 21,053 0.4% | USD 11,771,3640.7% | USD 559.130.2% | |
| NBIX (Neurocrine Biosciences Inc) | 74,333 0.5% | USD 11,451,7421.3% | USD 154.060.8% | |
| ROIV (Roivant Sciences Ltd) | 510,264 0.5% | USD 11,174,782-0.5% | USD 21.9-0.9% | |
| RVMD (Revolution Medicines Inc) | 140,270 0.5% | USD 11,081,3300.6% | USD 790.1% | |
| BBIO (BridgeBio Pharma Inc) | 143,441 0.5% | USD 10,687,789-0.4% | USD 74.51-0.9% | |
| VTRS (Viatris Inc) | 871,298 0.5% | USD 10,159,3350.5% | USD 11.660.1% | |
| ASND (Ascendis Pharma AS) | 45,594 0.4% | USD 9,722,465-2.8% | USD 213.24-3.3% | |
| SMMT (Summit Therapeutics PLC) | 557,087 0.5% | USD 9,682,172-0.6% | USD 17.38-1.1% | |
| SNY (Sanofi ADR) | 201,346 0.5% | USD 9,628,366-1.3% | USD 47.82-1.8% | |
| GH (Guardant Health Inc) | 93,340 0.4% | USD 9,583,2181.0% | USD 102.670.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 119,149 0.5% | USD 9,503,324-0.9% | USD 79.76-1.3% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,670 0.4% | USD 9,344,369-1.5% | USD 560.55-1.9% | |
| MRNA (Moderna Inc) | 291,524 0.5% | USD 8,722,3982.0% | USD 29.921.6% | |
| EXEL (Exelixis Inc) | 201,704 0.5% | USD 8,346,5121.7% | USD 41.381.2% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 45,560 0.4% | USD 7,723,7871.7% | USD 169.531.2% | |
| BMRN (Biomarin Pharmaceutical Inc) | 143,868 0.5% | USD 7,498,400-1.8% | USD 52.12-2.2% | |
| BNTX (BioNTech SE) | 75,581 0.5% | USD 7,090,254-0.6% | USD 93.81-1.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 103,362 0.5% | USD 7,075,129-1.9% | USD 68.45-2.3% | |
| RNA (Avidity Biosciences Inc) | 96,537 0.5% | USD 6,937,1490.5% | USD 71.860.0% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 49,832 0.5% | USD 5,607,097-0.5% | USD 112.52-0.9% | |
| CYTK (Cytokinetics Inc) | 89,324 0.4% | USD 5,552,380-1.4% | USD 62.16-1.9% | |
| HALO (Halozyme Therapeutics Inc) | 87,374 0.5% | USD 5,543,8802.5% | USD 63.452.0% | |
| AXSM (Axsome Therapeutics Inc) | 37,308 0.5% | USD 5,455,922-0.9% | USD 146.24-1.3% | |
| KRYS (Krystal Biotech Inc) | 21,684 0.5% | USD 5,268,778-0.2% | USD 242.98-0.7% | |
| NUVL (Nuvalent Inc) | 49,894 0.5% | USD 5,237,3730.6% | USD 104.970.2% | |
| KYMR (Kymera Therapeutics Inc) | 53,662 0.4% | USD 4,597,760-4.0% | USD 85.68-4.5% | |
| PTCT (PTC Therapeutics Inc) | 59,606 0.5% | USD 4,544,9581.3% | USD 76.250.8% | |
| PTGX (Protagonist Therapeutics Inc) | 46,751 0.5% | USD 4,431,527-0.1% | USD 94.79-0.6% | |
| PRAX (Praxis Precision Medicines Inc) | 15,803 0.4% | USD 4,367,9493.3% | USD 276.42.8% | |
| PCVX (Vaxcyte Inc) | 97,422 0.5% | USD 4,319,6910.1% | USD 44.34-0.4% | |
| COGT (Cogent Biosciences Inc) | 105,032 0.5% | USD 4,226,488-4.0% | USD 40.24-4.4% | |
| CRSP (Crispr Therapeutics AG) | 68,230 0.5% | USD 3,837,938-0.3% | USD 56.25-0.8% | |
| ADMA (ADMA Biologics Inc) | 177,946 0.5% | USD 3,510,8750.2% | USD 19.73-0.3% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 70,934 0.5% | USD 3,498,465-1.9% | USD 49.32-2.3% | |
| ALKS (Alkermes Plc) | 124,026 0.5% | USD 3,493,812-0.7% | USD 28.17-1.2% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 125,802 0.5% | USD 3,429,3630.9% | USD 27.260.4% | |
| IMVT (Immunovant Inc) | 130,334 0.5% | USD 3,388,684-1.1% | USD 26-1.6% | |
| SRRK (Scholar Rock Holding Corp) | 71,525 0.5% | USD 3,235,791-3.0% | USD 45.24-3.5% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 234,579 0.5% | USD 2,922,8542.5% | USD 12.462.0% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,517 0.5% | USD 2,884,702-2.9% | USD 64.8-3.4% | |
| ACLX (Arcellx Inc) | 41,751 0.5% | USD 2,853,263-4.5% | USD 68.34-4.9% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,609 0.5% | USD 2,817,7842.2% | USD 192.881.8% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,605 0.5% | USD 2,658,0100.1% | USD 76.81-0.4% | |
| RARE (Ultragenyx) | 72,051 0.5% | USD 2,610,4080.5% | USD 36.23 | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,817 0.5% | USD 2,600,2020.2% | USD 28.95-0.2% | |
| VCYT (Veracyte Inc) | 58,902 0.5% | USD 2,564,0042.1% | USD 43.531.6% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,553 0.5% | USD 2,539,385-0.6% | USD 80.48-1.1% | |
| FOLD (Amicus Therapeutics Inc) | 231,975 0.5% | USD 2,523,8883.6% | USD 10.883.1% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,567 0.5% | USD 2,509,921-0.6% | USD 43.6-1.0% | |
| GRAL (GRAIL, LLC) | 26,912 0.4% | USD 2,450,0680.7% | USD 91.040.2% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,425 0.5% | USD 2,398,943-0.9% | USD 64.1-1.4% | |
| VERA (Vera Therapeutics Inc) | 48,076 0.5% | USD 2,365,820-0.7% | USD 49.21-1.2% | |
| TVTX (Travere Therapeutics Inc) | 67,047 0.5% | USD 2,330,5540.3% | USD 34.76-0.2% | |
| APLS (Apellis Pharmaceuticals Inc) | 94,306 0.5% | USD 2,316,155-2.2% | USD 24.56-2.7% | |
| CGON (CG Oncology, Inc. Common stock) | 56,891 0.5% | USD 2,261,417-2.5% | USD 39.75-2.9% | |
| IDYA (Ideaya Biosciences Inc) | 65,659 0.5% | USD 2,191,041-1.5% | USD 33.37-1.9% | |
| DYN (Dyne Therapeutics Inc) | 106,169 0.5% | USD 2,079,8512.1% | USD 19.591.7% | |
| BEAM (Beam Therapeutics Inc) | 76,306 0.5% | USD 2,047,290-1.5% | USD 26.83-1.9% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,965 0.5% | USD 1,984,1050.7% | USD 47.280.3% | |
| WVE (Wave Life Sciences Ltd) | 119,954 0.5% | USD 1,932,459-2.3% | USD 16.11-2.7% | |
| DNLI (Denali Therapeutics Inc) | 110,177 0.5% | USD 1,910,469-3.1% | USD 17.34-3.6% | |
| EWTX (Edgewise Therapeutics Inc) | 79,305 0.5% | USD 1,898,5621.8% | USD 23.941.4% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 72,284 0.5% | USD 1,890,227-0.9% | USD 26.15-1.4% | |
| OCUL (Ocular Therapeutix Inc) | 131,226 0.5% | USD 1,859,472-2.2% | USD 14.17-2.7% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,485 0.5% | USD 1,844,7088.9% | USD 35.838.4% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 50,080 0.5% | USD 1,803,882-1.9% | USD 36.02-2.4% | |
| ADPT (Adaptive Biotechnologies Corp) | 114,730 0.5% | USD 1,800,1142.1% | USD 15.691.6% | |
| HRMY (Harmony Biosciences Holdings) | 43,414 0.5% | USD 1,689,673-3.5% | USD 38.92-3.9% | |
| SRPT (Sarepta Therapeutics Inc) | 73,803 0.5% | USD 1,590,4550.5% | USD 21.550.1% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 100,272 0.5% | USD 1,573,268-0.6% | USD 15.69-1.0% | |
| IBRX (Immunitybio Inc) | 704,370 0.5% | USD 1,563,701-5.5% | USD 2.22-5.9% | |
| AVDL (Avadel Pharmaceuticals PLC) | 71,345 0.5% | USD 1,528,2100.7% | USD 21.420.3% | |
| SYRE (Spyre Therapeutics Inc.) | 45,740 0.5% | USD 1,524,972-0.4% | USD 33.34-0.8% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,852 0.5% | USD 1,476,4462.4% | USD 25.971.9% | |
| TWST (Twist Bioscience Corp) | 46,068 0.5% | USD 1,431,3330.9% | USD 31.070.5% | |
| VCEL (Vericel Corp Ord) | 38,524 0.5% | USD 1,405,7410.3% | USD 36.49-0.1% | |
| MNKD (MannKind Corp) | 233,442 0.5% | USD 1,386,6450.5% | USD 5.94 | |
| LEGN (Legend Biotech Corp) | 62,356 0.5% | USD 1,372,456-0.9% | USD 22.01-1.4% | |
| SNDX (Syndax Pharmaceuticals Inc) | 65,553 0.5% | USD 1,368,7473.0% | USD 20.882.5% | |
| STOK (Stoke Therapeutics Inc) | 41,086 0.5% | USD 1,355,0162.3% | USD 32.981.8% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,389 0.5% | USD 1,345,7630.4% | USD 41.55-0.1% | |
| ANIP (ANI Pharmaceuticals Inc) | 16,503 0.5% | USD 1,345,1601.8% | USD 81.511.4% | |
| RXRX (Recursion Pharmaceuticals Inc) | 319,557 0.5% | USD 1,342,139-2.6% | USD 4.2-3.0% | |
| TXG (10X Genomics Inc) | 84,956 0.5% | USD 1,338,9072.4% | USD 15.761.9% | |
| HROW (Harrow Health Inc) | 28,323 0.5% | USD 1,294,361-2.4% | USD 45.7-2.9% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 160,313 0.5% | USD 1,216,7760.7% | USD 7.590.3% | |
| AGIO (Agios Pharm) | 44,293 0.5% | USD 1,189,267-1.1% | USD 26.85-1.5% | |
| TSHA (Taysha Gene Therapies Inc) | 200,756 0.5% | USD 1,156,355-0.1% | USD 5.76-0.5% | |
| COLL (Collegium Pharmaceutical Inc) | 23,137 0.5% | USD 1,133,9441.2% | USD 49.010.8% | |
| NRIX (Nurix Therapeutics Inc) | 59,110 0.5% | USD 1,123,6810.1% | USD 19.01-0.3% | |
| ARDX (Ardelyx Inc) | 177,257 0.5% | USD 1,098,9930.3% | USD 6.2-0.2% | |
| IMCR (Immunocore Holdings Ltd) | 30,219 0.5% | USD 1,088,488-1.7% | USD 36.02-2.1% | |
| RLAY (Relay Therapeutics Inc) | 126,866 0.5% | USD 1,075,8246.1% | USD 8.485.6% | |
| FTRE (Fortrea Holdings Inc.) | 66,799 0.5% | USD 1,072,7922.6% | USD 16.062.2% | |
| NVCR (Novocure Ltd) | 82,179 0.5% | USD 1,065,862-2.2% | USD 12.97-2.6% | |
| SANA (Sana Biotechnology Inc) | 193,290 0.5% | USD 981,913-0.7% | USD 5.08-1.2% | |
| INVA (Innoviva Inc) | 48,280 0.5% | USD 972,359-1.9% | USD 20.14-2.4% | |
| GMAB (Genmab AS) | 30,780 0.5% | USD 971,7251.3% | USD 31.570.8% | |
| ANAB (AnaptysBio Inc) | 20,554 0.4% | USD 936,4401.8% | USD 45.561.4% | |
| DVAX (Dynavax Technologies Corporation) | 86,245 0.5% | USD 935,7580.9% | USD 10.850.5% | |
| AMPH (Amphastar P) | 34,156 0.5% | USD 898,6444.6% | USD 26.314.1% | |
| PCRX (Pacira BioSciences, Inc.) | 33,018 0.5% | USD 880,9201.9% | USD 26.681.5% | |
| XNCR (Xencor Inc) | 52,452 0.5% | USD 880,6692.1% | USD 16.791.6% | |
| XERS (Xeris Pharmaceuticals Inc) | 122,383 0.5% | USD 862,800-1.2% | USD 7.05-1.7% | |
| PGEN (Precigen Inc) | 224,198 0.5% | USD 854,1943.7% | USD 3.813.3% | |
| SVRA (Savara Inc) | 126,654 0.5% | USD 837,183-4.0% | USD 6.61-4.5% | |
| CSTL (Castle Biosciences Inc) | 21,380 0.5% | USD 831,2541.1% | USD 38.880.6% | |
| QURE (Uniqure NV) | 40,609 0.5% | USD 829,6425.2% | USD 20.434.7% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 65,561 0.5% | USD 823,446-3.7% | USD 12.56-4.1% | |
| GRFS (Grifols SA ADR) | 89,783 0.5% | USD 810,740-0.8% | USD 9.02999-1.2% | |
| SPRY (Silverback Therapeutics Inc) | 76,335 0.5% | USD 808,3883.9% | USD 10.593.4% | |
| URGN (UroGen Pharma Ltd) | 35,228 0.5% | USD 804,9605.3% | USD 22.854.8% | |
| NVAX (Novavax Inc) | 119,471 0.5% | USD 786,1190.6% | USD 6.580.2% | |
| PHAT (Phathom Pharmaceuticals Inc) | 53,240 0.5% | USD 782,0961.4% | USD 14.690.9% | |
| ABCL (Abcellera Biologics Inc) | 219,870 0.5% | USD 771,744-2.6% | USD 3.51-3.0% | |
| ERAS (Erasca Inc) | 223,336 0.5% | USD 766,042-4.3% | USD 3.43-4.7% | |
| ELVN (Enliven Therapeutics Inc.) | 43,499 0.5% | USD 746,8782.3% | USD 17.171.8% | |
| TNGX (Tango Therapeutics Inc) | 81,783 0.5% | USD 745,861-2.0% | USD 9.12-2.5% | |
| NTLA (Intellia Therapeutics Inc) | 79,950 0.5% | USD 730,7431.8% | USD 9.141.3% | |
| ABUS (Arbutus Biopharma Corp) | 143,721 0.5% | USD 711,4195.6% | USD 4.955.1% | |
| KURA (Kura Oncology Inc) | 66,534 0.5% | USD 702,5993.8% | USD 10.563.3% | |
| ARVN (Arvinas Inc) | 56,928 0.5% | USD 702,492-1.5% | USD 12.34-1.9% | |
| MNMD (Mind Medicine Inc) | 57,022 0.5% | USD 688,826-3.3% | USD 12.08-3.7% | |
| VIR (Vir Biotechnology Inc) | 101,540 0.5% | USD 682,3490.9% | USD 6.720.4% | |
| KROS (Keros Therapeutics Inc) | 31,534 0.5% | USD 669,467-0.8% | USD 21.23-1.3% | |
| JANX (Janux Therapeutics Inc) | 44,147 0.5% | USD 667,503-0.7% | USD 15.12-1.2% | |
| KALV (Kalvista Pharmaceuticals Inc) | 39,441 0.5% | USD 666,5530.4% | USD 16.9-0.1% | |
| ORIC (Oric Pharmaceuticals Inc) | 71,385 0.5% | USD 658,884-1.1% | USD 9.23001-1.6% | |
| TBPH (Theravance Biopharma Inc) | 37,069 0.5% | USD 658,716-1.8% | USD 17.77-2.2% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,821 0.5% | USD 618,770-0.6% | USD 8.27-1.1% | |
| GERN (Geron Corporation) | 465,219 0.5% | USD 618,741-1.8% | USD 1.33-2.2% | |
| ZLAB (Zai Lab Ltd) | 35,158 0.5% | USD 609,640-2.0% | USD 17.34-2.4% | |
| PAHC (Phibro Animal Health Corporation) | 14,773 0.4% | USD 600,8181.7% | USD 40.671.3% | |
| REPL (Replimune Group Inc) | 58,852 0.5% | USD 585,577-1.8% | USD 9.94999-2.3% | |
| IOVA (Iovance Biotherapeutics Inc) | 261,211 0.5% | USD 564,216-1.4% | USD 2.16-1.8% | |
| RGNX (Regenxbio Inc) | 38,681 0.5% | USD 534,9580.2% | USD 13.83-0.3% | |
| MGTX (MeiraGTx Holdings PLC) | 59,303 0.5% | USD 527,7970.2% | USD 8.90001-0.2% | |
| PRME (Prime Medicine, Inc. Common Stock) | 128,793 0.5% | USD 520,324-1.0% | USD 4.04-1.5% | |
| PACB (Pacific Biosciences of California) | 233,395 0.5% | USD 494,7970.5% | USD 2.12 | |
| CGEM (Cullinan Oncology LLC) | 45,042 0.5% | USD 487,354-8.8% | USD 10.82-9.2% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 128,256 0.5% | USD 460,4390.7% | USD 3.590.3% | |
| LYEL (Lyell Immunopharma Inc) | 14,149 0.5% | USD 458,428-5.6% | USD 32.4-6.0% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 115,161 0.5% | USD 422,6412.4% | USD 3.671.9% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,888 0.5% | USD 403,9241.5% | USD 10.951.0% | |
| PRTA (Prothena Corporation plc) | 40,474 0.5% | USD 403,526-3.3% | USD 9.97001-3.8% | |
| EOLS (Evolus Inc) | 51,682 0.5% | USD 369,0091.9% | USD 7.139991.4% | |
| GLPG (Galapagos NV ADR) | 11,134 0.5% | USD 346,379-1.4% | USD 31.11-1.8% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 278,594 0.5% | USD 342,671-4.9% | USD 1.23-5.4% | |
| TRDA (Entrada Therapeutics Inc) | 30,202 0.5% | USD 333,1280.0% | USD 11.03-0.5% | |
| SIGA (SIGA Technologies Inc) | 51,907 0.5% | USD 328,052-1.7% | USD 6.32-2.2% | |
| VNDA (Vanda Pharmaceuticals Inc) | 47,291 0.5% | USD 313,5396.9% | USD 6.629996.4% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,898 0.5% | USD 269,0421.1% | USD 3.410.6% | |
| AVXL (Anavex Life Sciences Corp) | 63,451 0.5% | USD 262,6873.5% | USD 4.143.0% | |
| AUTL (Autolus Therapeutics Ltd) | 160,660 0.5% | USD 260,2691.1% | USD 1.620.6% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,995 0.5% | USD 256,513-1.2% | USD 7.32999-1.6% | |
| ACIU (AC Immune Ltd) | 73,860 0.5% | USD 239,3063.3% | USD 3.239992.9% | |
| ALLO (Allogene Therapeutics Inc) | 161,981 0.5% | USD 238,112-2.2% | USD 1.47-2.6% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,981 0.5% | USD 195,2400.5% | USD 3.150.0% | |
| OABI (OmniAb Inc.) | 91,263 0.5% | USD 185,264-5.1% | USD 2.03-5.6% | |
| EDIT (Editas Medicine Inc) | 70,907 0.5% | USD 173,013-3.1% | USD 2.44-3.6% | |
| VYGR (Voyager Therapeutics Inc) | 38,042 0.5% | USD 165,863-0.2% | USD 4.36-0.7% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 21,071 0.5% | USD 152,765-2.4% | USD 7.25001-2.8% | |
| HUMA (Humacyte Inc) | 120,312 0.5% | USD 141,968-9.5% | USD 1.18-9.9% | |
| ALEC (Alector Inc) | 78,599 0.5% | USD 111,611-4.2% | USD 1.42001-4.7% | |
| MRSN (Mersana Therapeutics Inc) | 3,480 0.5% | USD 99,4931.3% | USD 28.58990.8% | |
| FATE (Fate Therapeutics Inc) | 80,558 0.5% | USD 90,225-2.1% | USD 1.12-2.6% | |
| BMEA (Biomea Fusion Inc) | 51,271 0.5% | USD 68,703-4.5% | USD 1.34-5.0% | |
| MGNX (MacroGenics Inc) | 45,632 0.5% | USD 62,516-1.7% | USD 1.37-2.1% | |
| STRO (Sutro Biopharma) | 5,612 0.5% | USD 55,7271.5% | USD 9.929971.0% | |
| PLRX (Pliant Therapeutics Inc) | 42,999 0.5% | USD 53,3191.3% | USD 1.240010.8% | |
| OKUR (OKUR) | 8,983 0.5% | USD 28,7464.7% | USD 3.200044.2% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 157,855 | USD 71,356,7741.4% | USD 452.041.4% | |
| AMGN (Amgen Inc) | 214,539 | USD 68,167,6220.1% | USD 317.740.1% | |
| REGN (Regeneron Pharmaceuticals Inc) | 77,059 | USD 57,123,066-0.7% | USD 741.29-0.7% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 96,965 | USD 38,548,436-3.7% | USD 397.55-3.7% | |
| INSM (Insmed Inc) | 157,664 | USD 31,061,3850.9% | USD 197.010.9% | |
| ARGX (argenx NV ADR) | 22,835 | USD 20,047,760-1.3% | USD 877.94-1.3% | |
| BIIB (Biogen Inc) | 109,360 | USD 19,039,5760.9% | USD 174.10.9% | |
| UTHR (United Therapeutics Corporation) | 33,735 | USD 16,664,7531.1% | USD 493.991.1% | |
| ILMN (Illumina Inc) | 114,644 | USD 15,462,036-1.2% | USD 134.87-1.2% | |
| INCY (Incyte Corporation) | 145,656 | USD 13,897,039-0.7% | USD 95.41-0.7% | |
| RPRX (Royalty Pharma Plc) | 322,450 | USD 12,378,856-1.1% | USD 38.39-1.1% | |
| MEDP (Medpace Holdings Inc) | 20,959 | USD 11,693,026-1.5% | USD 557.9-1.5% | |
| NBIX (Neurocrine Biosciences Inc) | 73,999 | USD 11,307,047-1.3% | USD 152.8-1.3% | |
| ROIV (Roivant Sciences Ltd) | 507,974 | USD 11,226,2253.6% | USD 22.13.6% | |
| RVMD (Revolution Medicines Inc) | 139,640 | USD 11,020,3890.5% | USD 78.920.5% | |
| BBIO (BridgeBio Pharma Inc) | 142,797 | USD 10,731,1951.5% | USD 75.151.5% | |
| VTRS (Viatris Inc) | 867,386 | USD 10,105,0470.5% | USD 11.650.5% | |
| ASND (Ascendis Pharma AS) | 45,390 | USD 10,004,8644.9% | USD 220.424.9% | |
| SNY (Sanofi ADR) | 200,442 | USD 9,757,517-0.4% | USD 48.68-0.4% | |
| SMMT (Summit Therapeutics PLC) | 554,587 | USD 9,744,094-2.3% | USD 17.57-2.3% | |
| IONS (Ionis Pharmaceuticals Inc) | 118,615 | USD 9,586,4642.1% | USD 80.822.1% | |
| GH (Guardant Health Inc) | 92,922 | USD 9,484,5490.7% | USD 102.070.7% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,596 | USD 9,483,6180.0% | USD 571.440.0% | |
| MRNA (Moderna Inc) | 290,214 | USD 8,549,704-0.6% | USD 29.46-0.6% | |
| EXEL (Exelixis Inc) | 200,798 | USD 8,208,622-1.2% | USD 40.88-1.2% | |
| BMRN (Biomarin Pharmaceutical Inc) | 143,222 | USD 7,635,1650.6% | USD 53.310.6% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 45,356 | USD 7,597,1301.6% | USD 167.51.6% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 102,898 | USD 7,212,121-1.0% | USD 70.09-1.0% | |
| BNTX (BioNTech SE) | 75,241 | USD 7,133,599-1.2% | USD 94.81-1.2% | |
| RNA (Avidity Biosciences Inc) | 96,103 | USD 6,903,0780.3% | USD 71.830.3% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 49,608 | USD 5,633,484-3.5% | USD 113.56-3.5% | |
| CYTK (Cytokinetics Inc) | 88,924 | USD 5,633,3354.2% | USD 63.354.2% | |
| AXSM (Axsome Therapeutics Inc) | 37,140 | USD 5,503,034-0.4% | USD 148.17-0.4% | |
| HALO (Halozyme Therapeutics Inc) | 86,982 | USD 5,411,1500.5% | USD 62.210.5% | |
| KRYS (Krystal Biotech Inc) | 21,586 | USD 5,281,015-0.9% | USD 244.65-0.9% | |
| NUVL (Nuvalent Inc) | 49,670 | USD 5,205,416-1.0% | USD 104.8-1.0% | |
| KYMR (Kymera Therapeutics Inc) | 53,422 | USD 4,790,8852.1% | USD 89.682.1% | |
| PTCT (PTC Therapeutics Inc) | 59,338 | USD 4,488,3260.3% | USD 75.640.3% | |
| PTGX (Protagonist Therapeutics Inc) | 46,541 | USD 4,437,6843.4% | USD 95.353.4% | |
| COGT (Cogent Biosciences Inc) | 104,560 | USD 4,403,0225.2% | USD 42.115.2% | |
| PCVX (Vaxcyte Inc) | 96,984 | USD 4,315,788-0.2% | USD 44.5-0.2% | |
| PRAX (Praxis Precision Medicines Inc) | 15,733 | USD 4,229,0300.6% | USD 268.80.6% | |
| CRSP (Crispr Therapeutics AG) | 67,924 | USD 3,849,932-2.4% | USD 56.68-2.4% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 70,616 | USD 3,565,4022.4% | USD 50.492.4% | |
| ALKS (Alkermes Plc) | 123,468 | USD 3,518,838-2.3% | USD 28.5-2.3% | |
| ADMA (ADMA Biologics Inc) | 177,146 | USD 3,503,948-2.9% | USD 19.78-2.9% | |
| IMVT (Immunovant Inc) | 129,748 | USD 3,427,9426.5% | USD 26.426.5% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 125,236 | USD 3,400,1571.8% | USD 27.151.8% | |
| SRRK (Scholar Rock Holding Corp) | 71,203 | USD 3,337,2850.1% | USD 46.870.1% | |
| ACLX (Arcellx Inc) | 41,563 | USD 2,986,717-1.1% | USD 71.86-1.1% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,317 | USD 2,971,898-0.6% | USD 67.06-0.6% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 233,523 | USD 2,851,316-0.3% | USD 12.21-0.3% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,543 | USD 2,756,6263.5% | USD 189.553.5% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,449 | USD 2,655,3290.7% | USD 77.080.7% | |
| RARE (Ultragenyx) | 71,727 | USD 2,598,6690.1% | USD 36.230.1% | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,413 | USD 2,594,765-1.5% | USD 29.02-1.5% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,411 | USD 2,555,285-0.4% | USD 81.35-0.4% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,309 | USD 2,525,0350.9% | USD 44.060.9% | |
| VCYT (Veracyte Inc) | 58,638 | USD 2,512,0521.5% | USD 42.841.5% | |
| FOLD (Amicus Therapeutics Inc) | 230,929 | USD 2,436,3016.6% | USD 10.556.6% | |
| GRAL (GRAIL, LLC) | 26,792 | USD 2,433,249-4.5% | USD 90.82-4.5% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,257 | USD 2,421,705-1.1% | USD 65-1.1% | |
| VERA (Vera Therapeutics Inc) | 47,860 | USD 2,383,4288.2% | USD 49.88.2% | |
| APLS (Apellis Pharmaceuticals Inc) | 93,882 | USD 2,368,6431.1% | USD 25.231.1% | |
| TVTX (Travere Therapeutics Inc) | 66,745 | USD 2,324,728-0.5% | USD 34.83-0.5% | |
| CGON (CG Oncology, Inc. Common stock) | 56,635 | USD 2,318,637-1.6% | USD 40.94-1.6% | |
| IDYA (Ideaya Biosciences Inc) | 65,363 | USD 2,223,6491.4% | USD 34.021.4% | |
| BEAM (Beam Therapeutics Inc) | 75,962 | USD 2,078,320-0.5% | USD 27.36-0.5% | |
| DYN (Dyne Therapeutics Inc) | 105,691 | USD 2,036,666-0.8% | USD 19.27-0.8% | |
| WVE (Wave Life Sciences Ltd) | 119,412 | USD 1,977,463-1.1% | USD 16.56-1.1% | |
| DNLI (Denali Therapeutics Inc) | 109,681 | USD 1,972,0643.5% | USD 17.983.5% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,777 | USD 1,970,2031.4% | USD 47.161.4% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 71,958 | USD 1,907,607-2.5% | USD 26.51-2.5% | |
| OCUL (Ocular Therapeutix Inc) | 130,634 | USD 1,902,031-0.7% | USD 14.56-0.7% | |
| EWTX (Edgewise Therapeutics Inc) | 78,947 | USD 1,864,7280.8% | USD 23.620.8% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 49,854 | USD 1,839,6132.4% | USD 36.92.4% | |
| ADPT (Adaptive Biotechnologies Corp) | 114,212 | USD 1,763,4330.1% | USD 15.440.1% | |
| HRMY (Harmony Biosciences Holdings) | 43,218 | USD 1,750,7612.3% | USD 40.512.3% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,253 | USD 1,693,9124.7% | USD 33.054.7% | |
| IBRX (Immunitybio Inc) | 701,186 | USD 1,654,7997.8% | USD 2.367.8% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 99,820 | USD 1,582,147-0.2% | USD 15.85-0.2% | |
| SRPT (Sarepta Therapeutics Inc) | 73,469 | USD 1,581,788-1.0% | USD 21.53-1.0% | |
| SYRE (Spyre Therapeutics Inc.) | 45,534 | USD 1,530,853-2.2% | USD 33.62-2.2% | |
| AVDL (Avadel Pharmaceuticals PLC) | 71,023 | USD 1,517,051-0.1% | USD 21.36-0.1% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,596 | USD 1,442,0662.2% | USD 25.482.2% | |
| TWST (Twist Bioscience Corp) | 45,860 | USD 1,418,450-3.7% | USD 30.93-3.7% | |
| VCEL (Vericel Corp Ord) | 38,350 | USD 1,401,309-2.3% | USD 36.54-2.3% | |
| LEGN (Legend Biotech Corp) | 62,074 | USD 1,385,492-3.0% | USD 22.32-3.0% | |
| MNKD (MannKind Corp) | 232,384 | USD 1,380,3612.2% | USD 5.942.2% | |
| RXRX (Recursion Pharmaceuticals Inc) | 318,109 | USD 1,377,412-5.5% | USD 4.33-5.5% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,243 | USD 1,340,9861.4% | USD 41.591.4% | |
| SNDX (Syndax Pharmaceuticals Inc) | 65,257 | USD 1,329,285-0.2% | USD 20.37-0.2% | |
| HROW (Harrow Health Inc) | 28,195 | USD 1,326,857-7.9% | USD 47.06-7.9% | |
| STOK (Stoke Therapeutics Inc) | 40,900 | USD 1,324,751-2.1% | USD 32.39-2.1% | |
| ANIP (ANI Pharmaceuticals Inc) | 16,429 | USD 1,320,727-2.1% | USD 80.39-2.1% | |
| TXG (10X Genomics Inc) | 84,572 | USD 1,307,483-6.5% | USD 15.46-6.5% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 159,587 | USD 1,208,074-0.1% | USD 7.57-0.1% | |
| AGIO (Agios Pharm) | 44,093 | USD 1,202,416-0.7% | USD 27.27-0.7% | |
| TSHA (Taysha Gene Therapies Inc) | 199,846 | USD 1,157,1080.5% | USD 5.790.5% | |
| NRIX (Nurix Therapeutics Inc) | 58,842 | USD 1,122,117 | USD 19.07 | |
| COLL (Collegium Pharmaceutical Inc) | 23,033 | USD 1,120,0950.6% | USD 48.630.6% | |
| IMCR (Immunocore Holdings Ltd) | 30,083 | USD 1,107,0542.8% | USD 36.82.8% | |
| ARDX (Ardelyx Inc) | 176,453 | USD 1,095,7735.3% | USD 6.215.3% | |
| NVCR (Novocure Ltd) | 81,807 | USD 1,089,669-2.5% | USD 13.32-2.5% | |
| FTRE (Fortrea Holdings Inc.) | 66,497 | USD 1,045,3331.1% | USD 15.721.1% | |
| RLAY (Relay Therapeutics Inc) | 126,290 | USD 1,014,1093.1% | USD 8.033.1% | |
| INVA (Innoviva Inc) | 48,062 | USD 991,5190.0% | USD 20.630.0% | |
| SANA (Sana Biotechnology Inc) | 192,412 | USD 988,9982.8% | USD 5.142.8% | |
| GMAB (Genmab AS) | 30,640 | USD 959,338-3.1% | USD 31.31-3.1% | |
| DVAX (Dynavax Technologies Corporation) | 85,853 | USD 927,212-0.6% | USD 10.8-0.6% | |
| ANAB (AnaptysBio Inc) | 20,462 | USD 919,562-1.8% | USD 44.94-1.8% | |
| XERS (Xeris Pharmaceuticals Inc) | 121,825 | USD 873,4852.3% | USD 7.172.3% | |
| SVRA (Savara Inc) | 126,078 | USD 872,460-0.3% | USD 6.92-0.3% | |
| PCRX (Pacira BioSciences, Inc.) | 32,868 | USD 864,1002.2% | USD 26.292.2% | |
| XNCR (Xencor Inc) | 52,214 | USD 862,575-3.2% | USD 16.52-3.2% | |
| AMPH (Amphastar P) | 34,002 | USD 859,231-2.4% | USD 25.27-2.4% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 65,263 | USD 854,9450.2% | USD 13.10.2% | |
| PGEN (Precigen Inc) | 223,176 | USD 823,5191.9% | USD 3.691.9% | |
| CSTL (Castle Biosciences Inc) | 21,284 | USD 822,2011.7% | USD 38.631.7% | |
| GRFS (Grifols SA ADR) | 89,375 | USD 816,888-0.2% | USD 9.14001-0.2% | |
| ERAS (Erasca Inc) | 222,316 | USD 800,3386.5% | USD 3.66.5% | |
| ABCL (Abcellera Biologics Inc) | 218,866 | USD 792,295-3.2% | USD 3.62-3.2% | |
| QURE (Uniqure NV) | 40,425 | USD 788,692-1.2% | USD 19.51-1.2% | |
| NVAX (Novavax Inc) | 118,927 | USD 781,350-1.8% | USD 6.57-1.8% | |
| SPRY (Silverback Therapeutics Inc) | 75,987 | USD 778,107-8.7% | USD 10.24-8.7% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,998 | USD 771,651-0.1% | USD 14.56-0.1% | |
| URGN (UroGen Pharma Ltd) | 35,068 | USD 764,482-2.5% | USD 21.8-2.5% | |
| TNGX (Tango Therapeutics Inc) | 81,411 | USD 761,1932.7% | USD 9.352.7% | |
| ELVN (Enliven Therapeutics Inc.) | 43,301 | USD 730,055-10.2% | USD 16.86-10.2% | |
| NTLA (Intellia Therapeutics Inc) | 79,586 | USD 717,866-5.5% | USD 9.02-5.5% | |
| ARVN (Arvinas Inc) | 56,668 | USD 712,8830.1% | USD 12.580.1% | |
| MNMD (Mind Medicine Inc) | 56,762 | USD 712,363-0.3% | USD 12.55-0.3% | |
| KURA (Kura Oncology Inc) | 66,230 | USD 676,871-2.3% | USD 10.22-2.3% | |
| VIR (Vir Biotechnology Inc) | 101,076 | USD 676,1980.9% | USD 6.690.9% | |
| KROS (Keros Therapeutics Inc) | 31,390 | USD 675,199-0.8% | USD 21.51-0.8% | |
| ABUS (Arbutus Biopharma Corp) | 143,063 | USD 673,8270.9% | USD 4.710.9% | |
| JANX (Janux Therapeutics Inc) | 43,945 | USD 672,359-0.4% | USD 15.3-0.4% | |
| TBPH (Theravance Biopharma Inc) | 36,901 | USD 670,4912.8% | USD 18.172.8% | |
| ORIC (Oric Pharmaceuticals Inc) | 71,059 | USD 666,533-3.2% | USD 9.37999-3.2% | |
| KALV (Kalvista Pharmaceuticals Inc) | 39,261 | USD 663,9040.1% | USD 16.910.1% | |
| GERN (Geron Corporation) | 463,085 | USD 629,796-2.2% | USD 1.36-2.2% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,479 | USD 622,644-0.7% | USD 8.35999-0.7% | |
| ZLAB (Zai Lab Ltd) | 34,998 | USD 621,914-0.3% | USD 17.77-0.3% | |
| REPL (Replimune Group Inc) | 58,582 | USD 596,3653.1% | USD 10.183.1% | |
| PAHC (Phibro Animal Health Corporation) | 14,707 | USD 590,486-1.5% | USD 40.15-1.5% | |
| IOVA (Iovance Biotherapeutics Inc) | 260,011 | USD 572,024-2.2% | USD 2.2-2.2% | |
| CGEM (Cullinan Oncology LLC) | 44,836 | USD 534,445-3.7% | USD 11.92-3.7% | |
| RGNX (Regenxbio Inc) | 38,503 | USD 534,0377.9% | USD 13.877.9% | |
| MGTX (MeiraGTx Holdings PLC) | 59,031 | USD 526,5572.3% | USD 8.920012.3% | |
| PRME (Prime Medicine, Inc. Common Stock) | 128,201 | USD 525,624-4.0% | USD 4.1-4.0% | |
| PACB (Pacific Biosciences of California) | 232,317 | USD 492,512-2.3% | USD 2.12-2.3% | |
| LYEL (Lyell Immunopharma Inc) | 14,085 | USD 485,3693.1% | USD 34.463.1% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 127,664 | USD 457,037-2.7% | USD 3.58-2.7% | |
| PRTA (Prothena Corporation plc) | 40,288 | USD 417,3840.3% | USD 10.360.3% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 114,627 | USD 412,657-3.0% | USD 3.6-3.0% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,718 | USD 398,023-0.7% | USD 10.84-0.7% | |
| EOLS (Evolus Inc) | 51,442 | USD 362,1521.9% | USD 7.040011.9% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 277,294 | USD 360,482-1.5% | USD 1.3-1.5% | |
| GLPG (Galapagos NV ADR) | 11,082 | USD 351,189-2.7% | USD 31.69-2.7% | |
| SIGA (SIGA Technologies Inc) | 51,665 | USD 333,756-0.9% | USD 6.46-0.9% | |
| TRDA (Entrada Therapeutics Inc) | 30,062 | USD 333,0872.5% | USD 11.082.5% | |
| VNDA (Vanda Pharmaceuticals Inc) | 47,069 | USD 293,240-5.6% | USD 6.23-5.6% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,528 | USD 266,210-1.7% | USD 3.39-1.7% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,833 | USD 259,5060.3% | USD 7.450.3% | |
| AUTL (Autolus Therapeutics Ltd) | 159,904 | USD 257,4451.3% | USD 1.611.3% | |
| AVXL (Anavex Life Sciences Corp) | 63,153 | USD 253,875-2.2% | USD 4.02-2.2% | |
| ALLO (Allogene Therapeutics Inc) | 161,219 | USD 243,441-2.6% | USD 1.51-2.6% | |
| ACIU (AC Immune Ltd) | 73,512 | USD 231,563-2.2% | USD 3.15-2.2% | |
| OABI (OmniAb Inc.) | 90,833 | USD 195,291-0.5% | USD 2.15-0.5% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,691 | USD 194,327-1.3% | USD 3.15001-1.3% | |
| EDIT (Editas Medicine Inc) | 70,575 | USD 178,555-1.2% | USD 2.53-1.2% | |
| VYGR (Voyager Therapeutics Inc) | 37,864 | USD 166,223-0.5% | USD 4.39-0.5% | |
| HUMA (Humacyte Inc) | 119,746 | USD 156,867 | USD 1.31 | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,973 | USD 156,459-0.8% | USD 7.46002-0.8% | |
| ALEC (Alector Inc) | 78,231 | USD 116,5642.1% | USD 1.492.1% | |
| MRSN (Mersana Therapeutics Inc) | 3,464 | USD 98,2040.4% | USD 28.34990.4% | |
| FATE (Fate Therapeutics Inc) | 80,178 | USD 92,2053.6% | USD 1.153.6% | |
| BMEA (Biomea Fusion Inc) | 51,031 | USD 71,954-7.2% | USD 1.41001-7.2% | |
| MGNX (MacroGenics Inc) | 45,418 | USD 63,585-0.7% | USD 1.4-0.7% | |
| STRO (Sutro Biopharma) | 5,586 | USD 54,9100.2% | USD 9.829930.2% | |
| PLRX (Pliant Therapeutics Inc) | 42,799 | USD 52,643-6.8% | USD 1.23001-6.8% | |
| OKUR (OKUR) | 8,941 | USD 27,449-5.0% | USD 3.07001-5.0% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 157,855 1.4% | USD 70,392,2801.7% | USD 445.930.3% | |
| AMGN (Amgen Inc) | 214,539 1.4% | USD 68,090,3882.0% | USD 317.380.6% | |
| REGN (Regeneron Pharmaceuticals Inc) | 77,059 1.4% | USD 57,547,6614.3% | USD 746.82.8% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 96,965 1.4% | USD 40,010,6683.4% | USD 412.632.0% | |
| INSM (Insmed Inc) | 157,664 1.4% | USD 30,782,3194.3% | USD 195.242.8% | |
| ARGX (argenx NV ADR) | 22,835 1.5% | USD 20,311,5041.4% | USD 889.49-0.1% | |
| BIIB (Biogen Inc) | 109,360 1.2% | USD 18,864,600-1.7% | USD 172.5-2.8% | |
| UTHR (United Therapeutics Corporation) | 33,735 1.5% | USD 16,479,8852.3% | USD 488.510.8% | |
| ILMN (Illumina Inc) | 114,644 1.4% | USD 15,642,0272.5% | USD 136.441.1% | |
| INCY (Incyte Corporation) | 145,656 1.5% | USD 13,997,5422.4% | USD 96.11.0% | |
| RPRX (Royalty Pharma Plc) | 322,450 1.4% | USD 12,514,2852.8% | USD 38.811.4% | |
| MEDP (Medpace Holdings Inc) | 20,959 1.4% | USD 11,865,9382.4% | USD 566.151.0% | |
| NBIX (Neurocrine Biosciences Inc) | 73,999 1.4% | USD 11,451,3450.8% | USD 154.75-0.6% | |
| RVMD (Revolution Medicines Inc) | 139,640 1.4% | USD 10,963,1362.2% | USD 78.510.8% | |
| ROIV (Roivant Sciences Ltd) | 507,974 1.0% | USD 10,840,1656.5% | USD 21.345.4% | |
| BBIO (BridgeBio Pharma Inc) | 142,797 1.4% | USD 10,576,2603.3% | USD 74.0651.9% | |
| VTRS (Viatris Inc) | 867,386 1.0% | USD 10,053,0040.9% | USD 11.59-0.1% | |
| SMMT (Summit Therapeutics PLC) | 554,587 1.5% | USD 9,977,0201.8% | USD 17.990.3% | |
| SNY (Sanofi ADR) | 200,442 1.5% | USD 9,793,5962.8% | USD 48.861.2% | |
| ASND (Ascendis Pharma AS) | 45,390 1.2% | USD 9,539,1625.6% | USD 210.164.4% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,596 1.0% | USD 9,481,7934.5% | USD 571.333.4% | |
| GH (Guardant Health Inc) | 92,922 1.0% | USD 9,420,432-0.2% | USD 101.38-1.2% | |
| IONS (Ionis Pharmaceuticals Inc) | 118,615 1.0% | USD 9,387,1911.7% | USD 79.140.6% | |
| MRNA (Moderna Inc) | 290,214 1.0% | USD 8,599,0413.1% | USD 29.632.1% | |
| EXEL (Exelixis Inc) | 200,798 1.1% | USD 8,311,0291.9% | USD 41.390.8% | |
| BMRN (Biomarin Pharmaceutical Inc) | 143,222 1.1% | USD 7,589,334-0.2% | USD 52.99-1.3% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 45,356 2.0% | USD 7,478,7511.9% | USD 164.890.0% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 102,898 1.2% | USD 7,287,2364.1% | USD 70.822.8% | |
| BNTX (BioNTech SE) | 75,241 2.0% | USD 7,223,1362.3% | USD 960.3% | |
| RNA (Avidity Biosciences Inc) | 96,103 1.1% | USD 6,880,9751.5% | USD 71.60.4% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 49,608 1.3% | USD 5,834,89313.8% | USD 117.6212.3% | |
| AXSM (Axsome Therapeutics Inc) | 37,140 1.5% | USD 5,524,5751.1% | USD 148.75-0.3% | |
| CYTK (Cytokinetics Inc) | 88,924 1.4% | USD 5,403,9112.2% | USD 60.770.8% | |
| HALO (Halozyme Therapeutics Inc) | 86,982 1.5% | USD 5,384,1860.3% | USD 61.9-1.2% | |
| KRYS (Krystal Biotech Inc) | 21,586 1.6% | USD 5,326,8854.6% | USD 246.7752.9% | |
| NUVL (Nuvalent Inc) | 49,670 1.5% | USD 5,260,5501.7% | USD 105.910.2% | |
| KYMR (Kymera Therapeutics Inc) | 53,422 1.4% | USD 4,690,986-0.9% | USD 87.81-2.3% | |
| PTCT (PTC Therapeutics Inc) | 59,338 1.7% | USD 4,476,4593.5% | USD 75.441.8% | |
| PCVX (Vaxcyte Inc) | 96,984 1.7% | USD 4,324,5174.3% | USD 44.592.5% | |
| PTGX (Protagonist Therapeutics Inc) | 46,541 1.5% | USD 4,293,4072.5% | USD 92.251.0% | |
| PRAX (Praxis Precision Medicines Inc) | 15,733 1.6% | USD 4,205,1163.8% | USD 267.282.2% | |
| COGT (Cogent Biosciences Inc) | 104,560 1.6% | USD 4,186,5823.8% | USD 40.042.2% | |
| CRSP (Crispr Therapeutics AG) | 67,924 1.9% | USD 3,945,7052.8% | USD 58.090.9% | |
| ADMA (ADMA Biologics Inc) | 177,146 0.5% | USD 3,610,2352.5% | USD 20.382.0% | |
| ALKS (Alkermes Plc) | 123,468 1.8% | USD 3,601,5623.7% | USD 29.171.9% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 70,616 1.8% | USD 3,482,0754.5% | USD 49.312.6% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 125,236 0.5% | USD 3,341,2960.0% | USD 26.68-0.5% | |
| SRRK (Scholar Rock Holding Corp) | 71,203 0.5% | USD 3,334,4364.4% | USD 46.834.0% | |
| IMVT (Immunovant Inc) | 129,748 0.5% | USD 3,219,0485.8% | USD 24.815.3% | |
| ACLX (Arcellx Inc) | 41,563 2.0% | USD 3,021,2143.0% | USD 72.691.0% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 44,317 2.3% | USD 2,988,7380.0% | USD 67.44-2.2% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 233,523 0.5% | USD 2,860,6570.8% | USD 12.250.3% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,543 0.5% | USD 2,663,2600.0% | USD 183.13-0.5% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,449 0.5% | USD 2,636,3821.1% | USD 76.530.6% | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,413 0.5% | USD 2,635,001-0.6% | USD 29.47-1.0% | |
| RARE (Ultragenyx) | 71,727 0.5% | USD 2,596,5171.0% | USD 36.20.6% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,411 0.5% | USD 2,566,2790.9% | USD 81.70.5% | |
| GRAL (GRAIL, LLC) | 26,792 0.5% | USD 2,546,8480.6% | USD 95.060.1% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,309 0.5% | USD 2,502,1111.0% | USD 43.660.5% | |
| VCYT (Veracyte Inc) | 58,638 0.5% | USD 2,475,696-2.1% | USD 42.22-2.6% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,257 0.5% | USD 2,448,5302.1% | USD 65.721.6% | |
| CGON (CG Oncology, Inc. Common stock) | 56,635 0.5% | USD 2,356,5820.1% | USD 41.61-0.3% | |
| APLS (Apellis Pharmaceuticals Inc) | 93,882 0.5% | USD 2,343,7641.6% | USD 24.9651.2% | |
| TVTX (Travere Therapeutics Inc) | 66,745 2.9% | USD 2,336,7424.8% | USD 35.011.8% | |
| FOLD (Amicus Therapeutics Inc) | 230,929 3.0% | USD 2,286,1973.5% | USD 9.90.5% | |
| VERA (Vera Therapeutics Inc) | 47,860 3.1% | USD 2,202,5177.0% | USD 46.023.8% | |
| IDYA (Ideaya Biosciences Inc) | 65,363 0.5% | USD 2,193,5820.2% | USD 33.56-0.2% | |
| BEAM (Beam Therapeutics Inc) | 75,962 3.2% | USD 2,089,7153.6% | USD 27.510.4% | |
| DYN (Dyne Therapeutics Inc) | 105,691 0.5% | USD 2,052,519-0.9% | USD 19.42-1.4% | |
| WVE (Wave Life Sciences Ltd) | 119,412 0.5% | USD 2,000,151-16.8% | USD 16.75-17.2% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 71,958 3.1% | USD 1,955,818-5.2% | USD 27.18-8.1% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,777 0.5% | USD 1,943,0481.2% | USD 46.510.8% | |
| OCUL (Ocular Therapeutix Inc) | 130,634 3.2% | USD 1,916,401-1.8% | USD 14.67-4.8% | |
| DNLI (Denali Therapeutics Inc) | 109,681 3.1% | USD 1,905,1591.9% | USD 17.37-1.1% | |
| EWTX (Edgewise Therapeutics Inc) | 78,947 3.0% | USD 1,849,7281.6% | USD 23.43-1.3% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 49,854 3.5% | USD 1,797,2373.0% | USD 36.05-0.4% | |
| ADPT (Adaptive Biotechnologies Corp) | 114,212 3.1% | USD 1,761,1491.0% | USD 15.42-2.0% | |
| HRMY (Harmony Biosciences Holdings) | 43,218 3.2% | USD 1,711,0014.1% | USD 39.590.8% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,253 0.5% | USD 1,618,5703.4% | USD 31.582.9% | |
| SRPT (Sarepta Therapeutics Inc) | 73,469 3.4% | USD 1,597,9511.3% | USD 21.75-2.0% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 99,820 4.1% | USD 1,585,1426.9% | USD 15.882.7% | |
| SYRE (Spyre Therapeutics Inc.) | 45,534 4.1% | USD 1,564,5483.2% | USD 34.36-0.9% | |
| IBRX (Immunitybio Inc) | 701,186 0.5% | USD 1,535,597-4.3% | USD 2.19-4.8% | |
| AVDL (Avadel Pharmaceuticals PLC) | 71,023 0.5% | USD 1,519,1820.0% | USD 21.39-0.4% | |
| TWST (Twist Bioscience Corp) | 45,860 4.4% | USD 1,473,0232.3% | USD 32.12-2.0% | |
| RXRX (Recursion Pharmaceuticals Inc) | 318,109 0.5% | USD 1,456,939-3.5% | USD 4.58-4.0% | |
| HROW (Harrow Health Inc) | 28,195 4.8% | USD 1,440,7656.7% | USD 51.11.8% | |
| VCEL (Vericel Corp Ord) | 38,350 4.5% | USD 1,433,9073.8% | USD 37.39-0.7% | |
| LEGN (Legend Biotech Corp) | 62,074 0.5% | USD 1,428,323-1.0% | USD 23.01-1.5% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,596 0.5% | USD 1,411,504-3.1% | USD 24.94-3.6% | |
| TXG (10X Genomics Inc) | 84,572 0.5% | USD 1,398,821-5.2% | USD 16.54-5.6% | |
| STOK (Stoke Therapeutics Inc) | 40,900 0.5% | USD 1,353,381-2.7% | USD 33.09-3.1% | |
| MNKD (MannKind Corp) | 232,384 4.0% | USD 1,350,1513.4% | USD 5.81-0.5% | |
| ANIP (ANI Pharmaceuticals Inc) | 16,429 4.0% | USD 1,349,3144.1% | USD 82.130.1% | |
| SNDX (Syndax Pharmaceuticals Inc) | 65,257 4.0% | USD 1,331,8952.9% | USD 20.41-1.0% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,243 0.5% | USD 1,322,2851.6% | USD 41.011.1% | |
| AGIO (Agios Pharm) | 44,093 4.3% | USD 1,210,7942.3% | USD 27.46-1.9% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 159,587 4.4% | USD 1,209,6693.3% | USD 7.58-1.0% | |
| TSHA (Taysha Gene Therapies Inc) | 199,846 0.5% | USD 1,151,1134.1% | USD 5.763.6% | |
| NRIX (Nurix Therapeutics Inc) | 58,842 0.5% | USD 1,122,117-2.3% | USD 19.07-2.8% | |
| NVCR (Novocure Ltd) | 81,807 0.5% | USD 1,117,4843.8% | USD 13.663.3% | |
| COLL (Collegium Pharmaceutical Inc) | 23,033 0.5% | USD 1,113,876-0.6% | USD 48.36-1.0% | |
| IMCR (Immunocore Holdings Ltd) | 30,083 0.5% | USD 1,076,971-0.2% | USD 35.8-0.6% | |
| ARDX (Ardelyx Inc) | 176,453 0.5% | USD 1,041,0730.1% | USD 5.9-0.3% | |
| FTRE (Fortrea Holdings Inc.) | 66,497 0.5% | USD 1,034,0283.2% | USD 15.552.7% | |
| INVA (Innoviva Inc) | 48,062 5.3% | USD 991,0385.3% | USD 20.62 | |
| GMAB (Genmab AS) | 30,640 0.5% | USD 989,6723.9% | USD 32.33.4% | |
| RLAY (Relay Therapeutics Inc) | 126,290 0.5% | USD 983,7993.1% | USD 7.792.6% | |
| SANA (Sana Biotechnology Inc) | 192,412 0.5% | USD 962,0601.7% | USD 51.2% | |
| ANAB (AnaptysBio Inc) | 20,462 0.5% | USD 936,7502.3% | USD 45.781.8% | |
| DVAX (Dynavax Technologies Corporation) | 85,853 0.5% | USD 932,3640.1% | USD 10.86-0.4% | |
| XNCR (Xencor Inc) | 52,214 0.5% | USD 890,771-0.1% | USD 17.06-0.6% | |
| AMPH (Amphastar P) | 34,002 0.5% | USD 880,6521.2% | USD 25.90.7% | |
| SVRA (Savara Inc) | 126,078 0.5% | USD 874,9814.2% | USD 6.943.7% | |
| XERS (Xeris Pharmaceuticals Inc) | 121,825 0.5% | USD 853,9931.5% | USD 7.011.0% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 65,263 0.5% | USD 852,987-0.7% | USD 13.07-1.2% | |
| SPRY (Silverback Therapeutics Inc) | 75,987 6.6% | USD 852,57414.6% | USD 11.227.5% | |
| PCRX (Pacira BioSciences, Inc.) | 32,868 0.5% | USD 845,6942.7% | USD 25.732.2% | |
| GRFS (Grifols SA ADR) | 89,375 0.5% | USD 818,6752.8% | USD 9.162.3% | |
| ABCL (Abcellera Biologics Inc) | 218,866 0.5% | USD 818,559-0.3% | USD 3.74-0.8% | |
| ELVN (Enliven Therapeutics Inc.) | 43,301 0.5% | USD 812,760-6.5% | USD 18.77-6.9% | |
| CSTL (Castle Biosciences Inc) | 21,284 0.5% | USD 808,1530.3% | USD 37.97-0.1% | |
| PGEN (Precigen Inc) | 223,176 0.5% | USD 807,8973.6% | USD 3.623.1% | |
| QURE (Uniqure NV) | 40,425 0.5% | USD 798,394-1.5% | USD 19.75-1.9% | |
| NVAX (Novavax Inc) | 118,927 0.5% | USD 795,622-0.3% | USD 6.69-0.7% | |
| URGN (UroGen Pharma Ltd) | 35,068 0.5% | USD 784,1201.2% | USD 22.360.8% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,998 0.5% | USD 772,1810.6% | USD 14.570.1% | |
| NTLA (Intellia Therapeutics Inc) | 79,586 0.5% | USD 760,0462.4% | USD 9.551.9% | |
| ERAS (Erasca Inc) | 222,316 0.5% | USD 751,4284.2% | USD 3.383.7% | |
| TNGX (Tango Therapeutics Inc) | 81,411 0.5% | USD 740,840-0.3% | USD 9.1-0.8% | |
| MNMD (Mind Medicine Inc) | 56,762 0.5% | USD 714,6342.2% | USD 12.591.7% | |
| ARVN (Arvinas Inc) | 56,668 8.4% | USD 712,3175.0% | USD 12.57-3.2% | |
| KURA (Kura Oncology Inc) | 66,230 0.5% | USD 692,766-2.1% | USD 10.46-2.6% | |
| ORIC (Oric Pharmaceuticals Inc) | 71,059 0.5% | USD 688,562-2.6% | USD 9.69-3.1% | |
| KROS (Keros Therapeutics Inc) | 31,390 7.6% | USD 680,8496.9% | USD 21.69-0.7% | |
| JANX (Janux Therapeutics Inc) | 43,945 0.5% | USD 674,995-0.9% | USD 15.36-1.4% | |
| VIR (Vir Biotechnology Inc) | 101,076 0.5% | USD 670,1341.7% | USD 6.631.2% | |
| ABUS (Arbutus Biopharma Corp) | 143,063 0.5% | USD 668,1042.2% | USD 4.671.7% | |
| KALV (Kalvista Pharmaceuticals Inc) | 39,261 9.6% | USD 663,5119.9% | USD 16.90.2% | |
| TBPH (Theravance Biopharma Inc) | 36,901 0.5% | USD 652,4100.9% | USD 17.680.4% | |
| GERN (Geron Corporation) | 463,085 0.5% | USD 643,6889.1% | USD 1.398.6% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,479 0.5% | USD 627,113-0.6% | USD 8.42-1.1% | |
| ZLAB (Zai Lab Ltd) | 34,998 0.5% | USD 623,664-2.1% | USD 17.82-2.5% | |
| PAHC (Phibro Animal Health Corporation) | 14,707 0.5% | USD 599,4572.7% | USD 40.762.2% | |
| IOVA (Iovance Biotherapeutics Inc) | 260,011 0.5% | USD 585,0250.0% | USD 2.25-0.4% | |
| REPL (Replimune Group Inc) | 58,582 0.5% | USD 578,2041.0% | USD 9.869990.5% | |
| CGEM (Cullinan Oncology LLC) | 44,836 0.5% | USD 555,070-0.2% | USD 12.38-0.6% | |
| PRME (Prime Medicine, Inc. Common Stock) | 128,201 0.5% | USD 547,418-0.9% | USD 4.27-1.4% | |
| MGTX (MeiraGTx Holdings PLC) | 59,031 0.5% | USD 514,7504.4% | USD 8.719993.9% | |
| PACB (Pacific Biosciences of California) | 232,317 0.5% | USD 504,128-8.0% | USD 2.17-8.4% | |
| RGNX (Regenxbio Inc) | 38,503 0.5% | USD 494,764-1.1% | USD 12.85-1.6% | |
| LYEL (Lyell Immunopharma Inc) | 14,085 0.5% | USD 470,5807.3% | USD 33.416.8% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 127,664 0.5% | USD 469,8040.2% | USD 3.68-0.3% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 114,627 0.5% | USD 425,266-0.1% | USD 3.71-0.5% | |
| PRTA (Prothena Corporation plc) | 40,288 0.5% | USD 416,1755.2% | USD 10.334.7% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,718 0.5% | USD 400,9611.3% | USD 10.920.8% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 277,294 0.5% | USD 366,0280.5% | USD 1.32 | |
| GLPG (Galapagos NV ADR) | 11,082 0.5% | USD 360,9411.2% | USD 32.570.7% | |
| EOLS (Evolus Inc) | 51,442 0.5% | USD 355,464-1.9% | USD 6.91-2.4% | |
| SIGA (SIGA Technologies Inc) | 51,665 0.5% | USD 336,8564.8% | USD 6.524.3% | |
| TRDA (Entrada Therapeutics Inc) | 30,062 0.5% | USD 324,9702.6% | USD 10.812.1% | |
| VNDA (Vanda Pharmaceuticals Inc) | 47,069 0.5% | USD 310,655-1.8% | USD 6.59999-2.2% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,528 0.5% | USD 270,922-4.5% | USD 3.45001-5.0% | |
| AVXL (Anavex Life Sciences Corp) | 63,153 0.5% | USD 259,5591.2% | USD 4.110.7% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,833 0.5% | USD 258,809-0.7% | USD 7.42999-1.2% | |
| AUTL (Autolus Therapeutics Ltd) | 159,904 0.5% | USD 254,2474.4% | USD 1.593.9% | |
| ALLO (Allogene Therapeutics Inc) | 161,219 0.5% | USD 249,8895.2% | USD 1.554.7% | |
| ACIU (AC Immune Ltd) | 73,512 0.5% | USD 236,70916.0% | USD 3.2215.4% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,691 0.5% | USD 196,7941.4% | USD 3.190.9% | |
| OABI (OmniAb Inc.) | 90,833 0.5% | USD 196,1998.5% | USD 2.168.0% | |
| EDIT (Editas Medicine Inc) | 70,575 0.5% | USD 180,672-1.1% | USD 2.56-1.5% | |
| VYGR (Voyager Therapeutics Inc) | 37,864 0.5% | USD 166,9800.2% | USD 4.40999-0.2% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,973 0.5% | USD 157,717-1.5% | USD 7.52-2.0% | |
| HUMA (Humacyte Inc) | 119,746 0.5% | USD 156,8673.6% | USD 1.313.1% | |
| ALEC (Alector Inc) | 78,231 0.5% | USD 114,21712.8% | USD 1.4612.3% | |
| MRSN (Mersana Therapeutics Inc) | 3,464 0.5% | USD 97,7890.9% | USD 28.23010.4% | |
| FATE (Fate Therapeutics Inc) | 80,178 0.5% | USD 88,9982.3% | USD 1.110011.8% | |
| BMEA (Biomea Fusion Inc) | 51,031 0.5% | USD 77,567-0.8% | USD 1.52-1.3% | |
| MGNX (MacroGenics Inc) | 45,418 0.5% | USD 64,0391.2% | USD 1.409990.7% | |
| PLRX (Pliant Therapeutics Inc) | 42,799 0.5% | USD 56,4953.6% | USD 1.320013.1% | |
| STRO (Sutro Biopharma) | 5,586 0.5% | USD 54,7999.5% | USD 9.810069.0% | |
| OKUR (OKUR) | 8,941 0.5% | USD 28,879-6.5% | USD 3.22995-6.9% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 155,701 | USD 69,230,8931.7% | USD 444.641.7% | |
| AMGN (Amgen Inc) | 211,616 | USD 66,739,4540.5% | USD 315.380.5% | |
| REGN (Regeneron Pharmaceuticals Inc) | 76,013 | USD 55,201,4014.9% | USD 726.214.9% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 95,633 | USD 38,679,723-2.6% | USD 404.46-2.6% | |
| INSM (Insmed Inc) | 155,512 | USD 29,523,953-2.2% | USD 189.85-2.2% | |
| ARGX (argenx NV ADR) | 22,498 | USD 20,025,6950.1% | USD 890.110.1% | |
| BIIB (Biogen Inc) | 108,040 | USD 19,182,5021.0% | USD 177.551.0% | |
| UTHR (United Therapeutics Corporation) | 33,233 | USD 16,113,3521.8% | USD 484.861.8% | |
| ILMN (Illumina Inc) | 113,077 | USD 15,255,2182.1% | USD 134.912.1% | |
| INCY (Incyte Corporation) | 143,571 | USD 13,663,6520.0% | USD 95.170.0% | |
| RPRX (Royalty Pharma Plc) | 318,150 | USD 12,172,4190.4% | USD 38.260.4% | |
| MEDP (Medpace Holdings Inc) | 20,671 | USD 11,591,2633.1% | USD 560.753.1% | |
| NBIX (Neurocrine Biosciences Inc) | 72,962 | USD 11,355,0760.4% | USD 155.630.4% | |
| RVMD (Revolution Medicines Inc) | 137,740 | USD 10,727,1910.1% | USD 77.880.1% | |
| BBIO (BridgeBio Pharma Inc) | 140,787 | USD 10,235,2151.4% | USD 72.71.4% | |
| ROIV (Roivant Sciences Ltd) | 503,064 | USD 10,182,015-0.9% | USD 20.24-0.9% | |
| VTRS (Viatris Inc) | 858,516 | USD 9,958,7863.7% | USD 11.63.7% | |
| SMMT (Summit Therapeutics PLC) | 546,559 | USD 9,805,2685.4% | USD 17.945.4% | |
| SNY (Sanofi ADR) | 197,463 | USD 9,529,5640.9% | USD 48.260.9% | |
| GH (Guardant Health Inc) | 91,975 | USD 9,438,475-0.6% | USD 102.62-0.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 117,405 | USD 9,231,555-0.3% | USD 78.63-0.3% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,425 | USD 9,074,320-0.3% | USD 552.47-0.3% | |
| ASND (Ascendis Pharma AS) | 44,868 | USD 9,029,2362.3% | USD 201.242.3% | |
| MRNA (Moderna Inc) | 287,241 | USD 8,338,6062.8% | USD 29.032.8% | |
| EXEL (Exelixis Inc) | 198,525 | USD 8,153,422-1.9% | USD 41.07-1.9% | |
| BMRN (Biomarin Pharmaceutical Inc) | 141,667 | USD 7,607,518-0.1% | USD 53.7-0.1% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 44,475 | USD 7,337,0411.7% | USD 164.971.7% | |
| BNTX (BioNTech SE) | 73,733 | USD 7,058,829-0.1% | USD 95.735-0.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 101,633 | USD 6,999,4650.1% | USD 68.870.1% | |
| RNA (Avidity Biosciences Inc) | 95,032 | USD 6,780,5330.1% | USD 71.350.1% | |
| AXSM (Axsome Therapeutics Inc) | 36,600 | USD 5,462,9162.8% | USD 149.262.8% | |
| MRUS (Merus BV) | 55,573 | USD 5,377,7990.4% | USD 96.770.4% | |
| HALO (Halozyme Therapeutics Inc) | 85,715 | USD 5,370,0451.3% | USD 62.651.3% | |
| CYTK (Cytokinetics Inc) | 87,664 | USD 5,287,454-2.1% | USD 60.315-2.1% | |
| NUVL (Nuvalent Inc) | 48,937 | USD 5,174,5980.6% | USD 105.740.6% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 48,950 | USD 5,128,4924.0% | USD 104.774.0% | |
| KRYS (Krystal Biotech Inc) | 21,253 | USD 5,094,7692.2% | USD 239.722.2% | |
| KYMR (Kymera Therapeutics Inc) | 52,674 | USD 4,734,8663.5% | USD 89.893.5% | |
| PTCT (PTC Therapeutics Inc) | 58,356 | USD 4,324,1800.9% | USD 74.10.9% | |
| PTGX (Protagonist Therapeutics Inc) | 45,834 | USD 4,188,3113.2% | USD 91.383.2% | |
| PCVX (Vaxcyte Inc) | 95,355 | USD 4,146,989-2.8% | USD 43.49-2.8% | |
| PRAX (Praxis Precision Medicines Inc) | 15,488 | USD 4,051,3511.3% | USD 261.581.3% | |
| COGT (Cogent Biosciences Inc) | 102,928 | USD 4,031,6901.7% | USD 39.171.7% | |
| CRSP (Crispr Therapeutics AG) | 66,659 | USD 3,838,8921.0% | USD 57.591.0% | |
| ADMA (ADMA Biologics Inc) | 176,342 | USD 3,523,3130.9% | USD 19.980.9% | |
| ALKS (Alkermes Plc) | 121,321 | USD 3,472,2070.6% | USD 28.620.6% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 124,668 | USD 3,342,349-0.3% | USD 26.81-0.3% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 69,351 | USD 3,333,0090.3% | USD 48.060.3% | |
| SRRK (Scholar Rock Holding Corp) | 70,879 | USD 3,193,0990.9% | USD 45.050.9% | |
| IMVT (Immunovant Inc) | 129,158 | USD 3,042,9623.5% | USD 23.563.5% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 43,332 | USD 2,987,3083.3% | USD 68.943.3% | |
| ACLX (Arcellx Inc) | 40,743 | USD 2,932,6811.6% | USD 71.981.6% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 232,461 | USD 2,838,3492.0% | USD 12.212.0% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,477 | USD 2,664,202-1.0% | USD 184.03-1.0% | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,007 | USD 2,649,7380.0% | USD 29.770.0% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,293 | USD 2,608,3261.8% | USD 76.061.8% | |
| RARE (Ultragenyx) | 71,401 | USD 2,570,436-0.8% | USD 36-0.8% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,269 | USD 2,542,7952.2% | USD 81.322.2% | |
| GRAL (GRAIL, LLC) | 26,670 | USD 2,531,650-2.6% | USD 94.925-2.6% | |
| VCYT (Veracyte Inc) | 58,372 | USD 2,529,259-1.2% | USD 43.33-1.2% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,049 | USD 2,478,209-0.2% | USD 43.44-0.2% | |
| WVE (Wave Life Sciences Ltd) | 118,868 | USD 2,404,700-5.1% | USD 20.23-5.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,087 | USD 2,398,416-1.1% | USD 64.67-1.1% | |
| CGON (CG Oncology, Inc. Common stock) | 56,377 | USD 2,353,176 | USD 41.74 | |
| APLS (Apellis Pharmaceuticals Inc) | 93,454 | USD 2,306,4453.8% | USD 24.683.8% | |
| TVTX (Travere Therapeutics Inc) | 64,840 | USD 2,229,199-0.4% | USD 34.38-0.4% | |
| FOLD (Amicus Therapeutics Inc) | 224,302 | USD 2,209,3750.4% | USD 9.850.4% | |
| IDYA (Ideaya Biosciences Inc) | 65,065 | USD 2,188,787-1.3% | USD 33.64-1.3% | |
| DYN (Dyne Therapeutics Inc) | 105,209 | USD 2,071,5656.8% | USD 19.696.8% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 69,769 | USD 2,063,0693.4% | USD 29.573.4% | |
| VERA (Vera Therapeutics Inc) | 46,422 | USD 2,058,351-0.7% | USD 44.34-0.7% | |
| BEAM (Beam Therapeutics Inc) | 73,590 | USD 2,016,3663.5% | USD 27.43.5% | |
| OCUL (Ocular Therapeutix Inc) | 126,630 | USD 1,951,368-3.4% | USD 15.41-3.4% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,587 | USD 1,919,6561.6% | USD 46.161.6% | |
| DNLI (Denali Therapeutics Inc) | 106,391 | USD 1,869,290-10.6% | USD 17.57-10.6% | |
| EWTX (Edgewise Therapeutics Inc) | 76,674 | USD 1,820,2411.7% | USD 23.741.7% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 48,189 | USD 1,744,442-1.4% | USD 36.2-1.4% | |
| ADPT (Adaptive Biotechnologies Corp) | 110,805 | USD 1,744,0715.9% | USD 15.745.9% | |
| HRMY (Harmony Biosciences Holdings) | 41,865 | USD 1,644,0391.2% | USD 39.271.2% | |
| IBRX (Immunitybio Inc) | 697,966 | USD 1,605,3223.6% | USD 2.33.6% | |
| SRPT (Sarepta Therapeutics Inc) | 71,087 | USD 1,578,1310.1% | USD 22.20.1% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,019 | USD 1,565,26315.4% | USD 30.6815.4% | |
| AVDL (Avadel Pharmaceuticals PLC) | 70,697 | USD 1,518,5720.8% | USD 21.480.8% | |
| SYRE (Spyre Therapeutics Inc.) | 43,740 | USD 1,516,0282.9% | USD 34.662.9% | |
| RXRX (Recursion Pharmaceuticals Inc) | 316,647 | USD 1,510,406 | USD 4.77 | |
| AUPH (Aurinia Pharmaceuticals Inc) | 95,861 | USD 1,482,970-0.4% | USD 15.47-0.4% | |
| TXG (10X Genomics Inc) | 84,184 | USD 1,475,746-1.7% | USD 17.53-1.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,336 | USD 1,457,4120.3% | USD 25.870.3% | |
| LEGN (Legend Biotech Corp) | 61,790 | USD 1,443,414-2.2% | USD 23.36-2.2% | |
| TWST (Twist Bioscience Corp) | 43,946 | USD 1,440,5503.8% | USD 32.783.8% | |
| STOK (Stoke Therapeutics Inc) | 40,712 | USD 1,390,31512.1% | USD 34.1512.1% | |
| VCEL (Vericel Corp Ord) | 36,702 | USD 1,381,463-1.9% | USD 37.64-1.9% | |
| HROW (Harrow Health Inc) | 26,910 | USD 1,350,8823.8% | USD 50.23.8% | |
| MNKD (MannKind Corp) | 223,542 | USD 1,305,4851.2% | USD 5.841.2% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,095 | USD 1,301,292-1.4% | USD 40.545-1.4% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,801 | USD 1,296,1560.4% | USD 82.030.4% | |
| SNDX (Syndax Pharmaceuticals Inc) | 62,756 | USD 1,294,0295.7% | USD 20.625.7% | |
| AGIO (Agios Pharm) | 42,268 | USD 1,183,5044.3% | USD 284.3% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 152,925 | USD 1,171,4060.3% | USD 7.660.3% | |
| NRIX (Nurix Therapeutics Inc) | 58,570 | USD 1,148,5580.3% | USD 19.610.3% | |
| COLL (Collegium Pharmaceutical Inc) | 22,927 | USD 1,120,2133.9% | USD 48.863.9% | |
| TSHA (Taysha Gene Therapies Inc) | 198,922 | USD 1,106,0064.7% | USD 5.564.7% | |
| IMCR (Immunocore Holdings Ltd) | 29,945 | USD 1,078,918-1.7% | USD 36.03-1.7% | |
| NVCR (Novocure Ltd) | 81,429 | USD 1,076,4914.1% | USD 13.224.1% | |
| ARDX (Ardelyx Inc) | 175,635 | USD 1,039,7592.1% | USD 5.922.1% | |
| FTRE (Fortrea Holdings Inc.) | 66,189 | USD 1,002,1015.2% | USD 15.145.2% | |
| RLAY (Relay Therapeutics Inc) | 125,704 | USD 954,0930.1% | USD 7.590.1% | |
| GMAB (Genmab AS) | 30,498 | USD 952,7581.0% | USD 31.241.0% | |
| SANA (Sana Biotechnology Inc) | 191,518 | USD 946,09913.6% | USD 4.9413.6% | |
| INVA (Innoviva Inc) | 45,639 | USD 941,076-0.4% | USD 20.62-0.4% | |
| DVAX (Dynavax Technologies Corporation) | 85,455 | USD 931,4600.1% | USD 10.90.1% | |
| ANAB (AnaptysBio Inc) | 20,368 | USD 915,5422.6% | USD 44.952.6% | |
| XNCR (Xencor Inc) | 51,972 | USD 891,8402.1% | USD 17.162.1% | |
| AMPH (Amphastar P) | 33,844 | USD 870,1290.2% | USD 25.710.2% | |
| ELVN (Enliven Therapeutics Inc.) | 43,099 | USD 869,3073.5% | USD 20.173.5% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 64,959 | USD 859,408-0.1% | USD 13.23-0.1% | |
| XERS (Xeris Pharmaceuticals Inc) | 121,257 | USD 841,524-1.0% | USD 6.94-1.0% | |
| SVRA (Savara Inc) | 125,490 | USD 839,5283.7% | USD 6.693.7% | |
| PCRX (Pacira BioSciences, Inc.) | 32,716 | USD 823,7891.7% | USD 25.181.7% | |
| ABCL (Abcellera Biologics Inc) | 217,844 | USD 821,2722.4% | USD 3.772.4% | |
| QURE (Uniqure NV) | 40,237 | USD 810,373-3.1% | USD 20.14-3.1% | |
| CSTL (Castle Biosciences Inc) | 21,186 | USD 805,492-0.6% | USD 38.02-0.6% | |
| NVAX (Novavax Inc) | 118,371 | USD 797,8211.2% | USD 6.741.2% | |
| GRFS (Grifols SA ADR) | 88,957 | USD 796,1651.5% | USD 8.951.5% | |
| PGEN (Precigen Inc) | 222,132 | USD 779,683 | USD 3.51 | |
| URGN (UroGen Pharma Ltd) | 34,904 | USD 774,520-2.2% | USD 22.19-2.2% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,750 | USD 767,5132.4% | USD 14.552.4% | |
| SPRY (Silverback Therapeutics Inc) | 71,284 | USD 744,2055.1% | USD 10.445.1% | |
| TNGX (Tango Therapeutics Inc) | 81,029 | USD 743,0360.5% | USD 9.170.5% | |
| NTLA (Intellia Therapeutics Inc) | 79,214 | USD 742,2350.8% | USD 9.370.8% | |
| ERAS (Erasca Inc) | 221,272 | USD 721,347-1.2% | USD 3.26-1.2% | |
| KURA (Kura Oncology Inc) | 65,920 | USD 707,9810.7% | USD 10.740.7% | |
| ORIC (Oric Pharmaceuticals Inc) | 70,725 | USD 707,250-1.4% | USD 10-1.4% | |
| MNMD (Mind Medicine Inc) | 56,496 | USD 699,420-1.0% | USD 12.38-1.0% | |
| JANX (Janux Therapeutics Inc) | 43,739 | USD 681,454-1.0% | USD 15.58-1.0% | |
| ARVN (Arvinas Inc) | 52,281 | USD 678,607-0.9% | USD 12.98-0.9% | |
| VIR (Vir Biotechnology Inc) | 100,600 | USD 658,930-1.7% | USD 6.55-1.7% | |
| ABUS (Arbutus Biopharma Corp) | 142,389 | USD 653,5662.9% | USD 4.592.9% | |
| TBPH (Theravance Biopharma Inc) | 36,727 | USD 646,762-1.1% | USD 17.61-1.1% | |
| KROS (Keros Therapeutics Inc) | 29,164 | USD 636,9421.4% | USD 21.841.4% | |
| ZLAB (Zai Lab Ltd) | 34,834 | USD 636,766-2.2% | USD 18.28-2.2% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,127 | USD 630,8213.2% | USD 8.513.2% | |
| KALV (Kalvista Pharmaceuticals Inc) | 35,821 | USD 603,9424.3% | USD 16.864.3% | |
| GERN (Geron Corporation) | 460,895 | USD 589,9464.1% | USD 1.284.1% | |
| IOVA (Iovance Biotherapeutics Inc) | 258,781 | USD 584,8450.4% | USD 2.260.4% | |
| PAHC (Phibro Animal Health Corporation) | 14,639 | USD 583,6574.2% | USD 39.874.2% | |
| REPL (Replimune Group Inc) | 58,306 | USD 572,565-4.7% | USD 9.82-4.7% | |
| CGEM (Cullinan Oncology LLC) | 44,624 | USD 556,0150.8% | USD 12.460.8% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,595 | USD 552,4863.3% | USD 4.333.3% | |
| PACB (Pacific Biosciences of California) | 231,219 | USD 547,989-2.5% | USD 2.37-2.5% | |
| RGNX (Regenxbio Inc) | 38,321 | USD 500,4722.7% | USD 13.062.7% | |
| MGTX (MeiraGTx Holdings PLC) | 58,753 | USD 492,938-0.6% | USD 8.39001-0.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 127,060 | USD 468,8512.2% | USD 3.692.2% | |
| LYEL (Lyell Immunopharma Inc) | 14,019 | USD 438,5146.9% | USD 31.286.9% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 114,087 | USD 425,5451.1% | USD 3.731.1% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,544 | USD 395,7723.0% | USD 10.833.0% | |
| PRTA (Prothena Corporation plc) | 40,098 | USD 395,767-4.4% | USD 9.86999-4.4% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 275,982 | USD 364,2960.8% | USD 1.320.8% | |
| EOLS (Evolus Inc) | 51,200 | USD 362,4961.4% | USD 7.081.4% | |
| GLPG (Galapagos NV ADR) | 11,030 | USD 356,6002.2% | USD 32.332.2% | |
| SIGA (SIGA Technologies Inc) | 51,423 | USD 321,394 | USD 6.25 | |
| TRDA (Entrada Therapeutics Inc) | 29,920 | USD 316,853 | USD 10.59 | |
| VNDA (Vanda Pharmaceuticals Inc) | 46,847 | USD 316,21711.4% | USD 6.7499911.4% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,158 | USD 283,7148.0% | USD 3.630018.0% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,671 | USD 260,7266.1% | USD 7.526.1% | |
| AVXL (Anavex Life Sciences Corp) | 62,855 | USD 256,448-7.5% | USD 4.07999-7.5% | |
| AUTL (Autolus Therapeutics Ltd) | 159,148 | USD 243,4962.7% | USD 1.532.7% | |
| ALLO (Allogene Therapeutics Inc) | 160,457 | USD 237,4764.2% | USD 1.484.2% | |
| ACIU (AC Immune Ltd) | 73,164 | USD 204,1289.8% | USD 2.790019.8% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,401 | USD 194,0270.6% | USD 3.160.6% | |
| EDIT (Editas Medicine Inc) | 70,243 | USD 182,6326.6% | USD 2.66.6% | |
| OABI (OmniAb Inc.) | 90,403 | USD 180,8060.5% | USD 20.5% | |
| VYGR (Voyager Therapeutics Inc) | 37,686 | USD 166,5723.0% | USD 4.423.0% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,875 | USD 160,1116.5% | USD 7.669996.5% | |
| HUMA (Humacyte Inc) | 119,180 | USD 151,359 | USD 1.27 | |
| ALEC (Alector Inc) | 77,863 | USD 101,2221.6% | USD 1.31.6% | |
| MRSN (Mersana Therapeutics Inc) | 3,448 | USD 96,923-0.1% | USD 28.1099-0.1% | |
| FATE (Fate Therapeutics Inc) | 79,798 | USD 86,9803.8% | USD 1.093.8% | |
| BMEA (Biomea Fusion Inc) | 50,791 | USD 78,21814.9% | USD 1.5414.9% | |
| MGNX (MacroGenics Inc) | 45,204 | USD 63,2860.7% | USD 1.400010.7% | |
| PLRX (Pliant Therapeutics Inc) | 42,599 | USD 54,5271.6% | USD 1.280011.6% | |
| STRO (Sutro Biopharma) | 5,560 | USD 50,0406.0% | USD 96.0% | |
| OKUR (OKUR) | 8,899 | USD 30,8804.2% | USD 3.470054.2% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 155,701 | USD 68,042,894-1.1% | USD 437.01-1.1% | |
| AMGN (Amgen Inc) | 211,616 | USD 66,415,682-2.3% | USD 313.85-2.3% | |
| REGN (Regeneron Pharmaceuticals Inc) | 76,013 | USD 52,645,084-1.5% | USD 692.58-1.5% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 95,633 | USD 39,707,778-3.4% | USD 415.21-3.4% | |
| INSM (Insmed Inc) | 155,512 | USD 30,195,765-1.2% | USD 194.17-1.2% | |
| ARGX (argenx NV ADR) | 22,498 | USD 20,009,946-1.3% | USD 889.41-1.3% | |
| BIIB (Biogen Inc) | 108,040 | USD 18,997,754-2.5% | USD 175.84-2.5% | |
| UTHR (United Therapeutics Corporation) | 33,233 | USD 15,830,872-0.7% | USD 476.36-0.7% | |
| ILMN (Illumina Inc) | 113,077 | USD 14,940,8643.8% | USD 132.133.8% | |
| INCY (Incyte Corporation) | 143,571 | USD 13,662,216-1.6% | USD 95.16-1.6% | |
| RPRX (Royalty Pharma Plc) | 318,150 | USD 12,118,334-1.5% | USD 38.09-1.5% | |
| NBIX (Neurocrine Biosciences Inc) | 72,962 | USD 11,310,5690.0% | USD 155.020.0% | |
| MEDP (Medpace Holdings Inc) | 20,671 | USD 11,246,678-0.9% | USD 544.08-0.9% | |
| RVMD (Revolution Medicines Inc) | 137,740 | USD 10,717,549-2.8% | USD 77.81-2.8% | |
| ROIV (Roivant Sciences Ltd) | 503,064 | USD 10,277,598-2.7% | USD 20.43-2.7% | |
| BBIO (BridgeBio Pharma Inc) | 140,787 | USD 10,090,204-3.5% | USD 71.67-3.5% | |
| VTRS (Viatris Inc) | 858,516 | USD 9,606,7940.9% | USD 11.190.9% | |
| GH (Guardant Health Inc) | 91,975 | USD 9,492,740-0.9% | USD 103.21-0.9% | |
| SNY (Sanofi ADR) | 197,463 | USD 9,444,655-1.3% | USD 47.83-1.3% | |
| SMMT (Summit Therapeutics PLC) | 546,559 | USD 9,302,434-8.6% | USD 17.02-8.6% | |
| IONS (Ionis Pharmaceuticals Inc) | 117,405 | USD 9,258,558-3.3% | USD 78.86-3.3% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,425 | USD 9,098,136-2.6% | USD 553.92-2.6% | |
| ASND (Ascendis Pharma AS) | 44,868 | USD 8,822,395-5.1% | USD 196.63-5.1% | |
| EXEL (Exelixis Inc) | 198,525 | USD 8,312,242-0.7% | USD 41.87-0.7% | |
| MRNA (Moderna Inc) | 287,241 | USD 8,111,6861.0% | USD 28.241.0% | |
| BMRN (Biomarin Pharmaceutical Inc) | 141,667 | USD 7,613,1850.8% | USD 53.740.8% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 44,475 | USD 7,216,514-4.0% | USD 162.26-4.0% | |
| BNTX (BioNTech SE) | 73,733 | USD 7,067,308-1.5% | USD 95.85-1.5% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 101,633 | USD 6,995,3990.3% | USD 68.830.3% | |
| RNA (Avidity Biosciences Inc) | 95,032 | USD 6,775,7820.1% | USD 71.30.1% | |
| CYTK (Cytokinetics Inc) | 87,664 | USD 5,400,102-3.9% | USD 61.6-3.9% | |
| MRUS (Merus BV) | 55,573 | USD 5,355,0140.1% | USD 96.360.1% | |
| AXSM (Axsome Therapeutics Inc) | 36,600 | USD 5,315,052-1.6% | USD 145.22-1.6% | |
| HALO (Halozyme Therapeutics Inc) | 85,715 | USD 5,303,187-1.6% | USD 61.87-1.6% | |
| NUVL (Nuvalent Inc) | 48,937 | USD 5,142,789-2.6% | USD 105.09-2.6% | |
| KRYS (Krystal Biotech Inc) | 21,253 | USD 4,986,8040.3% | USD 234.640.3% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 48,950 | USD 4,929,755-4.2% | USD 100.71-4.2% | |
| KYMR (Kymera Therapeutics Inc) | 52,674 | USD 4,576,317-7.9% | USD 86.88-7.9% | |
| PTCT (PTC Therapeutics Inc) | 58,356 | USD 4,287,415-4.5% | USD 73.47-4.5% | |
| PCVX (Vaxcyte Inc) | 95,355 | USD 4,266,183-3.1% | USD 44.74-3.1% | |
| PTGX (Protagonist Therapeutics Inc) | 45,834 | USD 4,059,059-1.9% | USD 88.56-1.9% | |
| PRAX (Praxis Precision Medicines Inc) | 15,488 | USD 3,997,917-4.7% | USD 258.13-4.7% | |
| COGT (Cogent Biosciences Inc) | 102,928 | USD 3,965,816-4.4% | USD 38.53-4.4% | |
| CRSP (Crispr Therapeutics AG) | 66,659 | USD 3,802,229-0.6% | USD 57.04-0.6% | |
| ADMA (ADMA Biologics Inc) | 176,342 | USD 3,491,5722.1% | USD 19.82.1% | |
| ALKS (Alkermes Plc) | 121,321 | USD 3,450,369-3.3% | USD 28.44-3.3% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 124,668 | USD 3,352,3230.5% | USD 26.890.5% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 69,351 | USD 3,321,9131.1% | USD 47.91.1% | |
| AKRO (Akero Therapeutics Inc) | 58,890 | USD 3,218,339 | USD 54.65 | |
| SRRK (Scholar Rock Holding Corp) | 70,879 | USD 3,163,330-1.4% | USD 44.63-1.4% | |
| IMVT (Immunovant Inc) | 129,158 | USD 2,939,636-1.8% | USD 22.76-1.8% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 43,332 | USD 2,891,978-4.6% | USD 66.74-4.6% | |
| ACLX (Arcellx Inc) | 40,743 | USD 2,886,234-4.4% | USD 70.84-4.4% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 232,461 | USD 2,782,5580.8% | USD 11.970.8% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,477 | USD 2,690,2610.6% | USD 185.830.6% | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,007 | USD 2,648,848-4.1% | USD 29.76-4.1% | |
| GRAL (GRAIL, LLC) | 26,670 | USD 2,599,258-2.3% | USD 97.46-2.3% | |
| RARE (Ultragenyx) | 71,401 | USD 2,591,856-0.4% | USD 36.3-0.4% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,293 | USD 2,563,059-1.8% | USD 74.74-1.8% | |
| VCYT (Veracyte Inc) | 58,372 | USD 2,559,028-1.2% | USD 43.84-1.2% | |
| WVE (Wave Life Sciences Ltd) | 118,868 | USD 2,533,07715.1% | USD 21.3115.1% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,269 | USD 2,487,449-3.3% | USD 79.55-3.3% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,049 | USD 2,482,772-2.3% | USD 43.52-2.3% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,087 | USD 2,425,490-3.7% | USD 65.4-3.7% | |
| CGON (CG Oncology, Inc. Common stock) | 56,377 | USD 2,353,176-2.5% | USD 41.74-2.5% | |
| TVTX (Travere Therapeutics Inc) | 64,840 | USD 2,237,6280.6% | USD 34.510.6% | |
| APLS (Apellis Pharmaceuticals Inc) | 93,454 | USD 2,222,3360.0% | USD 23.780.0% | |
| IDYA (Ideaya Biosciences Inc) | 65,065 | USD 2,217,415-3.6% | USD 34.08-3.6% | |
| FOLD (Amicus Therapeutics Inc) | 224,302 | USD 2,200,403-0.4% | USD 9.81-0.4% | |
| DNLI (Denali Therapeutics Inc) | 106,391 | USD 2,091,647-0.2% | USD 19.66-0.2% | |
| VERA (Vera Therapeutics Inc) | 46,422 | USD 2,073,207-0.8% | USD 44.66-0.8% | |
| OCUL (Ocular Therapeutix Inc) | 126,630 | USD 2,019,749-1.0% | USD 15.95-1.0% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 69,769 | USD 1,995,393-3.1% | USD 28.6-3.1% | |
| BEAM (Beam Therapeutics Inc) | 73,590 | USD 1,948,663-2.3% | USD 26.48-2.3% | |
| DYN (Dyne Therapeutics Inc) | 105,209 | USD 1,940,054-16.9% | USD 18.44-16.9% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,587 | USD 1,888,882-3.7% | USD 45.42-3.7% | |
| EWTX (Edgewise Therapeutics Inc) | 76,674 | USD 1,789,571-0.9% | USD 23.34-0.9% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 48,189 | USD 1,769,982-3.8% | USD 36.73-3.8% | |
| ADPT (Adaptive Biotechnologies Corp) | 110,805 | USD 1,646,562-0.6% | USD 14.86-0.6% | |
| HRMY (Harmony Biosciences Holdings) | 41,865 | USD 1,625,199-0.3% | USD 38.82-0.3% | |
| SRPT (Sarepta Therapeutics Inc) | 71,087 | USD 1,575,9991.4% | USD 22.171.4% | |
| IBRX (Immunitybio Inc) | 697,966 | USD 1,549,485-1.8% | USD 2.22-1.8% | |
| RXRX (Recursion Pharmaceuticals Inc) | 316,647 | USD 1,510,406-1.0% | USD 4.77-1.0% | |
| AVDL (Avadel Pharmaceuticals PLC) | 70,697 | USD 1,506,5530.0% | USD 21.310.0% | |
| TXG (10X Genomics Inc) | 84,184 | USD 1,501,8432.1% | USD 17.842.1% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 95,861 | USD 1,488,721-1.0% | USD 15.53-1.0% | |
| LEGN (Legend Biotech Corp) | 61,790 | USD 1,475,545-8.6% | USD 23.88-8.6% | |
| SYRE (Spyre Therapeutics Inc.) | 43,740 | USD 1,473,163-2.7% | USD 33.68-2.7% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,336 | USD 1,453,750-2.3% | USD 25.805-2.3% | |
| VCEL (Vericel Corp Ord) | 36,702 | USD 1,408,6232.9% | USD 38.382.9% | |
| TWST (Twist Bioscience Corp) | 43,946 | USD 1,387,815-2.0% | USD 31.58-2.0% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,019 | USD 1,356,085-5.0% | USD 26.58-5.0% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,095 | USD 1,320,388-1.0% | USD 41.14-1.0% | |
| HROW (Harrow Health Inc) | 26,910 | USD 1,301,6371.9% | USD 48.371.9% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,801 | USD 1,290,4680.4% | USD 81.670.4% | |
| MNKD (MannKind Corp) | 223,542 | USD 1,289,8372.5% | USD 5.772.5% | |
| STOK (Stoke Therapeutics Inc) | 40,712 | USD 1,240,495-7.7% | USD 30.47-7.7% | |
| SNDX (Syndax Pharmaceuticals Inc) | 62,756 | USD 1,224,370-2.4% | USD 19.51-2.4% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 152,925 | USD 1,168,347-0.8% | USD 7.64-0.8% | |
| NRIX (Nurix Therapeutics Inc) | 58,570 | USD 1,145,044-8.9% | USD 19.55-8.9% | |
| AGIO (Agios Pharm) | 42,268 | USD 1,134,896-1.6% | USD 26.85-1.6% | |
| IMCR (Immunocore Holdings Ltd) | 29,945 | USD 1,097,185-3.9% | USD 36.64-3.9% | |
| COLL (Collegium Pharmaceutical Inc) | 22,927 | USD 1,078,257-1.8% | USD 47.03-1.8% | |
| TSHA (Taysha Gene Therapies Inc) | 198,922 | USD 1,056,276-2.6% | USD 5.31-2.6% | |
| NVCR (Novocure Ltd) | 81,429 | USD 1,034,1485.3% | USD 12.75.3% | |
| ARDX (Ardelyx Inc) | 175,635 | USD 1,018,683-1.4% | USD 5.8-1.4% | |
| RLAY (Relay Therapeutics Inc) | 125,704 | USD 952,836-0.7% | USD 7.58-0.7% | |
| FTRE (Fortrea Holdings Inc.) | 66,189 | USD 952,460-2.6% | USD 14.39-2.6% | |
| INVA (Innoviva Inc) | 45,639 | USD 945,184-1.4% | USD 20.71-1.4% | |
| GMAB (Genmab AS) | 30,498 | USD 943,303-3.2% | USD 30.93-3.2% | |
| DVAX (Dynavax Technologies Corporation) | 85,455 | USD 930,605-0.7% | USD 10.89-0.7% | |
| ANAB (AnaptysBio Inc) | 20,368 | USD 892,118-1.6% | USD 43.8-1.6% | |
| XNCR (Xencor Inc) | 51,972 | USD 873,649-4.9% | USD 16.81-4.9% | |
| AMPH (Amphastar P) | 33,844 | USD 868,099-1.4% | USD 25.65-1.4% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 64,959 | USD 860,057-3.1% | USD 13.24-3.1% | |
| XERS (Xeris Pharmaceuticals Inc) | 121,257 | USD 850,0120.3% | USD 7.010.3% | |
| ELVN (Enliven Therapeutics Inc.) | 43,099 | USD 840,000-5.0% | USD 19.49-5.0% | |
| QURE (Uniqure NV) | 40,237 | USD 836,125-4.5% | USD 20.78-4.5% | |
| SANA (Sana Biotechnology Inc) | 191,518 | USD 833,103-6.0% | USD 4.35-6.0% | |
| PCRX (Pacira BioSciences, Inc.) | 32,716 | USD 810,3751.4% | USD 24.771.4% | |
| CSTL (Castle Biosciences Inc) | 21,186 | USD 810,3650.4% | USD 38.250.4% | |
| SVRA (Savara Inc) | 125,490 | USD 809,411-0.3% | USD 6.45-0.3% | |
| ABCL (Abcellera Biologics Inc) | 217,844 | USD 801,6662.5% | USD 3.682.5% | |
| URGN (UroGen Pharma Ltd) | 34,904 | USD 792,321-1.6% | USD 22.7-1.6% | |
| NVAX (Novavax Inc) | 118,371 | USD 788,351-1.8% | USD 6.66-1.8% | |
| GRFS (Grifols SA ADR) | 88,957 | USD 784,601-1.8% | USD 8.82-1.8% | |
| PGEN (Precigen Inc) | 222,132 | USD 779,683-4.9% | USD 3.51-4.9% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,750 | USD 749,578-4.6% | USD 14.21-4.6% | |
| TNGX (Tango Therapeutics Inc) | 81,029 | USD 738,984-5.0% | USD 9.11999-5.0% | |
| NTLA (Intellia Therapeutics Inc) | 79,214 | USD 736,690-1.5% | USD 9.3-1.5% | |
| ERAS (Erasca Inc) | 221,272 | USD 730,198-1.2% | USD 3.3-1.2% | |
| ORIC (Oric Pharmaceuticals Inc) | 70,725 | USD 717,152-3.6% | USD 10.14-3.6% | |
| SPRY (Silverback Therapeutics Inc) | 71,284 | USD 707,850-0.7% | USD 9.93-0.7% | |
| MNMD (Mind Medicine Inc) | 56,496 | USD 706,200-3.8% | USD 12.5-3.8% | |
| KURA (Kura Oncology Inc) | 65,920 | USD 703,366-8.3% | USD 10.67-8.3% | |
| JANX (Janux Therapeutics Inc) | 43,739 | USD 688,452-5.1% | USD 15.74-5.1% | |
| ARVN (Arvinas Inc) | 52,281 | USD 684,881-1.7% | USD 13.1-1.7% | |
| VIR (Vir Biotechnology Inc) | 100,600 | USD 669,9961.2% | USD 6.661.2% | |
| TBPH (Theravance Biopharma Inc) | 36,727 | USD 654,108-1.7% | USD 17.81-1.7% | |
| ZLAB (Zai Lab Ltd) | 34,834 | USD 651,396-1.8% | USD 18.7-1.8% | |
| ABUS (Arbutus Biopharma Corp) | 142,389 | USD 635,055-1.3% | USD 4.46-1.3% | |
| KROS (Keros Therapeutics Inc) | 29,164 | USD 627,9011.0% | USD 21.531.0% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,127 | USD 611,548-4.5% | USD 8.25-4.5% | |
| REPL (Replimune Group Inc) | 58,306 | USD 600,552-4.0% | USD 10.3-4.0% | |
| IOVA (Iovance Biotherapeutics Inc) | 258,781 | USD 582,257-2.6% | USD 2.25-2.6% | |
| KALV (Kalvista Pharmaceuticals Inc) | 35,821 | USD 578,867-4.2% | USD 16.16-4.2% | |
| GERN (Geron Corporation) | 460,895 | USD 566,901-3.1% | USD 1.23-3.1% | |
| PACB (Pacific Biosciences of California) | 231,219 | USD 561,8624.7% | USD 2.434.7% | |
| PAHC (Phibro Animal Health Corporation) | 14,639 | USD 560,381-4.5% | USD 38.28-4.5% | |
| CGEM (Cullinan Oncology LLC) | 44,624 | USD 551,553-0.6% | USD 12.36-0.6% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,595 | USD 534,623-0.5% | USD 4.19-0.5% | |
| MGTX (MeiraGTx Holdings PLC) | 58,753 | USD 495,875-2.5% | USD 8.43999-2.5% | |
| RGNX (Regenxbio Inc) | 38,321 | USD 487,443-3.9% | USD 12.72-3.9% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 127,060 | USD 458,6874.0% | USD 3.614.0% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 114,087 | USD 420,9812.2% | USD 3.692.2% | |
| PRTA (Prothena Corporation plc) | 40,098 | USD 413,811-3.8% | USD 10.32-3.8% | |
| LYEL (Lyell Immunopharma Inc) | 14,019 | USD 410,3363.2% | USD 29.273.2% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,544 | USD 384,077-5.1% | USD 10.51-5.1% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 275,982 | USD 361,536-5.8% | USD 1.31-5.8% | |
| EOLS (Evolus Inc) | 51,200 | USD 357,3760.1% | USD 6.980.1% | |
| GLPG (Galapagos NV ADR) | 11,030 | USD 348,8790.4% | USD 31.630.4% | |
| SIGA (SIGA Technologies Inc) | 51,423 | USD 321,3941.6% | USD 6.251.6% | |
| TRDA (Entrada Therapeutics Inc) | 29,920 | USD 316,853-4.1% | USD 10.59-4.1% | |
| VNDA (Vanda Pharmaceuticals Inc) | 46,847 | USD 283,893-1.3% | USD 6.06-1.3% | |
| AVXL (Anavex Life Sciences Corp) | 62,855 | USD 277,1911.6% | USD 4.410011.6% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,158 | USD 262,611-4.0% | USD 3.36-4.0% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,671 | USD 245,817-4.2% | USD 7.08999-4.2% | |
| AUTL (Autolus Therapeutics Ltd) | 159,148 | USD 237,131-6.3% | USD 1.49-6.3% | |
| ALLO (Allogene Therapeutics Inc) | 160,457 | USD 227,849-2.1% | USD 1.42-2.1% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,401 | USD 192,799-1.9% | USD 3.14-1.9% | |
| ACIU (AC Immune Ltd) | 73,164 | USD 185,837-8.6% | USD 2.54001-8.6% | |
| OABI (OmniAb Inc.) | 90,403 | USD 179,902 | USD 1.99 | |
| EDIT (Editas Medicine Inc) | 70,243 | USD 171,3930.8% | USD 2.440.8% | |
| VYGR (Voyager Therapeutics Inc) | 37,686 | USD 161,673-0.7% | USD 4.29-0.7% | |
| HUMA (Humacyte Inc) | 119,180 | USD 151,359-1.5% | USD 1.27-1.6% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,875 | USD 150,300-3.4% | USD 7.2-3.4% | |
| ALEC (Alector Inc) | 77,863 | USD 99,6654.9% | USD 1.284.9% | |
| MRSN (Mersana Therapeutics Inc) | 3,448 | USD 97,0270.8% | USD 28.14010.8% | |
| FATE (Fate Therapeutics Inc) | 79,798 | USD 83,788-1.9% | USD 1.05-1.9% | |
| BMEA (Biomea Fusion Inc) | 50,791 | USD 68,060-0.7% | USD 1.34-0.7% | |
| MGNX (MacroGenics Inc) | 45,204 | USD 62,8344.5% | USD 1.390014.5% | |
| PLRX (Pliant Therapeutics Inc) | 42,599 | USD 53,675-1.6% | USD 1.26001-1.6% | |
| STRO (Sutro Biopharma) | 5,560 | USD 47,204-0.1% | USD 8.48993-0.1% | |
| OKUR (OKUR) | 8,899 | USD 29,634-2.6% | USD 3.33004-2.6% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 155,701 | USD 68,826,070-3.0% | USD 442.04-3.0% | |
| AMGN (Amgen Inc) | 211,616 | USD 67,977,408-2.6% | USD 321.23-2.6% | |
| REGN (Regeneron Pharmaceuticals Inc) | 76,013 | USD 53,456,902-2.1% | USD 703.26-2.1% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 95,633 | USD 41,124,103-6.1% | USD 430.02-6.1% | |
| INSM (Insmed Inc) | 155,512 | USD 30,565,884-3.7% | USD 196.55-3.7% | |
| ARGX (argenx NV ADR) | 22,498 | USD 20,265,2980.0% | USD 900.760.0% | |
| BIIB (Biogen Inc) | 108,040 | USD 19,494,738-0.5% | USD 180.44-0.5% | |
| UTHR (United Therapeutics Corporation) | 33,233 | USD 15,935,556-2.0% | USD 479.51-2.0% | |
| ILMN (Illumina Inc) | 113,077 | USD 14,389,048-1.3% | USD 127.25-1.3% | |
| INCY (Incyte Corporation) | 143,571 | USD 13,883,316-5.7% | USD 96.7-5.7% | |
| RPRX (Royalty Pharma Plc) | 318,150 | USD 12,302,861-2.7% | USD 38.67-2.7% | |
| MEDP (Medpace Holdings Inc) | 20,671 | USD 11,351,8930.2% | USD 549.170.2% | |
| NBIX (Neurocrine Biosciences Inc) | 72,962 | USD 11,308,380-0.3% | USD 154.99-0.3% | |
| RVMD (Revolution Medicines Inc) | 137,740 | USD 11,027,4640.5% | USD 80.060.5% | |
| ROIV (Roivant Sciences Ltd) | 503,064 | USD 10,559,3130.1% | USD 20.990.1% | |
| BBIO (BridgeBio Pharma Inc) | 140,787 | USD 10,452,0270.8% | USD 74.240.8% | |
| SMMT (Summit Therapeutics PLC) | 546,559 | USD 10,179,6611.7% | USD 18.6251.7% | |
| GH (Guardant Health Inc) | 91,975 | USD 9,581,0362.1% | USD 104.172.1% | |
| IONS (Ionis Pharmaceuticals Inc) | 117,405 | USD 9,569,682-0.2% | USD 81.51-0.2% | |
| SNY (Sanofi ADR) | 197,463 | USD 9,565,108-2.2% | USD 48.44-2.2% | |
| VTRS (Viatris Inc) | 858,516 | USD 9,520,9421.5% | USD 11.091.5% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,425 | USD 9,338,762-1.5% | USD 568.57-1.5% | |
| ASND (Ascendis Pharma AS) | 44,868 | USD 9,293,0600.8% | USD 207.120.8% | |
| EXEL (Exelixis Inc) | 198,525 | USD 8,371,799-4.9% | USD 42.17-4.9% | |
| MRNA (Moderna Inc) | 287,241 | USD 8,034,1311.0% | USD 27.971.0% | |
| BMRN (Biomarin Pharmaceutical Inc) | 141,667 | USD 7,550,851-0.2% | USD 53.3-0.2% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 44,475 | USD 7,513,607-0.4% | USD 168.94-0.4% | |
| BNTX (BioNTech SE) | 73,733 | USD 7,172,7461.1% | USD 97.281.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 101,633 | USD 6,972,02411.7% | USD 68.611.7% | |
| RNA (Avidity Biosciences Inc) | 95,032 | USD 6,771,980-0.5% | USD 71.26-0.5% | |
| CYTK (Cytokinetics Inc) | 87,664 | USD 5,621,892-2.3% | USD 64.13-2.3% | |
| AXSM (Axsome Therapeutics Inc) | 36,600 | USD 5,400,696-1.1% | USD 147.56-1.1% | |
| HALO (Halozyme Therapeutics Inc) | 85,715 | USD 5,389,759-0.7% | USD 62.88-0.7% | |
| MRUS (Merus BV) | 55,573 | USD 5,350,0130.1% | USD 96.270.1% | |
| NUVL (Nuvalent Inc) | 48,937 | USD 5,278,834-1.6% | USD 107.87-1.6% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 48,950 | USD 5,148,5610.6% | USD 105.180.6% | |
| KRYS (Krystal Biotech Inc) | 21,253 | USD 4,974,2650.0% | USD 234.050.0% | |
| KYMR (Kymera Therapeutics Inc) | 52,674 | USD 4,967,15841.5% | USD 94.341.5% | |
| PTCT (PTC Therapeutics Inc) | 58,356 | USD 4,488,160-0.4% | USD 76.91-0.4% | |
| PCVX (Vaxcyte Inc) | 95,355 | USD 4,403,494-0.6% | USD 46.18-0.6% | |
| PRAX (Praxis Precision Medicines Inc) | 15,488 | USD 4,196,9389.3% | USD 270.989.3% | |
| COGT (Cogent Biosciences Inc) | 102,928 | USD 4,147,9983.9% | USD 40.33.9% | |
| PTGX (Protagonist Therapeutics Inc) | 45,834 | USD 4,136,5190.7% | USD 90.250.7% | |
| CRSP (Crispr Therapeutics AG) | 66,659 | USD 3,823,5600.8% | USD 57.360.8% | |
| ALKS (Alkermes Plc) | 121,321 | USD 3,568,051-0.4% | USD 29.41-0.4% | |
| ADMA (ADMA Biologics Inc) | 176,342 | USD 3,419,271-2.3% | USD 19.39-2.3% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 124,668 | USD 3,336,116-2.5% | USD 26.76-2.5% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 69,351 | USD 3,287,2371.6% | USD 47.41.6% | |
| AKRO (Akero Therapeutics Inc) | 58,890 | USD 3,218,3390.2% | USD 54.650.2% | |
| SRRK (Scholar Rock Holding Corp) | 70,879 | USD 3,207,2750.5% | USD 45.250.5% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 43,332 | USD 3,032,373102.5% | USD 69.98102.5% | |
| ACLX (Arcellx Inc) | 40,743 | USD 3,018,2416.5% | USD 74.086.5% | |
| IMVT (Immunovant Inc) | 129,158 | USD 2,992,5911.4% | USD 23.171.4% | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,007 | USD 2,761,887-0.5% | USD 31.03-0.5% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 232,461 | USD 2,759,312-2.5% | USD 11.87-2.5% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,477 | USD 2,673,468-0.1% | USD 184.67-0.1% | |
| GRAL (GRAIL, LLC) | 26,670 | USD 2,661,666-1.2% | USD 99.8-1.2% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,293 | USD 2,609,354-0.9% | USD 76.09-0.9% | |
| RARE (Ultragenyx) | 71,401 | USD 2,602,5660.2% | USD 36.450.2% | |
| VCYT (Veracyte Inc) | 58,372 | USD 2,589,382-0.6% | USD 44.36-0.6% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,269 | USD 2,571,2500.6% | USD 82.230.6% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,049 | USD 2,540,392-1.1% | USD 44.53-1.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,087 | USD 2,518,207-0.8% | USD 67.9-0.8% | |
| CGON (CG Oncology, Inc. Common stock) | 56,377 | USD 2,412,936-1.2% | USD 42.8-1.2% | |
| DYN (Dyne Therapeutics Inc) | 105,209 | USD 2,335,6409.5% | USD 22.29.5% | |
| IDYA (Ideaya Biosciences Inc) | 65,065 | USD 2,299,397-1.5% | USD 35.34-1.5% | |
| TVTX (Travere Therapeutics Inc) | 64,840 | USD 2,223,364-2.0% | USD 34.29-2.0% | |
| APLS (Apellis Pharmaceuticals Inc) | 93,454 | USD 2,223,2710.7% | USD 23.790.7% | |
| FOLD (Amicus Therapeutics Inc) | 224,302 | USD 2,209,375-0.5% | USD 9.85-0.5% | |
| WVE (Wave Life Sciences Ltd) | 118,868 | USD 2,201,435147.3% | USD 18.52147.3% | |
| DNLI (Denali Therapeutics Inc) | 106,391 | USD 2,094,839-1.4% | USD 19.69-1.4% | |
| VERA (Vera Therapeutics Inc) | 46,422 | USD 2,090,3830.3% | USD 45.030.3% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 69,769 | USD 2,058,186-1.4% | USD 29.5-1.4% | |
| OCUL (Ocular Therapeutix Inc) | 126,630 | USD 2,040,00928.1% | USD 16.1128.1% | |
| BEAM (Beam Therapeutics Inc) | 73,590 | USD 1,994,2890.0% | USD 27.10.0% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,587 | USD 1,961,2433.2% | USD 47.163.2% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 48,189 | USD 1,840,820-0.8% | USD 38.2-0.8% | |
| EWTX (Edgewise Therapeutics Inc) | 76,674 | USD 1,806,439-0.1% | USD 23.56-0.1% | |
| ADPT (Adaptive Biotechnologies Corp) | 110,805 | USD 1,656,5351.4% | USD 14.951.4% | |
| HRMY (Harmony Biosciences Holdings) | 41,865 | USD 1,629,386-2.3% | USD 38.92-2.3% | |
| LEGN (Legend Biotech Corp) | 61,790 | USD 1,613,955-7.1% | USD 26.12-7.1% | |
| IBRX (Immunitybio Inc) | 697,966 | USD 1,577,403-1.3% | USD 2.26-1.3% | |
| SRPT (Sarepta Therapeutics Inc) | 71,087 | USD 1,553,962-1.8% | USD 21.86-1.8% | |
| RXRX (Recursion Pharmaceuticals Inc) | 316,647 | USD 1,526,2392.3% | USD 4.822.3% | |
| SYRE (Spyre Therapeutics Inc.) | 43,740 | USD 1,514,7163.5% | USD 34.633.5% | |
| AVDL (Avadel Pharmaceuticals PLC) | 70,697 | USD 1,507,260-0.1% | USD 21.32-0.1% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 95,861 | USD 1,503,1000.4% | USD 15.680.4% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,336 | USD 1,487,834-1.0% | USD 26.41-1.0% | |
| TXG (10X Genomics Inc) | 84,184 | USD 1,470,694-1.7% | USD 17.47-1.7% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,019 | USD 1,427,5122.8% | USD 27.982.8% | |
| TWST (Twist Bioscience Corp) | 43,946 | USD 1,415,940-0.2% | USD 32.22-0.2% | |
| VCEL (Vericel Corp Ord) | 36,702 | USD 1,368,9853.0% | USD 37.33.0% | |
| STOK (Stoke Therapeutics Inc) | 40,712 | USD 1,343,4966.9% | USD 336.9% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,095 | USD 1,333,547-0.3% | USD 41.55-0.3% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,801 | USD 1,285,253-0.5% | USD 81.34-0.5% | |
| HROW (Harrow Health Inc) | 26,910 | USD 1,277,4183.8% | USD 47.473.8% | |
| MNKD (MannKind Corp) | 223,542 | USD 1,258,541-0.9% | USD 5.63-0.9% | |
| NRIX (Nurix Therapeutics Inc) | 58,570 | USD 1,257,49818.7% | USD 21.4718.7% | |
| SNDX (Syndax Pharmaceuticals Inc) | 62,756 | USD 1,253,865-1.7% | USD 19.98-1.7% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 152,925 | USD 1,177,5231.4% | USD 7.71.4% | |
| AGIO (Agios Pharm) | 42,268 | USD 1,153,071-1.6% | USD 27.28-1.6% | |
| IMCR (Immunocore Holdings Ltd) | 29,945 | USD 1,141,204-1.7% | USD 38.11-1.7% | |
| COLL (Collegium Pharmaceutical Inc) | 22,927 | USD 1,098,433 | USD 47.91 | |
| TSHA (Taysha Gene Therapies Inc) | 198,922 | USD 1,084,1257.9% | USD 5.457.9% | |
| ARDX (Ardelyx Inc) | 175,635 | USD 1,032,734-1.7% | USD 5.88-1.7% | |
| NVCR (Novocure Ltd) | 81,429 | USD 982,034-0.4% | USD 12.06-0.4% | |
| FTRE (Fortrea Holdings Inc.) | 66,189 | USD 978,2733.8% | USD 14.783.8% | |
| GMAB (Genmab AS) | 30,498 | USD 974,1060.6% | USD 31.940.6% | |
| RLAY (Relay Therapeutics Inc) | 125,704 | USD 959,122-0.7% | USD 7.63-0.7% | |
| INVA (Innoviva Inc) | 45,639 | USD 958,4191.3% | USD 211.3% | |
| DVAX (Dynavax Technologies Corporation) | 85,455 | USD 937,4410.7% | USD 10.970.7% | |
| XNCR (Xencor Inc) | 51,972 | USD 918,8652.2% | USD 17.682.2% | |
| ANAB (AnaptysBio Inc) | 20,368 | USD 906,5800.4% | USD 44.510.4% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 50,254 | USD 895,5260.5% | USD 17.820.5% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 64,959 | USD 887,990-3.7% | USD 13.67-3.7% | |
| SANA (Sana Biotechnology Inc) | 191,518 | USD 886,728-9.7% | USD 4.63-9.7% | |
| ELVN (Enliven Therapeutics Inc.) | 43,099 | USD 884,391-5.9% | USD 20.52-5.9% | |
| AMPH (Amphastar P) | 33,844 | USD 880,282-2.8% | USD 26.01-2.8% | |
| QURE (Uniqure NV) | 40,237 | USD 875,9592.1% | USD 21.772.1% | |
| XERS (Xeris Pharmaceuticals Inc) | 121,257 | USD 847,5867.4% | USD 6.997.4% | |
| PGEN (Precigen Inc) | 222,132 | USD 819,6672.5% | USD 3.692.5% | |
| SVRA (Savara Inc) | 125,490 | USD 811,920-0.5% | USD 6.47-0.5% | |
| CSTL (Castle Biosciences Inc) | 21,186 | USD 807,187-1.4% | USD 38.1-1.4% | |
| URGN (UroGen Pharma Ltd) | 34,904 | USD 805,5840.4% | USD 23.080.4% | |
| NVAX (Novavax Inc) | 118,371 | USD 802,555-1.9% | USD 6.78-1.9% | |
| PCRX (Pacira BioSciences, Inc.) | 32,716 | USD 798,9251.8% | USD 24.421.8% | |
| GRFS (Grifols SA ADR) | 88,957 | USD 798,8341.5% | USD 8.981.5% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,750 | USD 785,9752.2% | USD 14.92.2% | |
| ABCL (Abcellera Biologics Inc) | 217,844 | USD 782,0600.8% | USD 3.590.8% | |
| TNGX (Tango Therapeutics Inc) | 81,029 | USD 777,878-0.3% | USD 9.59999-0.3% | |
| KURA (Kura Oncology Inc) | 65,920 | USD 767,309-2.6% | USD 11.64-2.6% | |
| NTLA (Intellia Therapeutics Inc) | 79,214 | USD 747,780-1.8% | USD 9.44-1.8% | |
| ORIC (Oric Pharmaceuticals Inc) | 70,725 | USD 744,027-4.4% | USD 10.52-4.4% | |
| ERAS (Erasca Inc) | 221,272 | USD 739,0482.1% | USD 3.342.1% | |
| MNMD (Mind Medicine Inc) | 56,496 | USD 734,4485.3% | USD 135.3% | |
| JANX (Janux Therapeutics Inc) | 43,739 | USD 725,1930.4% | USD 16.580.4% | |
| SPRY (Silverback Therapeutics Inc) | 71,284 | USD 712,8400.7% | USD 100.7% | |
| ARVN (Arvinas Inc) | 52,281 | USD 696,3834.1% | USD 13.324.1% | |
| TBPH (Theravance Biopharma Inc) | 36,727 | USD 665,493-2.3% | USD 18.12-2.3% | |
| ZLAB (Zai Lab Ltd) | 34,834 | USD 663,588-2.3% | USD 19.05-2.3% | |
| VIR (Vir Biotechnology Inc) | 100,600 | USD 661,9481.2% | USD 6.581.2% | |
| ABUS (Arbutus Biopharma Corp) | 142,389 | USD 643,5982.3% | USD 4.522.3% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,127 | USD 640,4579.1% | USD 8.649.1% | |
| REPL (Replimune Group Inc) | 58,306 | USD 625,6231.1% | USD 10.731.1% | |
| KROS (Keros Therapeutics Inc) | 29,164 | USD 621,776-1.7% | USD 21.32-1.7% | |
| KALV (Kalvista Pharmaceuticals Inc) | 35,821 | USD 603,9422.6% | USD 16.862.6% | |
| IOVA (Iovance Biotherapeutics Inc) | 258,781 | USD 597,7845.0% | USD 2.315.0% | |
| PAHC (Phibro Animal Health Corporation) | 14,639 | USD 586,7312.3% | USD 40.082.3% | |
| GERN (Geron Corporation) | 460,895 | USD 585,337-3.1% | USD 1.27-3.1% | |
| CGEM (Cullinan Oncology LLC) | 44,624 | USD 555,12317.5% | USD 12.4417.5% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,595 | USD 537,17512.6% | USD 4.2112.6% | |
| PACB (Pacific Biosciences of California) | 231,219 | USD 536,428-2.9% | USD 2.32-2.9% | |
| MGTX (MeiraGTx Holdings PLC) | 58,753 | USD 508,8010.1% | USD 8.660.1% | |
| RGNX (Regenxbio Inc) | 38,321 | USD 507,3700.6% | USD 13.240.6% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 127,060 | USD 440,898-0.3% | USD 3.47-0.3% | |
| PRTA (Prothena Corporation plc) | 40,098 | USD 430,252-3.1% | USD 10.73-3.1% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 114,087 | USD 411,854-2.4% | USD 3.61-2.4% | |
| FDMT (4D Molecular Therapeutics Inc) | 36,544 | USD 404,9083.6% | USD 11.083.6% | |
| LYEL (Lyell Immunopharma Inc) | 14,019 | USD 397,57912.3% | USD 28.3612.3% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 275,982 | USD 383,615-0.7% | USD 1.39-0.7% | |
| EOLS (Evolus Inc) | 51,200 | USD 356,8641.8% | USD 6.971.8% | |
| GLPG (Galapagos NV ADR) | 11,030 | USD 347,335-0.3% | USD 31.49-0.3% | |
| TRDA (Entrada Therapeutics Inc) | 29,920 | USD 330,3177.0% | USD 11.047.0% | |
| SIGA (SIGA Technologies Inc) | 51,423 | USD 316,251-0.8% | USD 6.14999-0.8% | |
| VNDA (Vanda Pharmaceuticals Inc) | 46,847 | USD 287,64113.9% | USD 6.1400113.9% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,158 | USD 273,5535.4% | USD 3.55.4% | |
| AVXL (Anavex Life Sciences Corp) | 62,855 | USD 272,791-1.4% | USD 4.34-1.4% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,671 | USD 256,5654.7% | USD 7.399994.7% | |
| AUTL (Autolus Therapeutics Ltd) | 159,148 | USD 253,0452.6% | USD 1.592.6% | |
| ALLO (Allogene Therapeutics Inc) | 160,457 | USD 232,6631.4% | USD 1.451.4% | |
| ACIU (AC Immune Ltd) | 73,164 | USD 203,396-0.7% | USD 2.78-0.7% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,401 | USD 196,4830.9% | USD 3.20.9% | |
| OABI (OmniAb Inc.) | 90,403 | USD 179,9022.1% | USD 1.992.1% | |
| EDIT (Editas Medicine Inc) | 70,243 | USD 169,988 | USD 2.42 | |
| VYGR (Voyager Therapeutics Inc) | 37,686 | USD 162,8040.9% | USD 4.320010.9% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,875 | USD 155,5194.5% | USD 7.450014.5% | |
| HUMA (Humacyte Inc) | 119,180 | USD 153,7424.9% | USD 1.294.9% | |
| MRSN (Mersana Therapeutics Inc) | 3,448 | USD 96,2680.5% | USD 27.920.5% | |
| ALEC (Alector Inc) | 77,863 | USD 94,993 | USD 1.22 | |
| FATE (Fate Therapeutics Inc) | 79,798 | USD 85,384-0.9% | USD 1.07-0.9% | |
| BMEA (Biomea Fusion Inc) | 50,791 | USD 68,56810.7% | USD 1.3510.7% | |
| MGNX (MacroGenics Inc) | 45,204 | USD 60,121-2.9% | USD 1.32999-2.9% | |
| PLRX (Pliant Therapeutics Inc) | 42,599 | USD 54,5275.8% | USD 1.280015.8% | |
| STRO (Sutro Biopharma) | 5,560 | USD 47,232-1.9% | USD 8.49496-1.9% | |
| OKUR (OKUR) | 8,899 | USD 30,43511.8% | USD 3.4200511.8% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
| Ticker | Number of Shares Held | Value of Shares Held | Share Price (delta previous report) | Comment |
|---|
| VRTX (Vertex Pharmaceuticals Inc) | 155,701 | USD 70,918,691-0.4% | USD 455.48-0.4% | |
| AMGN (Amgen Inc) | 211,616 | USD 69,810,002-3.0% | USD 329.89-3.0% | |
| REGN (Regeneron Pharmaceuticals Inc) | 76,013 | USD 54,604,699-0.6% | USD 718.36-0.6% | |
| ALNY (Alnylam Pharmaceuticals Inc) | 95,633 | USD 43,811,390-1.6% | USD 458.12-1.6% | |
| INSM (Insmed Inc) | 155,512 | USD 31,724,448-0.5% | USD 204-0.5% | |
| ARGX (argenx NV ADR) | 22,498 | USD 20,274,523-1.6% | USD 901.17-1.6% | |
| BIIB (Biogen Inc) | 108,040 | USD 19,587,652-0.4% | USD 181.3-0.4% | |
| UTHR (United Therapeutics Corporation) | 33,233 | USD 16,261,2391.1% | USD 489.311.1% | |
| INCY (Incyte Corporation) | 143,571 | USD 14,718,8992.1% | USD 102.522.1% | |
| ILMN (Illumina Inc) | 113,077 | USD 14,582,4100.7% | USD 128.960.7% | |
| RPRX (Royalty Pharma Plc) | 318,150 | USD 12,640,1001.5% | USD 39.731.5% | |
| NBIX (Neurocrine Biosciences Inc) | 72,962 | USD 11,346,3210.8% | USD 155.510.8% | |
| MEDP (Medpace Holdings Inc) | 20,671 | USD 11,330,1890.6% | USD 548.120.6% | |
| RVMD (Revolution Medicines Inc) | 137,740 | USD 10,969,6141.5% | USD 79.641.5% | |
| ROIV (Roivant Sciences Ltd) | 503,064 | USD 10,549,252-1.0% | USD 20.97-1.0% | |
| BBIO (BridgeBio Pharma Inc) | 140,787 | USD 10,367,555-1.5% | USD 73.64-1.5% | |
| SMMT (Summit Therapeutics PLC) | 546,559 | USD 10,007,495-2.7% | USD 18.31-2.7% | |
| SNY (Sanofi ADR) | 197,463 | USD 9,780,3421.3% | USD 49.531.3% | |
| IONS (Ionis Pharmaceuticals Inc) | 117,405 | USD 9,589,640-0.2% | USD 81.68-0.2% | |
| MDGL (Madrigal Pharmaceuticals Inc) | 16,425 | USD 9,482,153-1.5% | USD 577.3-1.5% | |
| VTRS (Viatris Inc) | 858,516 | USD 9,383,5801.6% | USD 10.931.6% | |
| GH (Guardant Health Inc) | 91,975 | USD 9,383,290-6.0% | USD 102.02-6.0% | |
| ASND (Ascendis Pharma AS) | 44,868 | USD 9,217,682-1.5% | USD 205.44-1.5% | |
| EXEL (Exelixis Inc) | 198,525 | USD 8,806,5690.0% | USD 44.360.0% | |
| MRNA (Moderna Inc) | 287,241 | USD 7,956,5768.7% | USD 27.78.7% | |
| BMRN (Biomarin Pharmaceutical Inc) | 141,667 | USD 7,565,018-0.8% | USD 53.4-0.8% | |
| JAZZ (Jazz Pharmaceuticals PLC) | 44,475 | USD 7,547,4081.7% | USD 169.71.7% | |
| BNTX (BioNTech SE) | 73,733 | USD 7,096,8010.3% | USD 96.250.3% | |
| RNA (Avidity Biosciences Inc) | 95,032 | USD 6,807,1420.1% | USD 71.630.1% | |
| ARWR (Arrowhead Pharmaceuticals Inc) | 101,633 | USD 6,244,332-5.0% | USD 61.44-5.0% | |
| CYTK (Cytokinetics Inc) | 87,664 | USD 5,756,895-1.3% | USD 65.67-1.3% | |
| AXSM (Axsome Therapeutics Inc) | 36,600 | USD 5,461,4520.8% | USD 149.220.8% | |
| HALO (Halozyme Therapeutics Inc) | 85,715 | USD 5,428,3310.6% | USD 63.330.6% | |
| NUVL (Nuvalent Inc) | 48,937 | USD 5,363,4952.6% | USD 109.62.6% | |
| MRUS (Merus BV) | 55,573 | USD 5,342,788-0.1% | USD 96.14-0.1% | |
| RYTM (Rhythm Pharmaceuticals Inc) | 48,950 | USD 5,120,170-1.0% | USD 104.6-1.0% | |
| KRYS (Krystal Biotech Inc) | 21,253 | USD 4,975,9655.5% | USD 234.135.5% | |
| PTCT (PTC Therapeutics Inc) | 58,356 | USD 4,508,293-0.8% | USD 77.255-0.8% | |
| PCVX (Vaxcyte Inc) | 95,355 | USD 4,432,1000.9% | USD 46.480.9% | |
| PTGX (Protagonist Therapeutics Inc) | 45,834 | USD 4,109,0182.7% | USD 89.652.7% | |
| COGT (Cogent Biosciences Inc) | 102,928 | USD 3,990,519-1.4% | USD 38.77-1.4% | |
| PRAX (Praxis Precision Medicines Inc) | 15,488 | USD 3,840,86930.5% | USD 247.9930.5% | |
| CRSP (Crispr Therapeutics AG) | 66,659 | USD 3,791,564-2.2% | USD 56.88-2.2% | |
| ALKS (Alkermes Plc) | 121,321 | USD 3,581,3960.8% | USD 29.520.8% | |
| KYMR (Kymera Therapeutics Inc) | 52,674 | USD 3,509,1420.6% | USD 66.620.6% | |
| ADMA (ADMA Biologics Inc) | 176,342 | USD 3,500,389-1.3% | USD 19.85-1.3% | |
| ACAD (ACADIA Pharmaceuticals Inc) | 124,668 | USD 3,420,8903.4% | USD 27.443.4% | |
| CRNX (Crinetics Pharmaceuticals Inc) | 69,351 | USD 3,236,611-1.6% | USD 46.67-1.6% | |
| AKRO (Akero Therapeutics Inc) | 58,890 | USD 3,212,450-0.1% | USD 54.55-0.1% | |
| SRRK (Scholar Rock Holding Corp) | 70,879 | USD 3,190,973-0.4% | USD 45.02-0.4% | |
| IMVT (Immunovant Inc) | 129,158 | USD 2,949,969-0.3% | USD 22.84-0.3% | |
| ACLX (Arcellx Inc) | 40,743 | USD 2,834,0831.6% | USD 69.561.6% | |
| AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) | 232,461 | USD 2,831,3752.0% | USD 12.182.0% | |
| ARQT (Arcutis Biotherapeutics Inc) | 89,007 | USD 2,777,0180.1% | USD 31.20.1% | |
| GRAL (GRAIL, LLC) | 26,670 | USD 2,693,137-3.6% | USD 100.98-3.6% | |
| LGND (Ligand Pharmaceuticals Incorporated) | 14,477 | USD 2,676,363-1.9% | USD 184.87-1.9% | |
| APGE (Apogee Therapeutics, Inc. Common Stock) | 34,293 | USD 2,631,9881.7% | USD 76.751.7% | |
| VCYT (Veracyte Inc) | 58,372 | USD 2,603,975-5.9% | USD 44.61-5.9% | |
| RARE (Ultragenyx) | 71,401 | USD 2,597,568-0.4% | USD 36.38-0.4% | |
| XENE (Xenon Pharmaceuticals Inc) | 57,049 | USD 2,567,7750.9% | USD 45.010.9% | |
| TARS (Tarsus Pharmaceuticals Inc) | 31,269 | USD 2,556,866-0.1% | USD 81.77-0.1% | |
| MIRM (Mirum Pharmaceuticals Inc) | 37,087 | USD 2,539,718-4.3% | USD 68.48-4.3% | |
| CGON (CG Oncology, Inc. Common stock) | 56,377 | USD 2,441,124-3.2% | USD 43.3-3.2% | |
| IDYA (Ideaya Biosciences Inc) | 65,065 | USD 2,333,882-0.4% | USD 35.87-0.4% | |
| TVTX (Travere Therapeutics Inc) | 64,840 | USD 2,269,400-0.9% | USD 35-0.9% | |
| FOLD (Amicus Therapeutics Inc) | 224,302 | USD 2,220,590-0.5% | USD 9.9-0.5% | |
| APLS (Apellis Pharmaceuticals Inc) | 93,454 | USD 2,208,3186.5% | USD 23.636.5% | |
| DYN (Dyne Therapeutics Inc) | 105,209 | USD 2,133,639-1.8% | USD 20.28-1.8% | |
| DNLI (Denali Therapeutics Inc) | 106,391 | USD 2,123,564-0.7% | USD 19.96-0.7% | |
| CNTA (Centessa Pharmaceuticals PLC ADR) | 69,769 | USD 2,086,7911.2% | USD 29.911.2% | |
| VERA (Vera Therapeutics Inc) | 46,422 | USD 2,084,3485.4% | USD 44.95.4% | |
| BEAM (Beam Therapeutics Inc) | 73,590 | USD 1,993,553-6.3% | USD 27.09-6.3% | |
| SUPN (Supernus Pharmaceuticals Inc) | 41,587 | USD 1,899,6941.3% | USD 45.681.3% | |
| MLYS (Mineralys Therapeutics, Inc. Common Stock) | 48,189 | USD 1,855,277-1.1% | USD 38.5-1.1% | |
| EWTX (Edgewise Therapeutics Inc) | 76,674 | USD 1,808,740-0.5% | USD 23.59-0.5% | |
| LEGN (Legend Biotech Corp) | 61,790 | USD 1,738,1531.2% | USD 28.131.2% | |
| HRMY (Harmony Biosciences Holdings) | 41,865 | USD 1,667,4834.1% | USD 39.834.1% | |
| ADPT (Adaptive Biotechnologies Corp) | 110,805 | USD 1,634,374-15.5% | USD 14.75-15.5% | |
| IBRX (Immunitybio Inc) | 697,966 | USD 1,598,342-0.4% | USD 2.29-0.4% | |
| OCUL (Ocular Therapeutix Inc) | 126,630 | USD 1,593,0051.2% | USD 12.581.2% | |
| SRPT (Sarepta Therapeutics Inc) | 71,087 | USD 1,582,397-2.5% | USD 22.26-2.5% | |
| AVDL (Avadel Pharmaceuticals PLC) | 70,697 | USD 1,508,674-0.1% | USD 21.34-0.1% | |
| ZYME (Zymeworks Inc. Common Stock) | 56,336 | USD 1,503,6080.6% | USD 26.690.6% | |
| GPCR (Structure Therapeutics Inc. American Depositary Shares) | 43,332 | USD 1,497,5545.2% | USD 34.565.2% | |
| AUPH (Aurinia Pharmaceuticals Inc) | 95,861 | USD 1,497,3492.0% | USD 15.622.0% | |
| TXG (10X Genomics Inc) | 84,184 | USD 1,495,950-2.1% | USD 17.77-2.1% | |
| RXRX (Recursion Pharmaceuticals Inc) | 316,647 | USD 1,491,407-4.3% | USD 4.71-4.3% | |
| SYRE (Spyre Therapeutics Inc.) | 43,740 | USD 1,463,103-0.2% | USD 33.45-0.2% | |
| TWST (Twist Bioscience Corp) | 43,946 | USD 1,419,456-1.6% | USD 32.3-1.6% | |
| OLMA (Olema Pharmaceuticals Inc) | 51,019 | USD 1,388,227-1.6% | USD 27.21-1.6% | |
| KNSA (Kiniksa Pharmaceuticals Ltd) | 32,095 | USD 1,337,3991.7% | USD 41.671.7% | |
| VCEL (Vericel Corp Ord) | 36,702 | USD 1,329,713-1.5% | USD 36.23-1.5% | |
| ANIP (ANI Pharmaceuticals Inc) | 15,801 | USD 1,292,048-1.2% | USD 81.77-1.2% | |
| SNDX (Syndax Pharmaceuticals Inc) | 62,756 | USD 1,275,2022.9% | USD 20.322.9% | |
| MNKD (MannKind Corp) | 223,542 | USD 1,269,719-0.5% | USD 5.68-0.5% | |
| STOK (Stoke Therapeutics Inc) | 40,712 | USD 1,256,779-0.6% | USD 30.87-0.6% | |
| HROW (Harrow Health Inc) | 26,910 | USD 1,231,133-2.2% | USD 45.75-2.2% | |
| AGIO (Agios Pharm) | 42,268 | USD 1,172,0921.1% | USD 27.731.1% | |
| IMCR (Immunocore Holdings Ltd) | 29,945 | USD 1,161,267-3.6% | USD 38.78-3.6% | |
| BCRX (BioCryst Pharmaceuticals Inc) | 152,925 | USD 1,160,701-3.1% | USD 7.59-3.1% | |
| COLL (Collegium Pharmaceutical Inc) | 22,927 | USD 1,098,4331.0% | USD 47.911.0% | |
| NRIX (Nurix Therapeutics Inc) | 58,570 | USD 1,059,5310.4% | USD 18.090.4% | |
| ARDX (Ardelyx Inc) | 175,635 | USD 1,050,2971.0% | USD 5.981.0% | |
| TSHA (Taysha Gene Therapies Inc) | 198,922 | USD 1,004,556-0.2% | USD 5.05-0.2% | |
| NVCR (Novocure Ltd) | 81,429 | USD 986,1053.0% | USD 12.113.0% | |
| SANA (Sana Biotechnology Inc) | 191,518 | USD 982,487-1.0% | USD 5.13-1.0% | |
| GMAB (Genmab AS) | 30,498 | USD 968,007-0.9% | USD 31.74-0.9% | |
| RLAY (Relay Therapeutics Inc) | 125,704 | USD 965,407-4.0% | USD 7.68-4.0% | |
| INVA (Innoviva Inc) | 45,639 | USD 946,553-0.3% | USD 20.74-0.3% | |
| FTRE (Fortrea Holdings Inc.) | 66,189 | USD 942,531-1.8% | USD 14.24-1.8% | |
| ELVN (Enliven Therapeutics Inc.) | 43,099 | USD 939,9891.9% | USD 21.811.9% | |
| DVAX (Dynavax Technologies Corporation) | 85,455 | USD 930,605-0.6% | USD 10.89-0.6% | |
| AMLX (Amylyx Pharmaceuticals Inc) | 64,959 | USD 922,418-2.0% | USD 14.2-2.0% | |
| AMPH (Amphastar P) | 33,844 | USD 906,004-1.4% | USD 26.77-1.4% | |
| ANAB (AnaptysBio Inc) | 20,368 | USD 903,3212.4% | USD 44.352.4% | |
| XNCR (Xencor Inc) | 51,972 | USD 899,116-4.6% | USD 17.3-4.6% | |
| EYPT (Eyepoint Pharmaceuticals Inc) | 50,254 | USD 891,5066.1% | USD 17.746.1% | |
| WVE (Wave Life Sciences Ltd) | 118,868 | USD 890,321-1.7% | USD 7.49-1.7% | |
| QURE (Uniqure NV) | 40,237 | USD 858,255-6.2% | USD 21.33-6.2% | |
| CSTL (Castle Biosciences Inc) | 21,186 | USD 818,627-2.5% | USD 38.64-2.5% | |
| NVAX (Novavax Inc) | 118,371 | USD 817,9440.7% | USD 6.910.7% | |
| SVRA (Savara Inc) | 125,490 | USD 815,6852.0% | USD 6.52.0% | |
| URGN (UroGen Pharma Ltd) | 34,904 | USD 802,094-5.4% | USD 22.98-5.4% | |
| PGEN (Precigen Inc) | 222,132 | USD 799,675-4.0% | USD 3.6-4.0% | |
| XERS (Xeris Pharmaceuticals Inc) | 121,257 | USD 789,383-3.1% | USD 6.51-3.1% | |
| KURA (Kura Oncology Inc) | 65,920 | USD 787,744-0.3% | USD 11.95-0.3% | |
| GRFS (Grifols SA ADR) | 88,957 | USD 787,269-0.5% | USD 8.84999-0.5% | |
| PCRX (Pacira BioSciences, Inc.) | 32,716 | USD 784,8570.0% | USD 23.990.0% | |
| TNGX (Tango Therapeutics Inc) | 81,029 | USD 780,309-2.7% | USD 9.63-2.7% | |
| ORIC (Oric Pharmaceuticals Inc) | 70,725 | USD 777,975-3.4% | USD 11-3.4% | |
| ABCL (Abcellera Biologics Inc) | 217,844 | USD 775,525-2.5% | USD 3.56-2.5% | |
| PHAT (Phathom Pharmaceuticals Inc) | 52,750 | USD 769,095-0.8% | USD 14.58-0.8% | |
| NTLA (Intellia Therapeutics Inc) | 79,214 | USD 761,247-1.3% | USD 9.61001-1.3% | |
| ERAS (Erasca Inc) | 221,272 | USD 723,5592.5% | USD 3.272.5% | |
| JANX (Janux Therapeutics Inc) | 43,739 | USD 722,1310.7% | USD 16.510.7% | |
| SPRY (Silverback Therapeutics Inc) | 71,284 | USD 707,850-0.4% | USD 9.93-0.4% | |
| MNMD (Mind Medicine Inc) | 56,496 | USD 697,726-0.6% | USD 12.35-0.6% | |
| TBPH (Theravance Biopharma Inc) | 36,727 | USD 681,286-0.8% | USD 18.55-0.8% | |
| ZLAB (Zai Lab Ltd) | 34,834 | USD 679,263-2.3% | USD 19.5-2.3% | |
| ARVN (Arvinas Inc) | 52,281 | USD 668,6741.9% | USD 12.791.9% | |
| VIR (Vir Biotechnology Inc) | 100,600 | USD 653,900-4.1% | USD 6.5-4.1% | |
| KROS (Keros Therapeutics Inc) | 29,164 | USD 632,5677.0% | USD 21.697.0% | |
| ABUS (Arbutus Biopharma Corp) | 142,389 | USD 629,3590.2% | USD 4.420.2% | |
| REPL (Replimune Group Inc) | 58,306 | USD 618,6270.8% | USD 10.610.8% | |
| GERN (Geron Corporation) | 460,895 | USD 603,7723.1% | USD 1.313.1% | |
| KALV (Kalvista Pharmaceuticals Inc) | 35,821 | USD 588,5390.2% | USD 16.430.2% | |
| DAWN (Day One Biopharmaceuticals Inc) | 74,127 | USD 587,086-5.0% | USD 7.92-5.0% | |
| PAHC (Phibro Animal Health Corporation) | 14,639 | USD 573,263-3.9% | USD 39.16-3.9% | |
| IOVA (Iovance Biotherapeutics Inc) | 258,781 | USD 569,318 | USD 2.2 | |
| PACB (Pacific Biosciences of California) | 231,219 | USD 552,613-5.2% | USD 2.39-5.2% | |
| MGTX (MeiraGTx Holdings PLC) | 58,753 | USD 508,2130.6% | USD 8.649990.6% | |
| RGNX (Regenxbio Inc) | 38,321 | USD 504,3041.4% | USD 13.161.4% | |
| PRME (Prime Medicine, Inc. Common Stock) | 127,595 | USD 477,205-2.9% | USD 3.74-2.9% | |
| CGEM (Cullinan Oncology LLC) | 44,624 | USD 472,5680.1% | USD 10.590.1% | |
| PRTA (Prothena Corporation plc) | 40,098 | USD 443,885-0.8% | USD 11.07-0.8% | |
| IRWD (Ironwood Pharmaceuticals Inc) | 127,060 | USD 442,169-6.7% | USD 3.48-6.7% | |
| MRVI (Maravai Lifesciences Holdings Inc) | 114,087 | USD 422,122 | USD 3.7 | |
| FDMT (4D Molecular Therapeutics Inc) | 36,544 | USD 391,021-4.4% | USD 10.7-4.4% | |
| LXRX (Lexicon Pharmaceuticals Inc) | 275,982 | USD 386,375-1.4% | USD 1.4-1.4% | |
| LYEL (Lyell Immunopharma Inc) | 14,019 | USD 353,980-0.8% | USD 25.25-0.8% | |
| EOLS (Evolus Inc) | 51,200 | USD 350,7200.6% | USD 6.850.6% | |
| GLPG (Galapagos NV ADR) | 11,030 | USD 348,438-0.6% | USD 31.59-0.6% | |
| SIGA (SIGA Technologies Inc) | 51,423 | USD 318,823-2.2% | USD 6.20001-2.2% | |
| TRDA (Entrada Therapeutics Inc) | 29,920 | USD 308,7741.6% | USD 10.321.6% | |
| AVXL (Anavex Life Sciences Corp) | 62,855 | USD 276,562-1.1% | USD 4.4-1.1% | |
| RCKT (Rocket Pharmaceuticals Inc) | 78,158 | USD 259,485-2.9% | USD 3.32001-2.9% | |
| VNDA (Vanda Pharmaceuticals Inc) | 46,847 | USD 252,5053.7% | USD 5.389993.7% | |
| AUTL (Autolus Therapeutics Ltd) | 159,148 | USD 246,679-1.3% | USD 1.55-1.3% | |
| BCYC (Bicycle Therapeutics Ltd) | 34,671 | USD 245,124-1.0% | USD 7.07-1.0% | |
| ALLO (Allogene Therapeutics Inc) | 160,457 | USD 229,454-0.7% | USD 1.43-0.7% | |
| ACIU (AC Immune Ltd) | 73,164 | USD 204,859-2.8% | USD 2.8-2.8% | |
| AVIR (Atea Pharmaceuticals Inc) | 61,401 | USD 194,6412.6% | USD 3.172.6% | |
| OABI (OmniAb Inc.) | 90,403 | USD 176,286-1.0% | USD 1.95-1.0% | |
| EDIT (Editas Medicine Inc) | 70,243 | USD 169,988-0.4% | USD 2.42-0.4% | |
| VYGR (Voyager Therapeutics Inc) | 37,686 | USD 161,296-1.6% | USD 4.28-1.6% | |
| ARCT (Arcturus Therapeutics Holdings Inc) | 20,875 | USD 148,8394.4% | USD 7.130014.4% | |
| HUMA (Humacyte Inc) | 119,180 | USD 146,591-5.4% | USD 1.23-5.4% | |
| MRSN (Mersana Therapeutics Inc) | 3,448 | USD 95,7681.1% | USD 27.77491.1% | |
| ALEC (Alector Inc) | 77,863 | USD 94,9930.8% | USD 1.220.8% | |
| FATE (Fate Therapeutics Inc) | 79,798 | USD 86,182-1.8% | USD 1.08-1.8% | |
| BMEA (Biomea Fusion Inc) | 50,791 | USD 61,9652.5% | USD 1.222.5% | |
| MGNX (MacroGenics Inc) | 45,204 | USD 61,929-0.7% | USD 1.36999-0.7% | |
| PLRX (Pliant Therapeutics Inc) | 42,599 | USD 51,545-7.6% | USD 1.21-7.6% | |
| STRO (Sutro Biopharma) | 5,560 | USD 48,150-7.7% | USD 8.66007-7.7% | |
| OKUR (OKUR) | 8,899 | USD 27,23116.4% | USD 3.0600116.4% | |
| THRD (Third Harmonic Bio Inc.) | 24,919 | USD 748 | USD 0.0300173 | |
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.